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I Zusammenfassung 
Proteine sind die zentralen Bausteine des Lebens. Um ihre Funktion 
erfüllen zu können, ist es von entscheidender Bedeutung, dass neu synthetisierte 
Polypeptidketten innerhalb kurzer Zeit in ihre einzigartige dreidimensionale 
Struktur falten. Obwohl die zur korrekten Faltung benötigte Information in der 
linearen Abfolge der Aminosäuren eines Proteins enthalten ist, benötigen 
Proteine zur Faltung unter zellulären Bedingungen die Unterstützung von so 
genannten „Helferproteinen“, bekannt als molekulare Chaperone. Diese Gruppe 
von Proteinen hat die Eigenschaft, dass sie an neu synthetisierte nicht-native 
Proteine bindet und dadurch unproduktive Nebenreaktionen verhindert, die 
andernfalls zu Fehlfaltung oder Aggregation führen würden. Bei der de novo 
Faltung von Proteinen im Zytosol sind vorrangig zwei Klassen von Chaperonen 
beteiligt: die Hsp70-artigen Chaperone und die Chaperonine. Die Hsp70-artigen 
Chaperone stabilisieren in erster Linie die naszenten Ketten bis eine komplette, 
zur Faltung fähige, Domäne am Ribosom synthetisiert wurde. Die 
tonnenförmigen Chaperonine hingegen stellen physikalisch definierte 
Faltungskompartimente bereit, in denen Proteine oder Proteindomänen, 
abgeschirmt von den aggregationsfördernden Bedingungen des Zytosols, falten 
können. Die Faltung von eukaryontischen Proteinen, die im Durchschnitt 
komplexer aufgebaut sind als ihre prokaryontischen Vertreter, verläuft in 
bakteriellen Expressionssystemen häufig ineffizient. Dieses Phänomen stellte in 
der Vergangenheit eine generelle Limitierung bei der Herstellung rekombinanter 
Proteine dar. 
In dieser Arbeit wurden mehrdomänige eukaryontische Proteine in 
zellfreien Translationssystemen synthetisiert, um den Einfluss einzelner 
Chaperone auf deren de novo Faltung zu untersuchen: Im Falle des 
eukaryontischen Enzyms Luziferase konnte gezeigt werden, dass dessen Faltung 
bei der Expression in einem Chaperon-dezimierten Escherichia coli-Lysat schnell 
und eng gekoppelt an die Translation erfolgt. Die Ausbeute an richtig gefaltetem 
Protein war allerdings sehr gering. Im Gegensatz dazu führte die Zugabe von 
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gereinigtem Triggerfaktor und DnaK/DnaJ/GrpE zum Lysat zu einer 
Ausbeutesteigerung an nativem Protein, wobei gleichzeitig die Faltung von 
Luziferase in Relation zur Translation erheblich verzögert wurde. Während das 
mehrdomänige bakterielle Protein β-Galaktosidase die endogene 
Chaperonmaschinerie optimal zu dessen Faltung nutzen kann (Agashe et al., 
2004), ist die ansonsten im eukaryontischen Zytosol beobachtete und sehr 
effektive co-translationale Domänenfaltung von Luziferase nicht mit dem 
prokaryontischen Chaperonsystem kompatibel. Das lässt darauf schließen, dass 
bei der Kopplung von Translation und Proteinfaltung in pro- und 
eukaryontischen Zellen grundlegende Unterschiede bestehen.  
Des Weiteren wurde das bakterielle Lysat, welches keine 
eukaryontischen Chaperone enthält, zur Bestimmung der Mindestanforderungen 
für die Faltung von neu synthetisiertem Aktin verwendet. Die in vitro Translation 
von Aktin in Anwesenheit verschiedener gereinigter Chaperone zeigte, dass 
einzig das eukaryontische Chaperonin TRiC für die de novo Faltung von Aktin 
ausreichend und absolut essentiell ist. Die native Konformation, des auf diese 
Weise produzierten Aktins, wurde durch dessen spezifische Bindung an DNase I 
und Aktinfilamentbildung nachgewiesen. Interessanter Weise erfolgte im 
TRiC-angereicherten Lysat die Aktinfaltung wesentlich langsamer als dies im 
eukaryontischen Zytosol der Fall ist. Lysate, die mit den bakteriellen Chaperonen 
GroEL/GroES bzw. DanK/DnaJ/GrpE ergänzt wurden, führten zwar zu 
größtenteils löslichem jedoch fehlgefaltetem Aktin. 
Zusätzlich konnte gezeigt werden, dass TRiC durch den partiellen 
Einschluss von Domänen großer modularer Proteine zu deren domänenweisen 
Faltung beiträgt. Diese Schlussfolgerung basiert auf der Beobachtung, dass bei 
der Expression von mehrdomänigen Aktinfusionsproteinen in vivo und in vitro 
diese entweder in das Aktin-Zytoskelett von Hefen integrieren bzw. einen 
stabilen Komplex mit DNase I formen. Der Mechanismus, mit dem TRiC die 
Faltung von mehrdomänigen Proteinen bewerkstelligt, könnte dabei dem 
kürzlich veröffentlichten endoproteolytischen Abbau von einzelnen 
Proteindomänen durch das Proteasom ähnlich sein (Liu et al., 2003). 
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II Summary 
Proteins are the central molecules of life. To become functionally active, 
newly synthesized polypeptide chains must fold into unique three-dimensional 
structures on a biologically relevant time scale. Although the information 
required for correct folding resides in the linear amino acid sequence of a protein, 
execution of the folding process under cellular conditions is critically dependent 
on the assistance of “helper proteins” termed molecular chaperones. This group 
of proteins shares the common function of binding to newly synthesized 
non-native proteins to prevent off-pathway reactions which otherwise would 
lead to misfolding and aggregation. Two major classes of chaperones, the Hsp70s 
and the chaperonins, have been implicated in de novo protein folding in the 
cytosol. While Hsp70s are primarily involved in stabilizing nascent chains until a 
complete domain has emerged from the ribosome and is competent for folding, 
the barrel-shaped chaperonins provide physically defined compartments inside 
which complete proteins or protein domains can fold unimpaired by 
aggregation. Proteins of eukaryotic origin which, on average, have a more 
complex architecture than their prokaryotic counterparts, often fold inefficiently 
upon expression in bacterial hosts. For many decades, this phenomenon placed 
great limitations on the recombinant production of proteins.  
In the present study, eukaryotic multi-domain proteins were 
synthesized in cell-free translation systems in order to investigate the 
contribution of individual chaperones to their de novo folding: Upon expression 
under chaperone-depleted conditions in an Escherichia coli based lysate, the 
modular eukaryotic protein firefly luciferase was demonstrated to fold by a rapid 
default-pathway, tightly coupled to translation. However, only a minor fraction 
of the translated protein chains folded correctly. In contrast, supplementation of 
the lysate with purified trigger factor and DnaK/DnaJ/GrpE increased the 
amount of native protein, but markedly delayed firefly luciferase folding relative 
to translation. Interestingly, while the bacterial multi-domain protein 
β-galactosidase uses the endogenous chaperone machinery effectively (Agashe et 
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al., 2004), the efficient co-translational domain folding of firefly luciferase 
observed in eukaryotes is not compatible with the prokaryotic chaperone system. 
Thus, important differences between bacterial and eukaryotic cells seem to exist 
in the coupling of translation and folding. 
Moreover, the bacterial lysate which did not contain any eukaryotic 
chaperones was further utilized to determine the minimum requirements for the 
folding of newly synthesized actin. By conducting in vitro translation reactions in 
the presence of purified components, the chaperonin TRiC was found to be the 
only eukaryotic chaperone absolutely necessary and sufficient for de novo actin 
folding. The actin thus produced bound DNase I and polymerized into filaments, 
hallmarks of its native state. Lysate supplementation with the bacterial 
chaperonin GroEL/GroES or the DnaK/DnaJ/GrpE chaperones led to mostly 
soluble actin, yet failed to facilitate its correct folding. Notably, actin folding in 
the TRiC-supplemented bacterial lysate occurred with slower kinetics when 
compared to the eukaryotic cytosol. 
Additionally, TRiC was demonstrated to be capable of mediating the 
domain-wise folding of modular proteins by their partial encapsulation in the 
chaperonin cavity. This was based on the fact that upon expression of actin 
multi-domain fusion proteins both in vivo and in vitro, the proteins properly 
integrated into yeast cytoskeleton structures as well as formed stable complexes 
with DNase I. The mechanism of how TRiC might promote the folding of 
individual protein domains is thereby reminiscent of the domain-wise 
endoproteolytical degradation of proteins by the proteasome, as reported 
recently (Liu et al., 2003). 
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1 Introduction 
Proteins are very diverse biomolecules and play crucial roles in virtually 
all biological processes. They are built from a repertoire of 20 different amino 
acids which are linked to each other by peptide bonds in order to form chains of 
various lengths. Proteins constitute the majority of the dry mass of a cell and 
fulfill a remarkable number of biological functions. Some proteins act as enzymes 
and are responsible for catalyzing thousands of chemical reactions involved in 
metabolism. Others provide structural building blocks or serve as transport and 
storage devices. Proteins are also involved in the control of cell division, 
differentiation of cells, their coordinated motion and the delivery of information 
between them. 
1.1 From DNA to protein 
1.1.1 Protein synthesis and structure 
Inside the cell, the information for the synthesis of individual proteins is 
encoded in genes as part of double-stranded DNA. Prior to synthesis, the gene is 
transcribed into a linear single-stranded messenger RNA (mRNA), and in the 
case of eukaryotic cells, exported from the nucleus into the cytosol. There, 
ribosomes, large ribonucleotide complexes, translate the mRNA into its amino 
acid sequences in a vectorial manner. The newly synthesized polypeptide chain 
exits these complexes through the ribosomal exit tunnel and generally adopts its 
unique three-dimensional structure during and upon release. The process in 
which the linear sequence of amino acids is converted into a three-dimensional 
structure is called protein folding. 
Amino acids consist of an amino group, a carboxyl group, a hydrogen 
atom, and a variable side chain, all of which are bonded to the central alpha 
carbon atom (Cα). Twenty kinds of side chains varying in size, charge, shape, 
hydrogen-bonding capacity, and chemical reactivity are commonly found in 
naturally occurring proteins. The α-carboxyl group of one amino acid is joined to 
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the α-amino group of another amino acid by a peptide-bond, forming a stable 
linear and unbranched backbone structure (Figure 1). By convention, the amino 
end is referred to as the beginning of a polypeptide chain. 
The structure of proteins is typically described in terms of four 
hierarchical levels of organization: The linear arrangement of amino acids 
constituting the polypeptide chain is called the primary structure. The secondary 
structure refers to the localized organization of parts of a polypeptide chain due 
to the formation of stabilizing hydrogen bonds between certain residues. As a 
consequence, the backbone folds periodically into one of two geometric 
arrangements: an α-helix, which is a spiral rodlike structure, or a β-sheet, a 
planar structure consisting of alignments of two or more β-strands, which are 
generally short and fully extended segments of the backbone. The tertiary 
structure of a protein describes the overall conformation of a polypeptide chain, 
that is, the three-dimensional arrangement of all the amino acids organized in 
secondary structural elements. The stability of the tertiary structures is mostly 
attained by hydrophobic interactions between nonpolar side chains and, in some 
proteins, disulfide bonds. For proteins consisting of only a single polypeptide 
chain, tertiary structures are the highest level of organization. The final 
association of multiple polypeptide chains resulting in an active and functional 
unit is referred to as quaternary structure, mainly stabilized by all types of 
noncovalent interactions between the subunits. 
1.1.2 The protein folding problem 
In order to fulfill their biological functions, proteins have to acquire a 
specific and unique three-dimensional structure, the so called “native state”. All 
the information necessary to reach this energetically favored and most stable 
folded conformation of a protein is contained in its amino acid sequence, as 
shown by pioneering experiments of Christian Anfinsen (Anfinsen, 1973). He 
demonstrated that correct refolding of fully denatured ribonuclease into its 
native and enzymatically active conformation occurs spontaneously and without 
any further assistance in free solution. Even more striking was the observation 
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that this refolding process can take place on a biologically relevant time scale 
(Schechter et al., 1970). 
 
 
 
Figure 1: Individual amino acids in a protein are linked by peptide bonds. 
 
Each amino acid has the same fundamental structure, differing only in the side chain, 
designated the R-group (R). The carbon atom to which the amino-, carboxyl-, and 
R-groups are attached is called the alpha carbon (Cα). Individual amino acids are linked 
by peptide bonds which are planar (blue shading) and do not allow rotation. Rotation 
within the polypeptide is only possible around the N-Cα and Cα-C bonds – their angles 
are described as psi (Ψ) and phi (Φ), respectively. 
 
While the structures of amino acids are relatively simple and similar to 
one another, three-dimensional conformations of proteins are exceedingly 
complex. Theoretically, proteins have an incomparably high number of possible 
conformations due to the nearly free rotation around the bond connecting the Cα 
and the carboxyl carbon and the bond between the Cα and the amino group in 
their peptide backbone (Figure 1). The angles of these rotations are defined as the 
dihedral angles Ψ (psi) and Φ (phi). The peptide bond itself is planar, resulting 
from the partial double bond character, caused by the resonance of electrons 
rapidly moving between the oxygen and the nitrogen. Furthermore, steric 
repulsions between amino acid side chains are responsible for the exclusion of 
most of the theoretically existing Ψ and Φ pairs. In 1968, Ramachandran 
calculated the energy contained in various pairs of Ψ and Φ angles and found the 
two most stable pairs, termed the α and the β conformation (Ramachandran and 
Sasisekharan, 1968). These two pairs of angles are found to occur almost 
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exclusively in folded proteins, including the most prominent examples of 
secondary structure: α-helices and β-strands. 
In order to get an idea of how long it would take a protein to reach its 
lowest-energy conformation through random folding, Levinthal computed the 
number of all theoretically possible conformations of a polypeptide containing 
150 amino acids (Levinthal, 1969). The result for this particular protein was ~10300 
possible conformations. Even if one assumes that each amino acid populates only 
the two lowest energy regions Ψ and Φ in the Ramachandran plot, there are still 
~1030 main-chain conformations for a small protein with 100 residues. Based on 
the physical speed limit of ~1011 s-1 possible interconversions between main-chain 
conformations, it would take about 1011 years (longer than the lifetime of the 
universe!) to populate the full number of potential conformers (Dinner et al., 
2000). This so called “Levinthal paradox” led to the conclusion that a protein 
cannot sample all the possible conformations during the process of folding. 
Rather, “folding is speeded and guided by the rapid formation of local 
interactions which then determine the further folding of the peptide. This 
suggests local amino acid sequences which form stable interactions and serve as 
nucleation points in the folding process”(Levinthal, 1969). 
1.1.3 Protein folding mechanisms 
As protein folding through random, unbiased adoption of all possible 
conformations would take “an eternity”, it was a logical step to assume that there 
must be defined pathways to reduce the choices in folding. The search for a 
single, general mechanism of protein folding led to various proposals, all of 
which simplified the folding process by uncoupling the formation of secondary 
structure from that of tertiary structure (Daggett and Fersht, 2003).  
The classical “nucleation-growth” mechanism (Wetlaufer, 1973) 
postulated that initially some neighboring amino acids form stable secondary 
structures, acting as nuclei from which native tertiary structure propagates in a 
stepwise manner. However, nucleation dropped from favor as it predicts the 
absence of folding intermediates, although the field of protein folding was 
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dominated by the study of folding intermediates at that time (Kim and Baldwin, 
1982; Ptitsyn, 1987). 
 Therefore, alternative models became more attractive: one was the 
“framework” model (Ptitsyn and Rashin, 1975; Kim and Baldwin, 1982; Kim and 
Baldwin, 1990) together with the closely related “diffusion-collision” model 
(Karplus and Weaver, 1976). This model predicts that local elements of native 
secondary structure form independently and then diffuse until they collide, 
successfully adhere, and coalesce to result in the final native tertiary structure. 
The second model, the “hydrophobic collapse” model (Schellman, 1955; 
Kauzmann, 1959; Tanford, 1962; Baldwin, 1989), hypothesized that a protein 
rapidly collapses around its hydrophobic side chains so that folding can occur in 
a confined volume, thereby reducing the number of possible conformations 
during the process of folding to the native sate.  
In the early 1990s, proteins were observed which folded by simple 
two-state kinetics without the formation of detectable intermediate structures 
(Jackson and Fersht, 1991). Others formed secondary and tertiary structure in 
parallel as they undergo hydrophobic collapse (Otzen et al., 1994). These findings 
led to the formulation of the “nucleation-condensation” mechanism (Fersht, 
1997) which unites features of both the “hydrophobic collapse” and the 
“framework” mechanism.  
Nowadays, the synergy of experimental data and protein folding 
simulations by molecular dynamics computations are beginning to describe 
folding and unfolding pathways at atomic-level resolution (Mayor et al., 2000; 
Fersht and Daggett, 2002; Vendruscolo and Dobson, 2005). Despite the 
tremendous progress within the last decade, these kinds of simulations are still 
limited to very small proteins and are not yet applicable to the large majority of 
proteins in the cell. 
1.1.4 Protein folding energy landscapes  
The “classical view” of protein folding along folding pathways has 
recently been replaced by the “new view” (Baldwin, 1995), the so-called “folding 
funnel” or “energy landscape” theory (Baldwin, 1995; Dill and Chan, 1997; 
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Dobson et al., 1998; Onuchic and Wolynes, 2004). Here, protein folding is 
described as a process of reaching a global minimum in free energy (satisfying 
Anfinsen’s thermodynamic hypothesis) and doing so quickly (satisfying 
Levinthal’s kinetic theory) by multiple down-hill routes on funnel-like energy 
landscapes (Figure 2).  
 
 
 
Figure 2: Energy landscape of a folding funnel. 
 
Protein folding proceeds from an unfolded state of high energy towards a unique three-
dimensional native structure where the energy level is lowest. In general, several folding 
pathways down the rugged energy landscape are possible. For instance, the red 
trajectory illustrates a fast track of folding whereas the yellow trajectory illustrates a slow 
track of folding in which a kinetically stable intermediate is populated, slowing down the 
folding process. Adapted from Dill and Chan (1997). 
 
The distinction between a pathway and a funnel is that the former describes a 
one-dimensional route through the space of all configurations possible, whereas 
the latter delineates folding as a progressive reduction in dimensionality of the 
accessible conformational space, beginning from the many degrees of freedom 
available to denatured chains, down to the almost a complete lack of freedom of 
the native protein (Dill and Chan, 1997). Thus, in the funnel theory, folding can 
occur either on a sub-second timescale by reducing all potential conformations to 
a subset of thermodynamically favored local minima (Schultz, 2000) or undergo a 
slow trajectory through many unproductive transition states in a more or less 
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rugged energy landscape (Bryngelson et al., 1995; Onuchic et al., 1995; Wolynes 
et al., 1995). Kinetic traps arising close to the bottom of the folding funnel 
correspond to the accumulation of misfolded proteins. Despite the information 
gained from these models addressing some principles of folding kinetics, they 
are not yet recipes for predicting the defined three-dimensional structure from a 
given amino acid sequence (Dill and Chan, 1997). 
1.1.5 Differences in protein folding in vitro and in vivo 
The process of protein folding in vitro has been studied extensively over 
the last few decades in order to gain insights in how proteins fold inside living 
cells. Most of the initial in vitro refolding experiments utilized small, single-
domain proteins that undergo cooperative and reversible folding reactions, since 
multi-domain proteins often refold very inefficiently due to aggregation. To 
investigate protein refolding, purified proteins are in general first unfolded in 
denaturants like guanidinium-hydrochlorid (6 M) or urea (8 M) and then rapidly 
diluted into aqueous solutions where refolding to the native state is allowed to 
occur spontaneously. In order to avoid protein aggregation during refolding, the 
experiments are usually performed in simple buffer systems and under 
optimized conditions (very low protein concentrations as well as optimal pH, 
salt, and temperature).  
Compared to in vitro protein refolding under idealized conditions, 
folding inside the cell is much more complex. Here, protein folding must be 
achieved in a highly crowded and dynamic environment that favors protein 
misfolding and aggregation (Figure 3). The total concentration of proteins and 
RNA in the cytosol of an Escherichia coli (E. coli) cell has been estimated to be in 
the range of 300-400 mg/ml (Zimmerman and Trach, 1991). Thus, a significant 
proportion of the cellular volume is already physically occupied by the large 
amount of mutually impenetrable macromolecules and is therefore inaccessible 
for other molecules. This phenomenon, designated as “excluded volume effect” 
or “macromolecular crowding” (Ellis, 2001; Minton, 2001), is also responsible for 
significant increases in the affinities and rate constants of many cellular reactions 
by several orders of magnitude. Thus, macromolecular crowding can result, 
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among other effects, in an increased propensity of folding protein molecules to 
aggregate (Zimmerman and Minton, 1993; Ellis and Hartl, 1996; Minton, 2000).  
 
 
 
Figure 3: Folding states accessible to a protein after synthesis on the ribosome. 
 
Upon synthesis on the ribosome, proteins are assumed to fold from a largely disordered 
unfolded state through a partially structured intermediate into their final globular native 
conformation. Native proteins can act as monomers, oligomers or assemble into highly 
ordered fibres and crystals, whilst preserving their overall structure. Instead, unfolded and 
partially folded proteins mostly form aggregated species that are frequently disordered. 
Exceptions are the so-called amyloid fibrils, which are thought to form through a 
nucleation growth mechanism, utilizing partially folded soluble precursor proteins as 
seeds. Adapted from Vendruscolo and Dobson (2005). 
 
Another major difference between protein refolding out of denaturant 
and folding in vivo is that in the cell folding is tightly coupled to the vectorial 
synthesis of polypeptide chains (N-terminus to C-terminus) on the ribosome. 
Thus, the folding information encoded in the amino acid sequence becomes 
available sequentially and not all at once, as is the case during in vitro refolding. 
Since stable folding requires the presence of at least a complete protein domain of 
~100-300 residues, nascent chains remain unfolded until the entire sequence of 
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such a folding competent unit has been synthesized and emerged from the 
ribosomal exit tunnel (Jaenicke, 1991). In eukaryotes, the rate of chain elongation 
was estimated to be approximately 4 amino acids per second (Thulasiraman et 
al., 1999). Hence, the synthesis of a complete domain takes more than a minute. 
During this time, nascent chains expose hydrophobic amino acid residues and 
segments of unstructured polypeptide backbone which are normally buried in 
the interior of a native protein and are thus susceptible to aggregation.  This 
propensity to aggregate is thought to be greatly increased by the high local 
concentration of identical nascent chains synthesized on neighboring ribosomes 
in a polysome (Ellis and Hartl, 1996). In order to minimize off-pathway reactions 
during de novo protein folding, nascent chains either have to fold 
co-translationally or need to be stabilized in a nonaggregated, folding-competent 
conformation until post-translational folding of a complete chain is possible 
(Netzer and Hartl, 1998). 
1.1.6 Protein misfolding and diseases  
Protein folding and unfolding belong to the most important mechanisms 
to generate and abolish cellular activities. Given the enormous complexity of the 
protein folding process, as described above, it is not surprising that the failure to 
fold correctly, or to remain correctly folded, will inevitably lead to 
malfunctioning in living systems and therefore to diseases (Thomas et al., 1995). 
The so-called “protein misfolding diseases” include pathological states in which 
impairment in the folding of a certain protein is accompanied by a reduction in 
the available amount of native protein normally necessary to fulfill its proper 
function. This reduction can, among other effects, result from an increased 
probability for misfolded proteins to be degraded by the quality control system 
of the endoplasmatic reticulum, as it is the case in cystic fibrosis (Amaral, 2004), 
or the improper trafficking of a protein to the site where it is needed, as it occurs 
in early-onset emphysema (Lomas and Carrell, 2002). The largest group of 
misfolding diseases, however, is associated with the conversion of proteins or 
protein fragments from their normally soluble form into insoluble, highly 
organized amyloid fibrils or plaques (Chiti and Dobson, 2006) (Figure 3). 
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Depending on the disease involved, such deposits can accumulate in a variety of 
organs including liver, spleen and brain (Dobson, 1999). The quantity of these 
aggregates can thereby range between an almost undetectable level and several 
grams to kilograms in certain manifestations of systemic amyloidosis. In recent 
years, most attention has been focused on the group of neurodegenerative 
diseases, associated with the formation of brain lesions, including Alzheimer’s 
disease, Parkinson’s disease, the polyglutamine-expansion diseases such as 
Huntington’s disease, as well as the prion diseases such as Creutzfeldt-Jakob 
disease (Barral et al., 2004). Interestingly, despite the native forms of the proteins 
involved in the respective diseases being quite different (they range from 
globular proteins to mostly unstructured polypeptides), the fibrils in which they 
appear in the disease state have many similar characteristics (Sunde and Blake, 
1997). For instance, all the fibrillar structures have very similar morphologies 
(long and unbranched), as evidenced by electron microscopy, and show a 
characteristic “cross-β” X-ray diffraction pattern. Furthermore, they all show 
specific optical properties on binding of special dye molecules, like Congo red, 
which have been utilized in diagnostics for more than a century (Dobson, 2004). 
In addition to the misfolding diseases described above, large-scale 
genome sequencing projects revealed mutations being responsible for a variety of 
inherited human diseases, such as McKusick-Kaufman Syndrome (MKKS) and 
Bardet-Biedel type 6 Syndrome (BBS6) (Slavotinek et al., 2000; Stone et al., 2000). 
Interestingly, a detailed analysis of the open reading frames harboring these 
mutations discovered heat shock proteins or proteins with similarities to this 
class of proteins which assist other proteins in folding, the so called molecular 
chaperones (Barral et al., 2004). Furthermore, these findings indicate that defects 
in the folding machinery can be directly associated with a variety of severe 
human diseases. 
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1.2 Molecular Chaperones 
Over the past 15 years, intense research efforts have demonstrated that 
efficient folding of newly synthesized proteins necessitates a complex cellular 
machinery of molecular chaperones (Ellis and Hemmingsen, 1989; Gething and 
Sambrook, 1992; Buchner, 1996; Hartl, 1996; Ellis and Hartl, 1999; Frydman, 2001; 
Hartl and Hayer-Hartl, 2002). The term “molecular chaperone” was originally 
coined to describe the specialized function of nucleoplasmin, a nuclear protein 
that promotes chromatin assembly by preventing improper interactions between 
histones and DNA (Laskey et al., 1978). This specific usage of the term was later 
generalized by John Ellis (Ellis, 1987). 
A key property, common to all chaperones, is their mediation of folding 
by minimizing improper interactions within and between molecules. To fulfill 
this function, molecular chaperones transiently bind to structural elements of 
non-native polypeptide chains, such as exposed hydrophobic residues and 
unstructured backbone regions, which are normally buried inside the globular 
structure of native proteins. Binding and release of substrate polypeptides by 
chaperones is often regulated in a complex ATP-dependent manner and may 
occur several times until folding is completed. Importantly, chaperones 
contribute neither steric information to the folding process nor are they part of 
the final native structure of the folded protein (Agashe and Hartl, 2000). 
Furthermore, chaperones do not catalyze or accelerate folding reactions in a 
classical sense, but rather increase the number of molecules that are on a 
productive folding pathway. Instead, real folding catalysts are peptidyl-prolyl 
cis-trans isomerases (PPIases) and protein disulfide isomerases (PDIs), which 
specifically catalyze rate-limiting steps in the folding process, such as the 
isomerization of peptide bonds preceding prolyl residues (Schmid et al., 1993) 
and the rearrangement of disulfide bonds (Freedman et al., 1994), respectively. 
Molecular chaperones are distributed ubiquitously across the 
boundaries of all three kingdoms of life and can fulfill their functions inside 
living cells over a wide temperature range. Although constitutively expressed 
under normal growth conditions, many chaperones are greatly upregulated upon 
Introduction   12                                  
exposure to elevated temperatures or other conditions of stress, such as 
starvation and exposure to toxins (Lindquist, 1986; Lindquist and Craig, 1988; 
Morimoto, 1998). Therefore, molecular chaperones are also referred to as “stress 
proteins” or “heat shock proteins” (Hsp).  At present, more than 25 different 
protein families are described as molecular chaperones, but not all of them are 
stress proteins. The most prominent chaperones belong to five sequence-related 
families and were initially classified according to their sequences and apparent 
molecular masses (in kDa): Hsp60, Hsp70, Hsp90, Hsp100 and the small heat 
shock proteins (sHsp). 
In addition to protein folding and refolding, molecular chaperones are 
also involved in many other cellular processes, such as protein degradation, 
targeting and signal transduction (Hartl, 1996; Ellis and Hart, 2000). 
1.2.1 Pathways of chaperone mediated protein folding in the cytosol  
In living cells, a multitude of molecular chaperones is required to 
mediate the correct folding of newly synthesized proteins into their unique three-
dimensional structures. In order to fulfill this challenging task, chaperones are 
thought to be organized in complex chaperone networks (Figure 4). Although 
individual differences in de novo protein folding exist, the essential principles of 
these networks are conserved among eubacteria and eukarya. Chaperones 
initially interact with nascent chains during their biogenesis and the 
polypeptides are then conveyed between functionally cooperating chaperones 
that complete their folding to the native sate (Young et al., 2004). 
Cytosolic protein folding generally starts with the interaction of nascent 
chains emerging at the peptide exit tunnel with ribosome-associated factors: 
these are trigger factor (TF; 1.2.2) in prokaryotes and the nascent chain-associated 
complex (NAC) in eukaryotes. Notably, some eukaryotes like Saccharomyces 
cerevisiae (S. cerevisiae) feature an additional ribosome associated complex, called 
RAC (ribosome-associated complex), which consists of Ssz (a member of the 
Hsp70 family) and zuotin (a Hsp40 homolog). All these factors, although 
structurally unrelated, are associated with the large ribosomal subunit and are 
believed to guide proteins to their correct folding pathway.  
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Upon completion of translation and release from this first set of 
ribosome-bound factors, the majority (>60% of total) of small proteins are 
thought to fold rapidly and without further assistance. Longer polypeptide 
chains (~10-20% of total) subsequently interact with a second class of nascent 
chain-binding chaperones, the classical Hsp70 proteins (1.2.3). These chaperones, 
not associated with the ribosome themselves, bind to short hydrophobic 
sequences of nascent chains thereby preventing their aggregation during 
elongation. Moreover, Hsp70 proteins together with their respective 
co-chaperones of the Hsp40 family are able to assist in both co-translational 
folding, while the nascent chain is still associated with the ribosome, and 
post-translational folding, once the protein is released.  
 
 
 
Figure 4: Models for chaperone-assisted folding of newly synthesized proteins in 
the cytosol of eubacteria and eukarya. 
 
N: native protein, TF: trigger factor, NAC: nascent-chain associated complex, PFD: 
prefoldin, DnaK/DnaJ: Hsp70/Hsp40 chaperone system in the bacterial cytosol, 
GroEL/GroES: bacterial chaperonin, TRiC: eukaryotic chaperonin. Detailed information is 
provided in the text. Adapted from Hartl and Hayer-Hartl (2002). 
 
Introduction   14                                  
Furthermore, a fraction of slow-folding and aggregation-sensitive proteins 
(~10-15% of total) require transfer to a protected folding environment provided 
by the central cavity of the multimeric chaperonins bacterial GroEL or the 
eukaryotic TRiC (1.2.4 and 1.3). Notably, TRiC mediated protein folding in the 
eukaryotic cytosol is facilitated in close cooperation with an additional factor, 
termed prefoldin (PFD), which directly binds to nascent chains and does not exist 
in bacteria. 
Finally, the correct folding of another, diverse subset of eukaryotic 
polypeptides (including transcription factors and regulatory kinases) strongly 
depends on the successive transfer from the Hsp70/40 system to chaperones of 
the Hsp90 family. Folding of these proteins is performed in a cooperative process 
between both chaperone systems, regulated by several cofactors. 
Despite the fact that proteins fold quite efficiently along individual 
folding pathways in bacteria and eukaryotes, the predominant folding 
mechanism for complex multi-domain proteins in both cytosols appear to be 
fundamentally different. Whereas folding of these proteins in bacteria occurs 
mostly post-translationally, folding of similar complex polypeptides in 
eukaryotes is generally facilitated in a co-translational manner.  Although it was 
proposed that the shift from a post-translational to a co-translational folding 
mechanism must have occurred during evolution (the so called “folding shift 
hypothesis”; Netzer and Hartl, 1997), it is not yet clear, whether the ability to 
support co-translational folding has been lost (or reduced) by prokaryotes or 
acquired by eukaryotes. 
Thus, the reduced efficiency of co-translational folding in prokaryotes 
might be a valid explanation for the low abundance of multi-domain proteins in 
these organisms (~13% of total compared to ~38% in eukaryotes; Netzer and 
Hartl, 1998), and why modular proteins of eukaryotic origin tend to misfold and 
form inclusion bodies upon expression in bacterial hosts (Marston, 1986; Baneyx, 
1999). 
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1.2.2 Trigger factor: a ribosome-associated chaperone 
Trigger factor (TF), initially discovered as an E. coli protein facilitating 
protein export into the periplasmic space (Crooke and Wickner, 1987), is now 
known to be one of the first bacterial chaperone to meet nascent chains as they 
emerge from the ribosome exit tunnel (Valent et al., 1995; Hesterkamp et al., 1996; 
Scholz et al., 1997; Valent et al., 1997). 
1.2.2.1 TF structure and localization at the ribosome 
E. coli TF (the tig gene product) is a 48 kDa protein composed of three 
individual domains (Figure 5A, bottom): The N-terminal ribosome-binding 
domain, containing the highly conserved and essential ribosome binding 
signature GFRxGxxP (aa 43-50), is exclusively responsible for the specific binding 
of TF to the ribosomal proteins L23 and L29 located in close proximity to the 
polypeptide exit tunnel (Hesterkamp et al., 1997; Kramer et al., 2002). 
Importantly, TF binding to the ribosome has been shown to be essential for its 
interaction with nascent chains and is markedly reduced upon mutation of its 
ribosome binding signature motif (Kramer et al., 2002). The second domain in 
sequence exhibits a catalytic activity as a peptidyl-prolyl cis/trans isomerase 
(PPIase). Its contribution to de novo protein folding still remains unclear, since it 
is not essential for TF function in vivo (Genevaux et al., 2004; Kramer et al., 
2004a). The C-terminal domain, comprising virtually half of the TF molecule, 
displays no sequence homology to any other protein (Hesterkamp and Bukau, 
1996). Recent studies using a photo-crosslinking approach demonstrated this 
domain to be directly involved in substrate binding (Lakshmipathy et al., 2007). 
Furthermore, deletion of the C-terminal domain drastically reduced the 
chaperone activity of TF in vitro and in vivo (Kramer et al., 2004b; Merz et al., 
2006).  
In 2004, Ferbitz et al. solved the crystal structure of E. coli TF, as well as 
the ribosome binding domain of TF in complex with ribosomes of archaeal origin 
(Ferbitz et al., 2004). As depicted in Figure 5A (top panel), TF adopts a fairly 
elongated structure which was proposed to resemble the shape of a “crouching 
dragon”. Thereby, the “tail” is formed by the N-terminal ribosome binding 
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domain, whereas the PPIase domain constitutes the “head”. The C-terminal 
domain is positioned in the middle of the three-dimensional structure, forming 
two “arms” and the back of the molecule. The result of this crescent TF structure 
is a large cavity, located between the tail and the arms of the protein. This 
so-called “cradle” is highly enriched in hydrophobic side chains and therefore 
supposedly the contact region for emerging nascent chains from the ribosome. 
 
 
 
Figure 5: Structure of E. coli TF. 
 
(A) Top: ribbon diagram of the extended TF structure. Bottom: domain arrangement 
comprising the N-terminal ribosome-binding domain (Tail), the central PPIase domain 
(Head) and the C-terminal domain (Arm1 and Arm2). Domain borders and the ribosome-
binding signature (residues 43-50) are indicated. (B) Model of full-length TF bound to the 
large ribosomal subunit of Haloarcula marismortui shown as slice along the peptide exit 
tunnel containing a modeled nascent chain (magenta), extruding from the peptidyl 
transferase center (PT). In all parts, the ribosome-binding “tail” is shown in red, the 
PPIase “head” in yellow and “arm1” and “arm2” in green and blue, respectively. Adapted 
from Ferbitz et al. (2004). 
 
A model of full-length TF bound to the L23 protein of an archaeal ribosome 
suggests TF to hunch over the polypeptide exit of the ribosome, exposing the 
hydrophobic inner surface of the cradle towards the area where the nascent chain 
exits the ribosome (Figure 5B). A similar orientation was shown for the 
N-terminal domain of Deinococcus radiodurans TF in complex with its cognate 50S 
subunit (Baram et al., 2005; Schlunzen et al., 2005). Interestingly, recent protease 
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protection studies utilizing model proteins such as firefly luciferase reported the 
cradle to form a shielded folding environment for nascent chains at the ribosome 
(Hoffmann et al., 2006; Tomic et al., 2006). 
1.2.2.2 Role of TF in protein folding 
The formation of a 1:1 complex between TF and vacant ribosomes is a 
prerequisite for its interaction with nascent chains emerging from the 
polypeptide exit tunnel (Kramer et al., 2002; Patzelt et al., 2002; Maier et al., 
2003). Since TF function is ATP-independent, the chaperone does not actively 
assist protein folding through regulated cycles of substrate binding and release. 
Instead, TF was for a long time thought to mainly bind to short nascent chains 
(Valent et al., 1995; Hesterkamp et al., 1996), mediated by sequences enriched in 
hydrophobic amino acids (Patzelt et al., 2001), in order to prevent early 
aggregation events. Recently, TF interactions were also reported for longer 
nascent chains (Hoffmann et al., 2006; Tomic et al., 2006). Additionally, Kasier 
et al. demonstrated that TF interaction with ribosomes and newly synthesized 
polypeptide chains occurs in a dynamic reaction cycle which involves all three 
functional domains of the chaperone (Kaiser et al., 2006). Upon release from TF, 
active folding of newly synthesized proteins can then be facilitated by the 
ATP-driven chaperones, located further downstream in the folding pathway. So 
far, a role of TF in post-translational folding has not yet been shown, but would 
be consistent with the observation that only approximately half the TF molecules 
are ribosome associated (Bukau et al., 2000) and that TF is able to bind unfolded 
proteins in vitro (Scholz et al., 1997). 
TF and DnaK (the main bacterial Hsp70 system) have been shown to 
have overlapping chaperone function in stabilizing nascent chains in a state 
competent for subsequent folding (Deuerling et al., 1999; Teter et al., 1999). 
Although not physically tethered to the ribosomes itself, DnaK is known to bind 
nascent chains during translation while these are still attached to the ribosome 
(Teter et al., 1999). In E. coli cells lacking TF (∆tig), DnaK can function as an 
effective substitute in chaperoning nascent chains during translation, reflected in 
an increased amount of this particular chaperone being transiently associated 
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with ribosome bound nascent chains. Furthermore, the simultaneous deletion of 
the genes encoding for TF and DnaK severely diminishes the viability of E. coli 
cells at temperatures above 30 °C and results in the accumulation of misfolded 
and aggregated proteins, including a number of large multi-domain proteins 
(Deuerling et al., 1999; Teter et al., 1999; Genevaux et al., 2004). Interestingly, 
recent results have demonstrated that some bacterial cells can cope with this loss 
of viability by the accumulation of suppressor mutations, when first grown at 
20 °C and gradually adapted to higher temperatures (Genevaux et al., 2004; 
Vorderwulbecke et al., 2004). Moreover, the growth defect can also be 
complemented by overproduction of SecB (a chaperone involved in protein 
translocation) and GroEL/GroES, utilized as backup system for TF and DnaK 
(Ullers et al., 2004; Vorderwulbecke et al., 2004). 
1.2.3 The Hsp70 chaperone system 
The members of the Hsp70 family are highly conserved ATPases found 
in the cytosol of prokaryotes, eukaryotes and some archaea, as well as within 
most eukaryotic organelles (Craig et al., 1993; Hartl, 1996; Hartl and Hayer-Hartl, 
2002). Hsp70s act on their substrates by a mechanism of binding and release, 
usually in a cofactor dependent manner, and play an essential role in a variety of 
cellular processes under both stress- and non-stress conditions. Among those, 
assisting in de novo protein folding and the prevention of aggregation are 
probably the most important ones. Additionally, they are also involved in protein 
targeting and membrane translocation, the dissociation of large aggregates, and 
protein degradation (Hartl, 1996; Bukau and Horwich, 1998).  
1.2.3.1 Hsp70 structure and reaction cycle 
Hsp70 chaperones typically consist of two major functional domains, a 
highly conserved N-terminal ATPase domain (44 kDa) and a less conserved 
C-terminal peptide binding domain (25 kDa). In the case of DnaK, crystal 
structures of both individual domains, but not of the entire molecule have been 
determined (Zhu et al., 1996; Harrison et al., 1997). Interestingly, the ATPase 
domain turned out to have a fold similar to that of monomeric actin, consisting of 
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two structural lobes with a deep nucleotide-binding cleft between them (Flaherty 
et al., 1991). The peptide binding domain is divided into a β-sandwich 
subdomain, comprising the peptide-binding cleft, and an α-helical extension that 
functions as a lid for substrate enclosure (Zhu et al., 1996). 
The ATP-regulated cycle of substrate binding and release is best 
understood for the bacterial DnaK, its Hsp40 co-chaperone DnaJ, and the 
nucleotide exchange factor GrpE (Bukau and Horwich, 1998; Naylor and Hartl, 
2001). During this cycle, DnaK alternates between two different structural states, 
dependent on the phosphorylation state of the nucleotide bound (Figure 6). 
 
 
 
Figure 6: Chaperone cycle of the bacterial Hsp70 chaperone system DnaK, DnaJ 
and GrpE. 
 
The cycle starts with the association of non-native substrate proteins with either DnaJ (J) 
(1a) or DnaK (K) in the ATP-bound open conformation (1b). DnaJ and substrate protein 
(2) then stimulate the ATP-hydrolysis of DnaK (3), resulting in the closure of its substrate 
binding pocket. The interaction of GrpE (E) with DnaK (4) efficiently promotes the 
exchange of bound ADP (5) for ATP (6). This results in the opening of the substrate 
binding cleft and the exchange of substrate proteins (7). The released protein can then 
either fold towards the native state (8) or rebind to DnaJ (9) or DnaK (1b). Adapted from 
Naylor and Hartl (2001). 
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In the ATP-bound state, the lid over the peptide-binding cleft is in an open 
conformation and substrate binding and release is allowed to occur rapidly. In 
the ADP-bound form, the binding pocket is closed and substrates are bound with 
high affinity. Cycling of DnaK between its different nucleotide-bound states is 
regulated by the cofactors DnaJ and GrpE (Szabo et al., 1994). Upon substrate 
binding of DnaK in the ATP-bound state, interaction with DnaJ stimulates the 
ATPase activity of DnaK, thus facilitating tight peptide capture (Mayer et al., 
2000). Importantly, DnaJ is itself a chaperone which can bind unfolded 
polypeptides and subsequently present them to the ATP-bound state of DnaK 
(Langer et al., 1992a; Rudiger et al., 2001). Substrate release from DnaK requires 
the exchange of bound ADP for ATP, catalyzed by the nucleotide exchange factor 
GrpE (Harrison et al., 1997). Furthermore, rebinding of ATP not only dissociates 
the DnaK:substrate complex but also resets DnaK to its initial low substrate 
affinity state completing the reaction cycle. 
Although the bacterial and eukaryotic Hsp70 systems have similar 
functional properties (Figure 4), a GrpE-like nucleotide exchange factor homolog 
is absent in the eukaryotic cytosol. Such a factor may be dispensable as the rate-
limiting step in the ATPase cycle of eukaryotic Hsp70 is normally not the 
dissociation of ADP but rather the hydrolysis of ATP itself (Hohfeld et al., 1995). 
1.2.3.2 Hsp70 substrates and folding mechanism 
Hsp70 proteins are known to recognize exposed hydrophobic amino 
acid side chains within an accessible polypeptide backbone, structural features 
which are common to most nascent chains and proteins in their non-native states. 
Nevertheless, there has been some controversy regarding the in vivo role of 
DnaK. This was based on the fact that, under non-stress conditions, deletion of 
DnaK in a certain wild-type E. coli strain is lethal, whereas in others it is not 
(Hesterkamp and Bukau, 1998; Teter et al., 1999). Importantly, DnaK is absolutely 
essential for cell viability under heat stress conditions (Bukau and Walker, 1989). 
Furthermore, downstream of TF, DnaK has been shown to interact transiently 
with a variety of nascent and newly synthesized polypeptides (~15% of total; 
Figure 4), preferentially in the size range of 30-75 kDa (Teter et al., 1999). For 
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some proteins, the half-life of DnaK transit has been determined to be <1 min, 
consistent with the rapid protein folding upon completion of synthesis. The 
extent of DnaK binding to nascent chains is modulated by TF since in ∆tig cells 
the fraction of nascent polypeptides interacting with DnaK increases more than 
twofold and is markedly enriched in short chains (Deuerling et al., 1999; Teter et 
al., 1999). Additional depletion of DnaK in ∆tig cells results in the aggregation of 
many large, newly synthesized proteins (Deuerling et al., 1999), arguing for 
DnaK to play an important role in facilitating the post-translational folding of 
complex multi-domain proteins, which do not fit into the central cavity of the 
GroEL chaperonin (size exclusion: ~60 kDa). Similar to DnaK, mammalian Hsp70 
was also shown to act co-translationally on a large subset of newly synthesized 
polypeptides, including a variety of multi-domain proteins (Frydman et al., 1994; 
Thulasiraman et al., 1999). 
The binding motif of putative Hsp70 target peptides was determined to 
be ~4-8 amino acids in length and of preferentially hydrophobic character (Flynn 
et al., 1991; Rudiger et al., 1997). It was predicted to occur, on average, every 36 
residues in every polypeptide and is normally buried in the interior of a folded 
protein  (Bukau and Horwich, 1998). 
From a mechanistic point of view, folding of an Hsp70-bound protein 
can only occur upon its release from the chaperone stabilized state. Once this has 
happened, the protein is given the chance to either fold spontaneously, to rebind 
to Hsp70 or to be transferred to another chaperone. In vitro, proteins can undergo 
multiple rounds of binding and release, as shown for the 62 kDa model protein 
firefly luciferase (Szabo et al., 1994). It is also possible that folding of especially 
large and complex proteins is mediated by binding and release of several Hsp70 
molecules acting on individual domains of the protein. 
1.2.4 The chaperonins 
The chaperonins (Hemmingsen et al., 1988) are a ubiquitous family of 
sequence-related and essential proteins which form large, multimeric, bi-toroidal 
structures enclosing a central cavity in each ring (Hartl, 1996; Bukau and 
Horwich, 1998; Carrascosa et al., 2001; Frydman, 2001). Characteristically, 
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ATP-regulated folding of complete proteins (or protein domains) is facilitated 
inside the sequestered space of these cavities, unimpaired by aggregation with 
other non-native proteins of the cellular environment (Martin et al., 1993; Spiess 
et al., 2004). Chaperonins are divided into two subgroups which are similar in 
architecture but distantly related in sequence: Group I chaperonins are found in 
the bacterial cytosol (GroEL) and in eukaryotic organelles of endosymbiotic 
origin (Cpn60 in chloroplasts and Hsp60 in mitochondria). They function in close 
cooperation with cofactors of the Hsp10 family (GroES in bacteria, Cpn10 in 
chloroplasts, and Hsp10 in mitochondria). Group II chaperonins exist in archaea 
(thermosome) and the eukaryotic cytosol (TRiC) whose function is independent 
of an Hsp10-like cofactor. 
Since the focus of this study mostly concerns TRiC, only a brief 
overview of the best characterized group I chaperonin system GroEL/GroES 
from E. coli will be given. GroEL is a homo-tetradecamer of nearly 800 kDa, 
composed of two identical back-to-back stacked seven-membered rings (Braig et 
al., 1994) (Figure 7A). Each ~60 kDa subunit consists of an equatorial 
ATP-binding, an intermediate, and an apical substrate-binding domain. In order 
to fold substrates efficiently, GroEL requires the cofactor GroES, a dome-shaped 
homo-heptameric ring of ~10 kDa subunits (Hunt et al., 1996). 
GroEL/GroES mediated protein folding is an alternating process 
involving the encapsulation of unfolded or partially folded substrate proteins 
under the GroES lid on either side of the GroEL cylinder (Hayer-Hartl et al., 1995; 
Bukau and Horwich, 1998). Folding starts with the binding of a substrate 
polypeptide to the apical domains, exposing hydrophobic surfaces, at the free 
end of a GroEL/GroES complex (Figure 7B). This step is closely followed by the 
binding of ATP and GroES at the interacting GroEL toroid, resulting in substrate 
encapsulation. Upon GroES binding, GroEL undergoes major conformational 
changes (Xu et al., 1997) leading to cavity enlargement and a shift in its surface to 
a predominantly hydrophilic lining (Lin and Rye, 2006). Enclosed in this 
so-called “Anfinsen cage”, single proteins up to ~60 kDa are given the chance to 
fold unimpaired by aggregation (Ellis, 2006). After ATP hydrolysis (~10-15 s), 
ATP binding to the opposite ring of GroEL results in the release of GroES and the 
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substrate protein. Proteins that have not acquired their native state are 
recaptured and subjected to another round of folding. 
 
 
 
Figure 7: The chaperonin system GroEL/GroES of E. coli. 
 
(A) Top: Space-filling model of the GroEL/GroES complex. The secondary structure of 
one subunit in the upper GroEL ring is shown and separately depicted with the apical (a), 
intermediate (i) and equatorial (e) domains highlighted. Bottom: Cross-section of the 
chaperonin complex, illustrating the central cage in the upper ring. Adapted from Lin and 
Rye (2006). (B) Simplified reaction cycle of protein folding in the GroEL/GroES cage. 
Substrate binding to the free GroEL-ring is closely followed by binding of ATP and 
GroES, resulting in substrate enclosure. During ATP-hydrolysis (10-15 s), the protein is 
given the chance to fold. After binding of ATP to the opposite ring, GroES and the 
substrate are released from the chaperonin. Adapted from Ellis (2006). 
 
Whereas GroEL interacts with almost any non-native model protein 
in vitro (Coyle et al., 1997), only ~10% of newly translated polypeptides in E. coli 
interact with the chaperonin under normal growth conditions (Ewalt et al., 1997) 
(Figure 4).  Recently, GroEL substrates where shown to preferentially consist of 
βα-barrel domains, including many essential proteins for cell viability (Houry et 
al., 1999; Kerner et al., 2005). Noteworthy, GroEL is also able to assist the folding 
of large proteins which cannot be encapsulated by the co-chaperonin GroES 
(Chaudhuri et al., 2001). 
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1.3 TRiC: the eukaryotic group II chaperonin 
Among the chaperonins, the eukaryotic group II chaperonin TRiC (TCP1 
ring complex; also termed CCT for chaperonin containing TCP1) is the most 
complex, not only with regard to its hetero-oligomeric subunit composition but 
also with respect to its function in protein folding (Gutsche et al., 1999; 
Carrascosa et al., 2001). 
1.3.1 Structure and subunit composition 
Unlike GroEL, which is a homo-oligomer, each of the two TRiC toroids 
consists of eight different, albeit homologous subunits, ranging between 
50-60 kDa in size (Frydman et al., 1992; Gao et al., 1992; Lewis et al., 1992). The 
individual subunits (TRiC α, β, γ, δ, ε, ζ, η, and θ) display ~30% identity to one 
another and are thought to be organized in a unique arrangement within each 
ring (Liou and Willison, 1997; Miller et al., 2006). Interestingly, whereas in all 
organisms and tissues studied, the eight subunits are encoded by unique genes, a 
tissue-specific ζ2-subunit was identified in mammalian testis (Kubota et al., 
1997). Notably, TRiC is not inducible by heat-shock (Lewis et al., 1992). The 
endogenous chaperonin concentrations were estimated to be ~0.5 µM in 
mammalian cells (Thulasiraman et al., 1999) and ~0.3 µM in yeast (Siegers et al., 
1999), respectively. 
Crystal structure analysis of the thermosome, the archaeal group II 
chaperonin from Thermoplasma acidophilum and homolog of TRiC, revealed 
domain folds of the individual subunits to be similar to that of GroEL (Ditzel et 
al., 1998). This observation is consistent with a high degree of sequence 
conservation in the equatorial (ATPase) domain and the intermediate domain 
between group I and group II chaperonins (Kim et al., 1994). No significant 
sequence similarity could be detected in the apical (substrate binding) domains 
of both groups. In fact, a direct comparison of thermosome and GroEL apical 
domains revealed an additional α-helical protrusion which is strictly conserved 
among group II chaperonins (Figure 8A), but is absent in group I chaperonins 
(Klumpp et al., 1997). These protrusions are thought to play an important role in 
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substrate binding and controlling access to the central cavity, independent of a 
GroES-like cofactor. Unfortunately, so far no high-resolution structure of the 
entire TRiC complex has been solved. However, the overall structure of TRiC, 
determined by cryoelectron microscopy (cryo-EM) (Llorca et al., 1999b; Llorca et 
al., 2000), is very similar to that of other group II chaperonins (Ditzel et al., 1998; 
Nitsch et al., 1998). It shows a barrel-shaped double-ring cylinder (150 Å x 160 Å) 
with every subunit interacting with only one subunit of the opposite ring (Llorca 
et al., 1999b) (Figure 8B, top panel), contrary to the staggered subunit 
arrangement observed in group I chaperonins (Braig et al., 1994). Closure of the 
chaperonin cavity was demonstrated to be ATP dependent and is accomplished 
by a ~70° clockwise rotation of the apical domains (Llorca et al., 1999b; Llorca et 
al., 2001), similar to an iris-like mechanism (Figure 8B, bottom panel). 
 
 
 
 
Figure 8: Structural properties of group II chaperonins. 
 
(A) Apical domain of the thermosome α-subunit. The insert depicts a structural 
comparison with the corresponding domain of GroEL (green), illustrating the additional 
α-helical protrusion (yellow) present in the apical domain of group II chaperonins. 
Adapted from Klump et al. (1997). (B) Three-dimensional reconstruction of the eukaryotic 
chaperonin TRiC. Top: Side view of the apo-TRiC complex in the open conformation. 
Adapted from Llorca et al. (2000). Bottom: Top view of the AMP-PNP-TRiC complex in 
the closed conformation. Adapted from Llorca et al. (2001). 
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1.3.2 Mechanism of TRiC mediated protein folding 
The mechanism by which group II chaperonins mediate folding of their 
substrate proteins is very poorly defined. Recent structural and biochemical data 
suggest a mechanism, similar to that of group I chaperonins, although differences 
exist. Similar to GroEL, folding is proposed to occur inside the central cavity and 
involves at least two different conformational stages of the chaperonin (Llorca et 
al., 2001; Meyer et al., 2003). In the nucleotide free or ADP-bound state, the apical 
domains of TRiC are in an open conformation exposing the substrate binding 
sites. On the other hand, binding of ATP results in lid-closure and substrate 
encapsulation. Importantly, unlike for GroEL, lid-closure is not solely triggered 
by ATP binding but instead requires the presence of an ATP-transition state, 
engaged during nucleotide hydrolysis (Meyer et al., 2003). How exactly 
ATP-hydrolysis triggers protein folding is not yet clear. One model suggests 
sequential anti-clockwise conformational changes in the apical domains of TRiC 
to actively convert bound substrate proteins from a largely unfolded towards a 
more compact (native) state (Lin and Sherman, 1997; Llorca et al., 2001) 
(Figure 9B). In contrast to folding by mechanical pushing, a recent model 
proposes distinct binding properties in individual subunits at different states of 
the chaperonin to be responsible for folding (Spiess et al., 2006). Surprisingly, 
although confinement of substrate proteins was shown to be essential for 
TRiC-assisted folding (Meyer et al., 2003), the substrates are not liberated into the 
central cavity but instead remain bound to the chaperonin apical domains until 
their release (Llorca et al., 2001). Finally, negative inter-ring cooperativity (Kafri 
et al., 2001) and lid-closure in only one ring of TRiC after incubation with an 
ATP-transition state analog (Meyer et al., 2003) strongly argue for a “two-stroke 
mechanism” of the chaperonin. 
1.3.3 TRiC substrates  
TRiC was initially found to facilitate the folding of the cytoskeletal 
proteins actin and tubulin in vitro (Gao et al., 1992; Yaffe et al., 1992). 
Subsequently, the crucial role of TRiC for the folding of these proteins could also 
be demonstrated in vivo. Temperature-sensitive mutations in the genes encoding 
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for individual TRiC subunits displayed cytoskeletal phenotypes in S. cerevisiae, 
including defects in actin and tubulin assembly as well as aberrant budding 
patterns (Chen et al., 1994; Ursic et al., 1994). Therefore, TRiC was for a long time 
assumed to be a highly specialized chaperone exclusively responsible for the 
folding of cytoskeletal proteins (Lewis et al., 1996). 
This view changed upon the identification of new TRiC substrates, 
including firefly luciferase (Frydman et al., 1994), Gα-transducin (Farr et al., 
1997), cyclin E (Won et al., 1998), and the Von Hippel-Lindau tumor suppressor 
protein VHL (Feldman et al., 1999). It was even proposed that the substrate 
specificity of TRiC for actin and tubulin was based on an artifact, resulting from 
the high abundance of these proteins in cell extracts. Hence, other putative 
chaperonin substrates have possibly been overlooked. This would be in line with 
the high affinity of TRiC for cytoskeletal proteins (Melki and Cowan, 1994) and 
the observation that in vivo ~50-60% of the chaperonin capacity is devoted to the 
folding of actin and tubulin (Siegers et al., 2003). However, a pulse-chase analysis 
in mammalian cells revealed TRiC to interact with a broader range of proteins 
than the ones previously cited (Thulasiraman et al., 1999). Approximately 9-15% 
of the total synthesized proteins, mostly ranging from 30 to 60 kDa in size, were 
shown to associate transiently with the chaperonin (Figure 4). Notably, 
chaperonin interactions were also demonstrated for several proteins of 
100-120 kDa which clearly exceed the ~50 kDa size limit of the central cavity 
determined for group II chaperonins (Ditzel et al., 1998). More recently, 
proteomic analyses of protein complexes in yeast identified a new set of 
TRiC-associated proteins, the so-called “WD40-repeat proteins” (Ho et al., 2002). 
For several of these proteins, folding was demonstrated to be critically dependent 
on the chaperonin, thus, providing evidence for the first class of structurally 
defined TRiC substrates (Camasses et al., 2003; Siegers et al., 2003). WD40-repeat 
proteins are characterized by the content of four or more copies of a 40-60 amino 
acid long sequence motif ending with the conserved dipetide tryptophan-
aspartate (WD). Their common fold is defined as a β-propeller and consists 
entirely of anti-parallel β-strands (Smith et al., 1999). Interestingly, the interaction 
of TRiC with protein domains enriched in β-strands was also noted for several 
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other TRiC substrates, including the well characterized tumor suppressor protein 
VHL (Feldman et al., 2003). Based on these results it is tempting to speculate that 
β-strands constitute a possible chaperonin-recognition motif and that TRiC plays 
a role in folding of β-sheet-containing domains or participates in their 
stabilization during de novo synthesis (Spiess et al., 2004). 
1.3.4 TRiC-substrate interaction 
By analogy to group I chaperonins, substrate recognition by TRiC is 
believed to occur at the apical domains of individual subunits. However, the 
nature and exact location of substrate binding sites are still undefined. One 
hypothesis suggested the flexible α-helical protrusions to contain the substrate 
binding site (Klumpp et al., 1997; Heller et al., 2004). However, these protrusions 
seem not to be essential as their deletion in an archaeal chaperonin did not 
impair substrate binding efficiency (Iizuka et al., 2004). Based on cryo-EM and 
evolutionary analyses, binding sites were also proposed to reside in the region 
lining the inner face of the cavity, consisting mostly of charged and polar amino 
acids (Pappenberger et al., 2002; Gomez-Puertas et al., 2004). Finally, recent data 
suggest substrate binding to be facilitated by hydrophobic interactions in an 
α-helical region (Spiess et al., 2006), analogous to the binding site defined in the 
distal region of the GroEL apical domains (Sigler et al., 1998; Chen and Sigler, 
1999). Although quite diverse, all mentioned substrate binding sites are not 
mutually exclusive. Instead, given the sequence diversity in the apical domains 
of TRiC, it is feasible that different subunits recognize different types of motifs in 
a substrate protein, including hydrophobic as well as polar sites (Rommelaere et 
al., 1999; Hynes and Willison, 2000; Spiess et al., 2004). Additionally, this may 
provide TRiC with the versatility of fine-tuning its interactions with certain 
proteins, in a manner not possible for homo-oligomeric group I chaperonins. 
The specific interactions between actin and individual TRiC subunits 
were initially investigated by cryo-EM analyses (Llorca et al., 1999a; Llorca et al., 
2000). Thereby, actin was shown to bind across the chaperonin cavity by 
interacting with apical domains of two TRiC subunits via the tips of its two 
subdomains (Figure 9B). Moreover, actin:TRiC complexes were found in either of 
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two different 1:4 arrangements: TRiC δ-TRiC β and TRiC δ-TRiC ε, based on the 
proposed clockwise subunit orientation within the ring (Llorca et al., 1999a).  
 
 
 
Figure 9: Interaction between actin and TRiC. 
 
(A) Atomic structure of actin (Kabsch et al., 1990). The two topological domains of actin, 
historically named the large and small domain, are colored in red and blue. The putative 
TRiC-binding site on the tip of both domains is highlighted in yellow. (B) Three-
dimensional reconstruction of the TRiC:actin complex in the nucleotide-free, open 
conformation. Top: top view; bottom: side, cut view. (C) Three-dimensional reconstruction 
of the TRiC:actin complex in the presence of ATP, generating the closed chaperonin 
conformation where folding occurs. The actin molecule in (B) and (C) has been colored 
as in (A). The yellow arrow indicates the sequential conformational change in the TRiC 
subunits induced by ATP binding, as proposed by Lin and Sherman (1997). The subunit 
arrangement within one ring of the chaperonin is depicted according to Liou and Willison 
(1997). Adapted from Gomez-Puertas et al. (2004). 
 
Thus, unlike for GroEL, actin binding to TRiC was proposed to be both subunit-
specific and geometry-dependent. Interestingly, in both bound orientations, actin 
was observed opened up across its nucleotide-binding cleft, presumably in a 
quasi-native and nucleotide-free state. The importance of the opening of the actin 
molecule during its interaction with TRiC was confirmed by an actin mutant, 
G150P, located in the hinge region between the small and large domains 
(Figure 9A). This point-mutation was proposed to block the opening of the actin 
molecule, hence, the interaction with the two sides of the TRiC cavity and 
consequently prevents its folding (McCormack et al., 2001). In contrast, recent 
photo-crosslinking studies demonstrated TRiC to contact newly synthesized 
actin with multiple chaperonin subunits while the chain emerges form the 
ribosomal tunnel (Etchells et al., 2005). Additionally, the interactions between the 
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polypeptide substrate and the chaperonin were suggested to be highly dynamic 
and to follow a preferred “interaction pathway”, depending on the chain length 
of the substrate protein. 
1.3.5 Role of TRiC in protein folding both in vitro and in vivo 
Shortly after its discovery, TRiC was demonstrated to be the only 
chaperone necessary and sufficient to mediate refolding of actin and tubulin 
upon dilution from denaturant (Tian et al., 1995). After several cycles of folding, 
the native product was generated with a half-time of approximately 15-30 min. 
Strikingly, these proteins cannot be folded by group I chaperonins such as GroEL 
or Cpn60, even after multiple rounds of binding and release in an 
ATP-dependent manner and regardless of the presence or absence of their 
respective co-chaperonins (Tian et al., 1995). Interestingly, the interaction 
between TRiC and its substrate proteins was shown to differ considerably during 
refolding and the situation engaged throughout de novo synthesis (Frydman and 
Hartl, 1996). When chemically denatured actin was allowed to refold in a 
eukaryotic cell lysate, the protein partitioned freely between the Hsp70/40 
system, the bulk cytosol, and the chaperonin TRiC. In contrast, during in vitro 
translation, Hsp70/40 and TRiC were sequentially recruited to the elongating 
actin chain, similar to the mechanism shown for firefly luciferase (Frydman et al., 
1994), in order to protect it from exposure to the bulk cytosol during folding 
(Frydman and Hartl, 1996). 
Subsequently, a hetero-oligomeric chaperone complex, termed Prefoldin 
(PFD) or GimC (for genes involved in microtubule biogenesis complex), was 
shown to participate in the maturation pathway of cytoskeletal proteins (Geissler 
et al., 1998; Vainberg et al., 1998). PFD (~90 kDa in size) consists of six subunits 
and has a unique quaternary structure resembling that of a jellyfish (Siegert et al., 
2000). The distal regions of the six α-helical coiled-coil tentacles emanating from 
a β-barrel body are partially unwound and expose hydrophobic residues 
responsible for substrate binding. In vitro, PFD was shown to bind nascent (or 
non-native) actin chains in an ATP-independent manner and promotes their 
transfer to TRiC for folding (Vainberg et al., 1998; Hansen et al., 1999). In the 
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yeast cytosol, PFD and TRiC were proposed to form an integrated “folding 
compartment” which functions in close cooperation with the translation 
machinery and facilitates the post-translational completion of actin folding 
sequestered from the bulk cytosol (Siegers et al., 1999). Interestingly, single 
PFD-deletions resulted in reduced speed and efficiency of actin folding with 
non-native chains being released into the cytosol. Moreover, actin folding in vivo 
was determined to proceed with an apparent half-time of ~1 min and most likely 
requires only a few chaperonin cycles. Thus, de novo folding is at least 20-times 
faster than chaperonin-assisted actin refolding out of denaturant (see above). 
Recently, photo-crosslinking experiments confirmed the co-translational 
interaction of TRiC with nascent chains, as proposed earlier (Frydman et al., 
1994; Dobrzynski et al., 1996; Frydman and Hartl, 1996; McCallum et al., 2000; 
Etchells et al., 2005). Hence, these data do no longer support the theory of TRiC 
binding its substrate proteins in a strictly post-translational manner (Hansen et 
al., 1999). However, the exact mechanism of how TRiC is recruited to nascent 
chains and whether further components (e.g. Hsp70/40 and PFD) are necessary 
to assist in this process remains to be elucidated. Given these findings and the 
structural divergence of group II compared to group I chaperonins, TRiC is 
suggested to mediate the co-translational folding of multi-domain proteins which 
are too large for their entire encapsulation (Young et al., 2004). Thus, discrete 
protein domains might be folded upon their sequestration in the central cavity, 
whilst the rest of the protein remains outside and extends through a gap in the 
apical domains (Frydman et al., 1994; Llorca et al., 2001). A TRiC mediated 
domain-wise folding of proteins in the eukaryotic cytosol (Netzer and Hartl, 
1997) would be in line with the large proteins (100-120 kDa in size) observed to 
transiently associate with the chaperonin (Thulasiraman et al., 1999). 
1.4 Cell-free protein synthesis 
Cell-free protein synthesis is a concept that is decades old and was 
already utilized to decipher the mechanism coupling the information stored in 
polynucleotides to the production of functional proteins in living cells (Nirenberg 
and Matthaei, 1961). Later, cell-free systems became a useful technique for 
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investigating the function of chaperones in the context of de novo protein 
synthesis, as mentioned previously (1.2.1). 
Cell-free systems are generally prepared from crude cell extracts, 
containing all the enzymes and factors necessary for protein synthesis. For 
increased efficiency, the lysates are additionally supplemented with essential 
nucleotides, amino acids, salts and energy-regenerating systems. Nowadays, the 
most commonly used systems are derived from E. coli extracts (S30 fraction: 
soluble fraction when centrifuged at 30,000 g), rabbit reticulocyte lysates (RRL) 
and wheat germs (WG). Cell-free protein translation is routinely performed by 
programming such extracts with either mRNA (uncoupled reaction) or DNA 
(coupled transcription-translation reaction), following incubation in the test-tube. 
In addition to the gene of interest, the DNA template must contain specific 
regulatory elements including promoter, ribosomal binding site, start codon, and 
transcription/translation termination regions. Typically, standard in vitro 
translations (performed in small scale batch reactions) yield several micrograms 
of a particular protein and are suitable for the expression of a variety of different 
protein families. 
Compared to the limitations faced by using traditional cell-based protein 
expression methods, cell-free protein synthesis offers a wide range of possible 
applications. Firstly, cell-free systems provide a simple and robust tool to rapidly 
convert genes into proteins, thereby leaving room for various application specific 
modifications. Since access to these systems is not restricted by a cell wall, 
reaction supplementation with additives and rapid sampling is feasible at any 
desired time. In this regard, synthesis conditions for each individual protein can 
be adjusted and controlled by the addition of particular helper molecules (e.g. 
molecular chaperones or crowding agents) to provide a defined environment 
supporting correct protein folding. Furthermore, cell-free translation systems are 
applicable to modifications which are usually not physiologically tolerated by 
living cells. This includes the incorporation of non-natural amino acids as well as 
the functional expression of toxic and/or unstable proteins. Upon 
supplementation with microsomes, RRL and WG are even capable of 
accomplishing several co- and post-translational modifications such as 
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phosphorylation, glycosylation or signal peptide cleavage. In recent years, 
improvements to cell-free protein synthesis resulted in milligram quantities of 
functional protein, thus, making these systems more suitable for protein 
consuming applications like NMR and X-ray crystallography. In summary, 
in vitro protein synthesis is a powerful technology, which contributes to a wide 
range of scientific and biotechnological questions. 
1.5 Aim of the study 
In vivo, a substantial fraction of newly synthesized proteins requires the 
assistance of molecular chaperones for efficient folding (Hartl and Hayer-Hartl, 
2002). Despite the evolutionary conservation of the major chaperone families, 
eukaryotic multi-domain proteins often fold with low yield upon recombinant 
expression in bacterial hosts (Baneyx and Mujacic, 2004). In view of the 
biotechnological interest in the production of recombinant proteins, the 
examination of this particular phenomenon is of great importance, since the 
folding requirements for each protein are quite distinct. 
The primary goal of this research project was to determine the role of 
molecular chaperones in the folding of modular eukaryotic proteins upon in vitro 
translation in an E. coli-based cell-free transcription/translation system. The well 
studied eukaryotic multi-domain proteins firefly luciferase and cytoskeletal actin 
served as model proteins. Importantly, correct folding of these proteins can be 
directly monitored by using an enzymatic luciferase assay or the interaction of 
actin with specific actin binding partners (e.g. DNase I and phalloidin), 
respectively. To accomplish the aims of this study, the bacterial lysate was 
supplemented with purified chaperones of bacterial (e.g. TF, DnaK/DnaJ/GrpE, 
and GroEL/GroES) or eukaryotic (TRiC) origin, and their effect on efficiency and 
mechanism of de novo folding of luciferase and actin analyzed. 
Secondly, the eukaryotic chaperonin TRiC was examined with regard to 
a possible domain-wise folding mechanism, suggested previously (Frydman et 
al., 1994). Therefore, various N- and C-terminal actin-fusion proteins, conceivably 
too large for complete encapsulation in the TRiC folding cage, were generated 
and served as multi-domain model substrates for chaperonin assisted folding. 
Introduction   34                                  
Upon expression of these modular proteins in S. cerevisiae, their ability to fold 
correctly and to integrate into endogenous actin cytoskeleton structures (cortical 
patches and actin cables) was examined. Additionally, the native state of actin 
within the fusion proteins was assessed by binding to DNase I upon in vitro 
translation in a eukaryotic cell-free system. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Laboratory equipment 
Abimed (Langenfeld, Germany): Gilson Pipetman (2 to 1000 µl). 
Amersham Pharmacia Biotech (Freiburg, Germany): ÄKTA Explorer; SMART-
System; chromatography columns: Mono-Q, HiTrap-Heparin, HiTrap-Chelating, 
Superdex 200, Superose 6; resins: CNBr-activated Sepharose 4B, Sephadex-G50, 
Source 30-Q; electrophoresis power supplies: EPS200, EPS600. 
Amicon (Beverly, MA, USA): concentration chambers: Centriprep, Centricon. 
Avestin (Mannheim, Germany): EmulsiFlex C5 homogenizer. 
Beckmann (Munich, Germany): centrifuges: Avanti J-25, Avanti J-20 XP, J-6MI, 
GS-6R; ultracentrifuges: Optima TLX, Optima LE-80K; DU 640 UV/VIS 
Spectrophotometer. 
Berthold (Bad-Wildbad, Germany): luminometer Lumat LB 9507. 
Biometra (Göttingen, Germany): T3 PCR-Thermocycler. 
Bio-Rad (Munich, Germany): electrophoresis chambers: MiniProtean 2 and 3, 
Sub-CellGT; electrophoresis power supply Power PAC 300; GelAirDryer; Micro 
BioSpin desalting columns. 
Eppendorf (Hamburg, Germany): centrifuges: 5415C, 5417R; Thermomixer 
Comfort. 
Fuji (Tokyo, Japan): Phosphoimager FLA-2000; ImageReader LAS-3000. 
Getinge (Getinge, Sweden): autoclave. 
Heraeus (Hanau, Germany): incubator B12. 
Hoefer Scientific Instruments (San Francisco, USA): SemiPhore blotting transfer 
unit. 
Kinematica AG (Littau, Switzerland): Polytron PT3100 tissue homogenizer. 
Mettler Toledo (Gießen, Germany): balances: AE160, AG285, PB602. 
Millipore (Eschborn, Germany): deionization system MilliQ plus PF; Millex-HA 
filters (0.22 µm); vacuum filtration unit (0.22 µm). 
MWG BiotechAG (Göttingen, Germany): gel documentation system BioCapt.  
New Brunswick Scientific (Nürtingen, Germany): orbital shaker and incubator 
Innova 4430. 
Raytest (Straubenhardt, Germany): AIDA gel imaging software version 3.5. 
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SA-Instruments (New Jersey, USA): fluorescence spectrometer Fluorolog-3. 
Savant (New York, USA): Speedvac DNA110. 
WTW (Weilheim, Germany): pH-Meter pH538. 
Zeiss (Jena, Germany): microscopes: Standard25, fluorescence microscopes: 
Axiovert200, Axio ImagerA.1 equipped with Metamorph 6.3 software. 
Philips (Amsterdam, Netherlands): electron microscope CM20. 
 
2.1.2 Chemicals 
Chemicals and biochemicals used in this work were of pro analysi grade 
and purchased from Fluka (Deisenhofen, Germany), Calbiochem (Bad Soden, 
Germany), Merck (Darmstadt, Germany), Sigma-Aldrich (Steinheim, Germany), 
Roth (Karlsruhe, Germany), and Roche (Mannheim, Germany) unless stated 
otherwise. 
Amersham Pharmacia Biotech (Freiburg, Germany): western blotting detection 
systems: ECL, X-ray film; gel filtration HMW und LMW calibration kit; native 
electrophoresis HMW calibration kit; radiolabeled amino acids: [35S]-Met. 
BioMol (Hamburg, Germany): IPTG, HEPES. 
BioRad (Munich, Germany): ethidiumbromide; Bradford Protein-Assay. 
Clontech (Mountain View, USA): herring testes carrier DNA. 
Difco (Heidelberg, Germany): Bacto tryptone, Bacto yeast extract, Bacto agar, 
Bacto peptone, Bacto yeast nitrogen base without amino acids. 
Fermentas (St. Leon-Rot, Germany): GeneRuler 1kb DNA Ladder. 
Invitrogen (Karlsruhe, Germany): protein marker for SDS PAGE. 
Molecular Probes (Eugene, USA): rhodamine phalloidin. 
National Diagnostic (Hessle, England): Protogel (AA:BA=30:0.8). 
New England Biolabs (Frankfurt a. Main, Germany): restriction enzymes; calf 
intestinal alkaline phosphatase (CIP); T4 DNA ligase; prestained protein marker 
for SDS PAGE. 
Promega (Mannheim, Germany): Luciferase Assay System; Pfu DNA 
polymerase; TNT Coupled Reticulocyte Lysate System. 
Qiagen (Hilden, Germany): QIAprep Plasmid Mini and Midi kits; QIAquick PCR 
purification and gel extraction kit; Ni-NTA agarose. 
Roche (Mannheim, Germany): RTS in vitro translation systems: RTS 100 E. coli 
HY Kit, RTS 100 Wheat Germ CECF Kit. 
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Schleicher & Schuell: protran nitrocellulose transfer membrane; fluted paper 
filter 595-1/2 (270 mm). 
 
2.1.3 Media and buffers 
Media and buffers were prepared with demineralized water and 
autoclaved or sterile filtered unless stated otherwise. Concentrations are given in 
(v/v) for liquids and (w/v) for solids, respectively. 
2.1.3.1 Media 
LB medium: 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, (+15 g/l agar for 
solid medium). 
YPD medium: 10 g/l yeast extract, 20 g/l peptone, 20 g/l glucose, (+20 g/l 
separately autoclaved agar for solid medium). 
SC-Drop-out medium: 6.7 g/l yeast nitrogen base without amino acids, 20 g/l 
glucose, 2 g/l Drop-out mix, (+15 g/l agar for solid medium). 
Drop-out mix: 0.5 g adenine hemisulfate, 0.2 g para-aminobenzoic acid, 4 g 
leucine, and 2 g alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, 
glutamic acid, glycine, histidine, inositole, isoleucine, lysine, methionine, 
phenylalanine, proline, serine, threonine, tryptophan, tyrosine, uracil, valine, 
respectively. For selective reasons, media lacking uracil, tryptophan, histidine or 
leucine were used for strains prototrophic for these amino acids. 
Carbon sources: 20% glucose; 20% raffinose; 20% galactose. All solutions were 
sterile filtered and added separately to the autoclaved media to the final 
concentrations indicated. 
2.1.3.2 Buffers and stock solutions 
PBS: 137 mM NaCl, 2.7 mM KCl, 8.4 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4. 
PonceauS: 0.2% PonceauS, 3% trichloracetic acid. 
TAE: 40 mM Tris-Acetate, 1 mM EDTA, pH 8.0. 
TBS: 50 mM Tris, 150 mM NaCl, pH 7.5. 
TBS-T: 0.1% Tween20 in TBS. 
All other buffers and solutions were prepared as convenient stock solutions and 
either autoclaved or filter sterilized before usage, if applicable. 
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2.1.4 Bacterial and yeast strains 
2.1.4.1 E. coli strains 
Strain Genotype Reference 
BL21(DE3) B F- dcm ompT hsdS(rB- mB-) gal (DE3) Novagene 
DH5αF’ F'/endA1 hsdR17(rK-mK+) supE44 thi-1 recA1 gyrA (Na1r) relA1 D(lacZYA-argF)U169(m80lacZDM15) Novagene 
2.1.4.2 Yeast strains 
Strain Genotype Reference 
YPH499 MATa ura3-52 lys2-801
amber ade2-101ochre trp1∆63  
his3∆200 leu2∆1 
(Sikorski and 
Hieter, 1989) 
∆reg (KSY355) MATa ura3-52 lys2-801amber ade2-101ochre trp1∆63 his3∆200 leu2∆1 ∆reg1::loxP Katja Siegers 
 
2.1.5 Plasmids and Oligonucleotides 
2.1.5.1 Plasmids 
Plasmid Description Reference 
pET3a luciferase firefly luciferase (FL) for expression in S30 and RRL lysate 
Suranjana 
Guha 
pET3a TFwt trigger factor wild type (TF) for expression in BL21(DE3)  
Suranjana 
Guha 
pET3a TFmt trigger factor FRK/AAA mutant  (TFFRK/AAA) for expression in BL21(DE3) 
Suranjana 
Guha 
pJMBiA1 yeast actin   for expression in S30 and RRL lysate 
José M. 
Barral 
pRSET6a mouse actin mouse β-actin for expression in BL21(DE3), S30 and RRL 
(Siegers et al., 
1999) 
pCHAct-L16-cGFP 
yeast actin-L16a)-GFP (AG) 
in pCHORF-L16-cGFP vector for expression 
in S30 and RRL lysate 
(Chang et al., 
2005) 
pMS BA BFP-L16
b)-yeast actin (BA) 
for subcloning this work 
pMS BG BFP-L15
c)-GFP (BG) 
for expression in S30 and RRL lysate this work 
pMS GA GFP-L18
d)-yeast actin (GA) 
for expression in S30 and RRL lysate this work 
pMS BAG BFP-L16
b)-yeast actin-L16a)-GFP (BAG) 
for expression in S30 and RRL lysate this work 
pMS BA-TEV BFP-L16TEV
e)-yeast actin (BA-TEV) 
for subcloning this work 
pMS BTAG BFP-L16TEV
e)-yeast actin-L16a)-GFP (BTAG) 
for expression in S30 and RRL lysate this work 
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pMS BTAG-G150P 
BFP-L16TEVe)-yeast actinG150P-L16a)-GFP 
(BTAG-G150P) for expression in S30 and  
RRL lysate 
this work 
pMS CAG mCherry-L16
b)-yeast actin-L16a)-GFP (CAG) 
for expression in S30 and RRL lysate this work 
pMS LA firefly luciferase-L17
f)-yeast actin (LA) 
for subcloning this work 
p415 yeast actin yeast actin for expression in yeast 
Hung-Chun 
Chang 
p415GAL1 GFP GFP for expression in yeast 
(Chang et al., 
2005) 
p415 BAG BFP-L16
b)-yeast actin-L16a)-GFP (BAG) 
for expression in yeast this work 
p415 BTAG BFP-L16TEV
e)-yeast actin-L16a)-GFP (BTAG) 
for expression in yeast this work 
p415 BTAG-G150P BFP-L16TEV
e)-yeast actinG150P-L16a)-GFP 
(BTAG-G150P) for expression in yeast this work 
p415 CAG mCherry-L16
b)-yeast actin-L16a)-GFP (CAG) 
for expression in yeast this work 
p415 CG mCherry-L15
c)-GFP (CG) 
for expression in yeast this work 
p415 GA GFP-L18
d)-yeast actin (GA) 
for expression in yeast this work 
p415GAL1Act-L16-cGFP 
yeast actin-L16a)-GFP (AG) in  
p415GAL1ORF-L16-cGFP vector for  
expression in yeast 
(Chang et al., 
2005) 
p415 LA firefly luciferase-L17
f)-yeast actin (LA) 
for subcloning this work 
pIVEX1.3WG CAG mCherry-L16
b)-yeast actin-L16a)-GFP (CAG) 
for expression in WG this work 
pIVEX1.3WG CG mCherry-L15
c)-GFP (CG) 
for expression in WG this work 
 
The linkers in all fusion proteins were designed according to the L16-linker described 
previously (Chang et al., 2005). Minimal differences in length and amino acid sequences 
are due to the restriction endonuclease sites used for cloning. Amino acids identical in all 
linkers are highlighted in gray: 
 
a) L16:   TSGSAASAAGAGEAAA 
b) L16:   SGSAASAAGAGEAAAH 
c) L15:   SGSAASAAGAGEAAA 
d) L18:   GASGSAASAAGAGEAAAH 
e) L16TEV:  SGSAASAAGAGENLYFQGEAAAH (ENLYFQG: TEV protease cleavage site) 
f) L17:  ASGSAASAAGAGEAAAH 
 
Construction of pMS GA: The coding region of GST in pCHGFP-L16-GST 
(Hung-Chun Chang) was excised with Nde I and Nhe I restriction endonucleases 
and replaced by the coding region of yeast actin from pCHAct-L16-cGFP excised 
with Nde I and Spe I. 
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Construction of pMS BA: The coding region of BFP was amplified by PCR 
(primer #1 and #2) from pGEMEX2BFP (Heim et al., 1994) and inserted into 
pMS GA at the Xba I and Not I restriction endonuclease sites, replacing GFP. 
 
Construction of pMS BAG: The coding region of GFP (including parts of yeast 
actin and the linker region) from pCHAct-L16-cGFP was excised with Kpn I and 
Dra III restriction endonucleases and inserted into pMS BA. 
 
Construction of pMS BG: The coding region of yeast actin from pMS BAG was 
excised with the double cutting Not I restriction endonuclease. The resulting 
backbone was religated. 
 
Construction of p415 BAG: The coding region of BA from pMS BAG was excised 
with Xba I and Spe I restriction endonucleases and inserted into p415GAL1Act-
L16-cGFP, replacing yeast actin. 
 
Construction of pMS CAG and p415 CAG: The coding region of mCherry was 
amplified by PCR (primer #3 and #4) from pRSETB mCherry (Shaner et al., 2004) 
and inserted between Xba I and Nde I restriction endonuclease sites in pCHAct-
L16-cGFP and p415GAL1Act-L16-cGFP, respectively. 
 
Construction of pIVEX1.3WG CAG: The coding region of CAG was amplified by 
PCR (primer #5 and #6) from p415 CAG and inserted into pIVEX1.3WG (Roche) 
at the Nco I and Sal I restriction endonuclease sites by partial digestion. 
 
Construction of pIVEX1.3WG CG and p415 CG: The coding region of yeast actin 
from pIVEX1.3WG CAG and p415 CAG, respectively, was excised with the 
double cutting Not I restriction endonuclease. The resulting backbone was 
religated. 
 
Construction of p415 GA: The coding region of yeast actin was at first excised 
from pMS GA and inserted into pCHLuc-L16-cGFP (Chang et al., 2005) at the 
Not I and Dra III restriction endonuclease sites (replacing GFP) resulting in 
pMS LA. Secondly, actin was amplified by PCR (primer #7 and #8) from pMS LA 
and inserted into p415GAL1Luc-L16-cGFP (Chang et al., 2005) at the Not I and 
Nhe I restriction endonuclease sites (replacing GFP) resulting in p415 LA. 
Thirdly, the coding region of actin was excised with Not I and Sal I restriction 
endonucleases from p415 LA and inserted into p415GAL1nGFP-L16-Luc (Chang 
et al., 2005), replacing firefly luciferase. 
  
Construction of pMS BA-TEV: The coding region of BFP was amplified by PCR 
(primer #1 and #9) from pMS BA and inserted back into the same plasmid at the 
Xba I and Not I restriction endonuclease sites. Thereby, a TEV protease cleavage 
site (ENLYFQG) was introduced into the linker between BFP and yeast actin. 
 
Construction of pMS BTAG and p415 BTAG: The coding region of BA-TEV was 
amplified by PCR (primer #1 and #10) from pMS BA-TEV and inserted between 
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Xba I and Spe I restriction endonuclease sites in pMS BAG and p415 BAG, 
respectively. 
 
Generation of pMS BTAG-G150P and p415 BTAG-G150P was performed by 
site-directed mutagenesis using pMS BTAG and p415 BTAG as template 
plasmids. PCR reactions were carried out in presence of primer #11 and #12, 
respectively. 
 
2.1.5.2 Oligonucleotides 
Primer Sequence  Direction 
#1 BFPup2 
5´ CTA GTC TAG AAA TAA TTT TGT TTA ACT TTA 
AGA AGG AGA TAT ACA TAC CAT GAG TAA AGG 
AGA AGA ACT TTT C 3´ 
forward 
#2 BFPdn 
5´ TTT TCC TTT TGC GGC CGC TTC GCC AGC ACC 
AGC AGC GGA GGC AGC GGA TCC ACT TTT GTA 
TAG TTC ATC CAT GCC ATG 3´ 
reverse 
#3 LimChf 
5´ C TAG TCT AGA AAT AAT TTT GTT TAA CTT 
TAA GAA GGA GAA TTC ATG GTG AGC AAG GGC 
GAG GAG GAT AAC 3´ 
forward 
#4 mChLir 
5´ GGG AAT TCC ATA TGC GCG GCC GCT TCG CCA 
GCA CCA GCA GCG GAG GCA GCG GAT CCA CTC 
TTG TAC AGC TCG TCC ATG CCG CCG GTG 3´ 
reverse 
#5 CAGf 5´ CAT GCC ATG GTG AGC AAG GGC GAG 3´ forward 
#6 CAGr 5´ TCC GCG GCC GCT ATG GCC GAC GTC GAC GGT ATC GAT AAG CTT TAG 3´ reverse 
#7 LiyAf2 5´ AGG AGC GGC CGC GCA TAT GGA TTC 3´ forward 
#8 yAr2 5´ CTA GCT AGC ACC GAA ACA CTT GTG GTG AAC G 3´ reverse 
#9 B-TEV-Ar 
5´ TTT TCC TTT TGC GGC CGC TTC GCC CTG AAA 
ATA CAG GTT TTC GCC AGC ACC AGC AGC GGA 
GGC AG 3´ 
reverse 
#10 yASper 5´ GG ACT AGT GAA ACA CTT GTG GTG AAC 3´ reverse 
#11 G150Pf  5´ CT TCC GGT AGA ACT ACT CCA ATT GTT TTG GAT TCC GGT G 3´ forward 
#12 G150Pr 5´ C ACC GGA ATC CAA AAC AAT TGG AGT AGT TCT ACC GGA AG 3´ reverse 
 
2.1.6 Antibodies 
Antibody Species Reference 
Primary Antibodies 
anti-Actin mouse, monoclonal Amersham N350 
anti-Act1p rabbit, polyclonal Katja Siegers 
anti-Adh1p rabbit, polyclonal Katja Siegers 
anti-CCTα rat, monoclonal StressGen CTA-191 
anti-GFP mouse, monoclonal  Roche 1 814 460 
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Secondary Antibodies 
anti-mouse IgG-HRP goat, polyclonal Sigma A4416 
anti-rabbit IgG-HRP goat, polyclonal Sigma A9169 
anti-rat IgG-HRP rabbit, polyclonal Sigma A5795 
 
2.1.7 Proteins 
2.1.7.1 Special enzymes 
Invitrogen (Karlsruhe, Germany): TEV protease. 
Roche (Mannheim, Germany): Benzonase, creatine kinase, DNase I, RNase A. 
Sigma-Aldrich (Steinheim, Germany): apyrase, lysozyme, firefly luciferase. 
2.1.7.2 Chaperones 
The following chaperones (purified according to the protocol 
referenced) were obtained from the laboratory collection of the Department of 
Cellular Biochemistry, Max Planck Institute of Biochemistry: 
DnaK (Jordan and McMacken, 1995) with modifications, 
DnaJ (Zylicz et al., 1985), 
GrpE-(His)6, 
GroES (Hayer-Hartl et al., 1996), 
GroEL (Hayer-Hartl et al., 1994) with modifications. 
 
2.2 Molecular biology methods 
All experimental methods used throughout this work were performed 
according to “Molecular Cloning” (Sambrook et al., 1989) unless stated 
otherwise. 
2.2.1 Plasmid purification 
A single E. coli colony containing the plasmid of interest was inoculated 
in LB medium (supplemented with the appropriate antibiotic) and shaken 
overnight at 37 °C. Plasmid DNA was purified using the QIAprep Plasmid kits 
according to the manufacturer’s protocol. 
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2.2.2 DNA analytical methods 
DNA concentrations were measured by UV absorption spectroscopy at 
λ=260 nm. An optical density of OD260=1 corresponds to approximately 50 µg/ml 
double stranded DNA and 31 µg/ml oligonucleotides, respectively. 
Agarose gel electrophoresis was performed with 1-2% TAE-buffered 
agarose gels (TAE, 2.1.3.2) supplemented with 10 µg/ml ethidiumbromide. Size 
fractionation of DNA fragments was carried out at 80-100 V in TAE buffer. Prior 
to electrophoresis, loading buffer (6x loading buffer: 60% glycerol, 0.25% 
bromphenol blue, 0.25% xylene cyanol FF) was added to the DNA samples to a 
1x concentration. 
Primers were purchased from Metabion (Martinsried, Germany), DNA 
sequencing was performed by Medigenomix GmbH (Martinsried, Germany) or 
Sequiserve (Vaterstetten, Germany). 
2.2.3 PCR amplification 
DNA was amplified using PCR (polymerase chain reaction) according to 
a standard protocol. Modifications in the reaction setup and the running 
conditions were made when necessary. 
Typical PCR reaction: 
DNA template     <0.2 µg/50 µl 
Primers      0.5 µM each 
dNTPs      200 µM each  
Pfu DNA Polymerase  3 U/50 µl 
Polymerase buffer   1x 
DMSO      10% 
 
Typical PCR cycling conditions (30 cyles): 
Initial denaturation  95 °C for 2 min 
Cycle denaturation  95 °C for 30-60 s 
Annealing     50-55 °C for 30-60 s 
Extension     72 °C for 2-6 min (2 min/kb of DNA) 
Final extension    72 °C for 10 min 
Pause      4 °C indefinite 
Following the PCR reaction, the amplified DNA was purified using the QIAquick 
PCR purification and gel extraction kit. 
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2.2.4 DNA restriction digestions and ligations 
DNA restriction digestions were performed according to the product 
instructions of the respective enzymes. Typically, a 20 µl preparative reaction 
containing the purified PCR product or plasmid DNA, 0.1 mg/ml BSA and 1 µl 
of each restriction enzyme in the appropriate reaction buffer was used. In order 
to avoid religation, dephosphorylation of vector DNA cohesive ends was carried 
out using calf intestinal alkaline phosphatase (CIP) following subsequent 
purification with QIAquick PCR purification and gel extraction kit according to 
the manufacturer’s instructions. 
DNA ligations were performed in the presence of T4 DNA ligase. 
Typically, for a 10 µl reaction containing 1 µg DNA consisting of 
dephosphorylated vector DNA and an insert fragment in a molar ratio between 
1:3 and 1:10, 1 µl T4 DNA ligase (400 U/µl) and 1x ligase buffer was used. The 
ligation was carried out for 1 h at 25 °C or, for increased efficiency, overnight at 
16 °C. The complete reaction was used to transform chemically competent E. coli 
DH5α cells. 
2.2.5 Preparation and transformation of competent E. coli cells 
Competent E. coli DH5α cells for standard cloning reactions were 
prepared as described (Nishimura et al., 1990). In brief, a 50 ml culture, 
inoculated with 0.5 ml of an E. coli DH5α overnight culture, was grown in 
medium A (LB medium supplemented with 10 mM MgSO4 and 0.2% glucose) to 
mid-logarithmic phase of growth. The cells were kept on ice for 10 min and then 
pelleted at 1,500 g for 10 min at 4 °C. After the cells were gently resuspended in 
0.5 ml of prechilled medium A, 2.5 ml of storage solution B (36% glycerol, 12% 
PEG-7500, 12 mM MgSO4 added to LB medium and filter sterilized) was added 
and mixed well without vortexing. Cells were divided in 50 µl aliquots and 
stored at -80 °C. 
For transformations, competent cells were thawed on ice, immediately 
mixed with 1 µl plasmid DNA or 10 µl of a ligation reaction and incubated on ice 
for 30 min. Cells were then subjected to a heat shock at 42 °C for 45 s and 
immediately chilled on ice for 2 min. 800 µl of prewarmed LB medium was 
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added and upon phenotypical expression for 60 min at 37 °C, the transformation 
reaction was plated on selective LB-agar plates and incubated at 37 °C overnight 
or until colonies had developed. 
2.2.6 Site-directed mutagenesis 
Plasmid DNA, encoding the gene of interest, was isolated from E. coli 
DH5α (supporting dam methylation of DNA) as described (2.2.1). The template 
DNA was amplified using PCR in the presence of complementary primers 
containing the mutation to be introduced. In contrast to a regular PCR reaction, 
the extension temperature was reduced to 69 °C and only 12-15 reaction cycles 
were performed. After reaction completion, the parental DNA was digested by 
Dpn I (20 U/50 µl PCR reaction, 1 h at 37 °C), an endonuclease specific for 
methylated DNA. Finally, 1 µl of the reaction was transformed in competent 
E. coli DH5α cell and the mutation of the isolated plasmid DNA confirmed by 
DNA sequencing. 
2.2.7 Yeast culture methods 
All experimental yeast techniques were performed according to “Yeast 
Protocols” (Evans, 1996) unless stated otherwise. 
2.2.7.1 Cultivation of yeast cells 
S. cerevisiae strains were grown in YPD or synthetic complete 
SC-Drop-out medium (2.1.3.1) at 30 °C on agar plates or in liquid culture. For 
short term storage, cells were streaked on agar plates and stored at 4 °C. For long 
term storage, liquid cultures were mixed in a 1:1 ratio with 50% glycerol and 
stored at -80 °C. 
The yeast strains used throughout this study contained a point mutation 
in the ade2-101 gene, thus, the media used for cultivation were additionally 
supplemented with 0.01% adenine. 
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2.2.7.2 Transformation of yeast cells 
Yeast transformations were performed with modifications to the 
protocol described (Gietz et al., 1992). In brief, 1-2 ml of exponentially growing 
cells (OD600~1.0) were pelleted at 2,500 g for 3 min and washed with TE/LiAc 
(made fresh from 10x stock solutions: 10x TE [0.1 M Tris, 10 mM EDTA, pH 7.5] 
and 10x LiAc [1 M LiAc]). Cells were resuspended in 100 µl TE/LiAc and mixed 
thoroughly with 50 µg of denatured herring sperm carrier DNA, 1 µg 
transforming DNA and 300 µl of a 40% PEG solution (40% PEG 4000, 1x TE, 
1x LiAc, made fresh from stocks of sterile 50% PEG, 10x TE, and 10x LiAc). After 
incubation at 30 °C for 30 min with gentle agitation, cells were subjected to heat 
shock for 15 min at 42 °C and subsequently pelleted at 4,500 g for 1 min. 
Transformation reactions were plated on selective agar plates and incubated at 
30 °C until colonies developed. 
2.2.7.3 Lysis of yeast cells 
For the preparation of yeast crude protein extracts under denaturing 
conditions approximately 2 OD600 units of cells were harvested (2,000 g for 5 min 
at 4 °C) and washed with H2O. The pellet was resuspended in H2O and 
incubated with 240 mM NaOH and 1% β-mercaptoethanol for 15 min on ice. TCA 
was added to a final concentration of 6.5% and incubated for 10 min on ice. The 
denatured proteins were pellet by centrifugation (20,000 g for 30 min at 4 °C) and 
the pellet resuspended in HU-buffer (8 M urea, 5% SDS, 200 mM Tris (pH 6.8), 
0.1 mM EDTA, 1% bromphenol blue). Prior to loading on SDS gels, samples were 
incubated at 65 °C for 10 min. 
For the preparation of cytosolic extracts under native conditions, an 
appropriate amount of yeast cells was harvested (2,000 g for 5 min at 4 °C) and 
resuspended in 250 µl glass-bead lysis buffer (PBS, 5 mM EDTA, EDTA-free 
Complete protease inhibitors, 10 µM Antipain, 10 µM Leupetin, 1 µM Aprotinin, 
0.3 µM Trypsin-inhibitor, 0.4 µM Pepstatin, 10 µM Chymostatin, 0.5% Tween20). 
Cell lysis was performed by agitation with glass-beads for 6x 30 s at 4 °C. Upon 
lysis, beads were washed twice with 250 µl yeast lysis buffer and combined with 
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the crude lysate. Non-lysed cells were separated from the lysate by centrifugation 
(2,000 g for 5 min at 4 °C). 
2.3 Protein biochemical methods 
2.3.1 Protein analytical methods 
2.3.1.1 Determination of protein concentrations 
Protein concentrations of complex protein mixtures and cell lysates were 
determined spectrophotometrically at λ=595 nm using Bradford reagent 
(Bradford, 1976) and BSA calibration curves. 
Concentrations of purified proteins were determined on the basis of the 
Beer-Lambert law and their theoretical extinction coefficients at λ=280 nm (Gill 
and von Hippel, 1989), as calculated by the ProtParam tool at the ExPASy 
proteomics server (http://www.expasy.ch) unless mentioned otherwise. Molar 
concentrations of chaperones are expressed for the native state oligomers. 
2.3.1.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed using a discontinuous buffer system  under 
denaturing and reducing conditions (Laemmli, 1970). Typically, gels were 
poured with a 5% polyacrylamide stacking gel on top of a 9-15% polyacrylamide 
separating gel, depending on the required resolution. SDS sample buffer was 
added to the protein samples to a 1x concentration. Prior to loading, samples 
were boiled at 95 °C for 5 min following a short centrifugation step at 20,000 g for 
2 min. Electrophoresis was carried out at a constant current of 30 mA/gel in 
running buffer. 
Stacking gel: 5% acrylamide/bisacrylamide (30:0.8), 130 mM Tris (pH 6.8), 0.1% 
SDS, 0.1% TEMED, 0.1% ammonium persulfate. 
Separating gel: 9-15% acrylamide/bisacrylamide (30:0.8), 0.75 M Tris (pH 8.8), 
0.1% SDS, 0.1% TEMED, 0.05% ammonium persulfate. 
4x SDS sample buffer: 240 mM Tris (pH 6.8), 8% SDS, 40% glycerol, 1.4 M 
β-mercaptoethanol, 0.02% bromphenol blue. 
Running buffer: 50 mM Tris-Base, 380 mM glycine, 0.1% SDS. 
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Coomassie stain: 0.1% Coomassie Brilliant Blue R250, 30% methanol, 10% acetic 
acid. 
Destain solution: 30% methanol, 10% acetic acid. 
SDS gels not intended for further immunodetection analysis were fixed 
and stained in Coomassie stain. Unspecific background stain was removed by 
incubation in destaining solution. Radiolabeled proteins were visualized and 
quantified by phosphoimaging (Fuji FLA-2000) and AIDA software. 
2.3.1.3 Bis-Tris native polyacrylamide gel electrophoresis (native-PAGE) 
The discontinuous native gel system utilized was performed essentially 
as described (Schagger and von Jagow, 1991). Gels were composed of two layers 
(5.5% polyacrylamide on top of 12.5%). The cathode buffer consisted of 50 mM 
Tricine and 15 mM Bis-Tris (pH 7.0). The anode buffer contained 50 mM Bis-Tris 
(pH 7.0). Reaction mixtures were adjusted with native gel loading buffer to final 
concentrations of 50 mM Bis-Tris (pH 7.0), 5% glycerol, 2 mM DTT, 0.01% 
bromphenol blue. The gels were initially run at 150 V for 45 min followed by 
300 V at 4 °C until the dye front migrated to the bottom of the gel. Proteins were 
visualized as mentioned previously (2.3.1.2). 
2.3.1.4 Western blot analysis of SDS-PAGE gels 
Western blotting was carried out in a semi-dry blotting unit. Upon 
separation by SDS-PAGE, proteins were transferred to nitrocellulose membranes 
by applying a constant current of ~1 mA/cm2 gel size in 25 mM Tris, 192 mM 
glycine, 20% methanol for 1.5 h. 
Prior to blocking the membranes with 5% skim milk powder in TBS 
(2.1.3.2) for 1 h, transfer efficiency was verified by PonceauS (2.1.3.2) staining. 
The membranes were then incubated with primary antibodies (diluted to a 
suitable concentration in 5% milk-TBS) for 1 h at RT or overnight at 4 °C, 
followed by the incubation with HRP-conjugated secondary antibodies (diluted 
1:1000 in milk-TBS) for 1 h at RT. Extensive washing between the incubation 
steps was performed with TBS-T (2.1.3.2). 
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Immunodetection was carried out with the ECL system and exposure to 
X-ray films or the ImageReader (Fuji LAS-3000), followed by quantitative image 
analysis with AIDA software, if required. 
2.3.1.5 Dot blot analysis 
Dot blots were performed for fast and qualitative protein detection in 
column fractions during protein purification. Typically, 2-5 µl of each fraction 
were applied to a nitrocellulose membrane and air-dried for 10 min. 
Immunodetection was carried out as described for western blotting analysis of 
SDS-PAGE gels (2.3.1.4) with the exception that all incubation times were 
reduced to half. 
2.3.2 TCA precipitation of proteins 
Protein solutions were concentrated by TCA precipitation, when 
necessary. Therefore, the protein sample was mixed 1:1 with 25% TCA and 
incubated for 15 min on ice. The precipitated proteins were pelleted by 
centrifugation (20,000 g for 15 min at 4 °C). After washing twice with acetone 
(-20 °C), pellets were resuspended in SDS sample buffer and boiled at 95 °C for 
5 min. 
2.3.3 Protein purification 
All protein purification steps were performed at 4-8 °C unless stated 
otherwise. 
2.3.3.1 Purification of TRiC from bovine testis 
The eukaryotic chaperonin TRiC was purified according to the protocol 
described by Ferreyra and Frydman (2000) with modifications. Fresh bovine 
testes (~200 g) were skinned, cut up in small pieces and subsequently 
homogenized using a Polytron tissue homogenizer in an equal volume of 
buffer A (50 mM HEPES pH 8.0, 2 mM EGTA, 10 mM NaCl, 5 mM MgCl2, 
10% glycerol, 2 mM DTT, 1 mM PMSF, EDTA-free Complete protease inhibitors). 
The homogenate was incubated with 5 U/ml Benzonase for 30 min and clarified 
by centrifugation (40,000 g for 45 min followed by 130,000 g for 1 h). The 
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supernatant was passed through a fluted filter paper and subsequently applied 
to a 250 ml Source 30-Q column equilibrated in buffer B (20 mM HEPES pH 8.0, 
2 mM EDTA, 5 mM MgCl2, 10% glycerol, 2 mM DTT). Elution was carried out by 
an NaCl gradient (0-300 mM) in buffer B. TRiC-containing fractions were pooled 
after identification by dot blot analysis with an antibody specific for the 
α-subunit of TRiC (anti-CCTα, 2.1.6). The NaCl concentration of this pool was 
adjusted to 200 mM prior to loading on a 20 ml HiTrap Heparin column 
equilibrated in buffer C (20 mM HEPES pH 7.4, 2 mM EDTA, 5 mM MgCl2, 10% 
glycerol, 2 mM DTT) containing 200 mM NaCl.  TRiC-containing material was 
eluted by an NaCl gradient (200-700 mM) in buffer C. TRiC fractions were 
pooled, diluted with buffer C to reach an NaCl concentration of 50 mM and 
applied to a 20 ml Mono-Q column equilibrated in buffer C containing 50 mM 
NaCl. After protein elution with a NaCl gradient (50-500 mM) in buffer C, TRiC-
containing fractions were concentrated with Centriprep devices (MWCO 
100,000 kDa) and passed through a HiLoad Superdex 200 column (XK 16/60) 
equilibrated in 20 mM HEPES pH 7.4, 1 mM MgCl2, 100 mM NaCl, 10% glycerol, 
1 mM DTT. Fractions eluting at ∼900 kDa were pooled and concentrated (as 
above) to ∼25 mg/ml, aliquoted and snap-frozen in liquid nitrogen. The protein 
yield was determined by Bradford analysis and was typically ~8 mg per 100 g of 
starting material. SDS-PAGE followed by Coomassie blue staining revealed TRiC 
purity to be >95%. Functionality of the TRiC complex was assessed by an actin 
refolding assay as described in section 2.4.4. 
2.3.3.2 Purification of Trigger Factor 
TF and TFFRK/AAA (residues 44FRK46 were replaced by alanines) were 
purified according to the protocol described by Hesterkamp et al. (1997) with 
modifications. E. coli BL21(DE3) cells harboring the expression vector pET3a 
encoding the C-terminally His6-tagged wild-type or FRK/AAA TF mutant were 
grown to OD600~0.5 in LB medium (supplemented with 100 µg/ml ampicillin). 
Expression was induced with 1 mM IPTG for 3 h at 37 °C. Cells were harvested 
by centrifugation (4,000 g for 1 h) and resuspended in buffer D (25 mM KPi 
pH 8.0, 300 mM NaCl, 10 mM imidazole, 10% glycerol) containing 0.5% 
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TritonX-100 and EDTA-free Complete protease inhibitors. The suspension was 
frozen in liquid nitrogen and thawed before incubation with lysozyme 
(0.5 mg/ml) for 30 min. Following Benzonase treatment (5 U/ml) for 30 min on 
ice, cell debris was removed by centrifugation for 30 min at 100,000 g. The 
supernatant was applied to a 15 ml Ni-NTA agarose column equilibrated in 
buffer D. After a washing step with buffer D containing 20 mM imidazole, 
protein elution was performed with 250 mM imidazole in buffer D. Fractions 
containing trigger factor were pooled and diluted with buffer E (20 mM HEPES 
pH 7.4, 1 mM DTT, 10% glycerol) to reach a final NaCl concentration of 50 mM. 
The diluted protein solution was loaded on an 8 ml Mono-Q column equilibrated 
in buffer E containing 50 mM NaCl. Protein elution was achieved by applying a 
shallow NaCl gradient from 50-500 mM in buffer E. Trigger factor containing 
fractions were pooled and dialyzed against 20 mM HEPES pH 7.4, 100 mM NaCl, 
1 mM DTT, 10% glycerol. Protein aliquots were snap-frozen in liquid nitrogen 
and stored at -80 °C. The accurate protein concentration of trigger factor samples 
was determined at 280 nm (theoretical extinction coefficient ε=15,930 M-1cm-1). 
2.3.3.3 Purification of mouse β-actin 
E. coli BL21(DE3) cells transformed with the bacterial expression vector 
pRSET6a encoding mouse β-actin (Siegers et al., 1999) were grown to OD600∼0.5 
in LB medium (supplemented with 100 µg/ml ampicillin). Expression of actin 
was induced with 1 mM IPTG for 3 h at 37 °C. Cells were harvested by 
centrifugation (2,000 g for 15 min) and the resulting pellets resuspended in lysis 
buffer (50 mM Tris pH 7.4, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, EDTA-free 
Complete protease inhibitors). Lysis was performed by freeze-thawing and 
incubation with 2 mg/ml lysozyme for 20 min. The lysate was incubated with 
5 U/ml Benzonase for 30 min and clarified by centrifugation (22,000 g for 
45 min). The pellet was washed extensively with IB-buffer (10 mM Tris pH 7.4, 
150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1.0% TritonX-100) followed by wash 
buffer (50 mM Tris pH 7.4, 100 mM NaCl, 1 mM DTT). The remaining actin 
inclusion bodies were resuspended in 20 mM Tris pH 7.4, 8 M urea, 2 mM DTT. 
SDS-PAGE followed by Coomassie blue staining revealed actin purity to be 
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>95%. Protein concentration of denatured mouse β-actin was determined at 
280 nm (theoretical extinction coefficient ε=42,320 M-1cm-1). This material was 
used as a protein standard for quantitative western blotting. 
2.3.3.4 Enrichment of the actin fusion protein CAG from yeast 
YPH499 S. cerevisiae cells were transformed with the yeast expression 
vector p415 encoding the C-terminally His6-tagged CAG actin-fusion protein and 
grown to OD600∼0.3 in SC-Leu medium. Expression was induced with 2% 
galactose for 24 h at 30 °C. Cells were harvested by centrifugation (4,000 g for 
30 min) and lysed in PBS, 300 mM NaCl, 5% glycerol, 1% TritionX-100, 
EDTA-free Complete protease inhibitors, 1 mM PMSF, 10 mM imidazole using 
an EmulsiFlex high-pressure homogenizer according to the manufacturer’s 
instructions. The lysate was cleared by centrifugation (40,000 g for 1 h) and the 
supernatant applied to a HiTrap metal-chelating column (pre-charged with 
Ni2+-ions) and equilibrated in buffer F (PBS, 5% glycerol, 300 mM NaCl) 
containing 10 mM imidazole. The column was washed with a gradient of 
10-50 mM imidazole in buffer F and the protein eluted with 500 mM imidazole in 
buffer F. CAG-containing fractions were concentrated with Centriprep devices 
(MWCO 30,000 kDa) and passed through a 120 ml HiLoad Superdex 200 column 
equilibrated in PBS containing 5% glycerol. Detection of CAG in the fractions was 
performed by SDS-PAGE and Coomassie blue staining followed by a 
concentration step as described above. Purity of the enriched CAG sample was 
estimated to be ~50% corresponding to ~0.5 µM CAG when compared to a 
purified standard protein of known concentration. Protein aliquots were 
snap-frozen in liquid nitrogen and stored at -80 °C. 
2.3.4 Protein synthesis using in vitro transcription/translation 
systems 
In vitro translations were performed from plasmids with a T7 promoter. 
For protein expression in a prokaryotic model system the coupled RTS 
E. coli 100 HY transcription/translation system from a bacterial S30 lysate (S30) 
was utilized. As a eukaryotic expression system the TNT coupled system from 
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rabbit reticulocyte lysate (RRL) or the coupled RTS 100 Wheat Germ CECF kit 
(WG) was used. S30 and RRL translation reactions were typically run for 1 h at 
30 °C. WG reactions were carried out for 24 h at 24 °C and 900 rpm in the CECF 
two-chamber device. The specific activity of [35S]-Met was identical in all 
reactions. For analysis of soluble and insoluble material, the reactions were 
centrifuged (22,000 g for 30 min at 4 °C) to separate supernatant and pellet 
fractions. For kinetic experiments, reactions were run for longer periods, as 
indicated. Unless indicated otherwise, chaperones were added to S30 translations 
in the following concentrations: TRiC: 5 µM; TF: 5 µM; DnaK/DnaJ/GrpE (KJE): 
10, 2 and 6 µM; and GroEL/ES (EL/ES): 1 and 2 µM. Chaperones added to the 
bacterial S30 lysate were buffer-exchanged into RTS reconstitution buffer (Roche) 
by passing them through Micro BioSpin desalting columns, when necessary. 
2.4 Biochemical and biophysical methods 
2.4.1 Luciferase activity assay 
Firefly luciferase (FL) activity measurements were performed with the 
Luciferase Assay System according to the manufacturer’s protocol. Translation 
aliquots were diluted 100-fold into stopping buffer (25 mM Tris-Phosphate buffer 
pH 7.4, 2 mM CDTA, 2 mM DTT, 1% TritonX-100, 1 mg/ml BSA) before 
measuring activity in a luminometer. Relative specific activities were calculated 
by normalizing activity values with relative band intensities of full-length protein 
upon SDS-PAGE and phosphoimaging analysis (2.3.1.2). 
2.4.2 Firefly luciferase refolding assay  
In vitro FL refolding was assayed using the method of Terada (Terada et 
al., 1997) with the following modifications: native FL was denatured in 50 mM 
HEPES pH 7.4, 5 mM DTT, 6 M GdnHCl at 30 °C for 30 min at a concentration of 
10 µM and subsequently placed on ice. To begin refolding, FL was diluted 
100-fold into unsupplemented E. coli S30 lysate and in lysates supplemented with 
either TF (5 µM) or KJE (10, 2, 6 µM) or all of the above. At given time points, 
aliquots were removed and luciferase activity was measured as described (2.4.1). 
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In all experiments, the refolding yield was expressed as a percent of the native 
enzyme control. 
2.4.3 Post-translational folding assay for firefly luciferase 
Firefly luciferase S30 translations were stopped after 22 min by adding 
RNase A (50 µg/ml). FL activity was measured immediately before and at 
regular intervals after RNase A addition up to 60 min. The resulting activities 
were normalized by setting the initial value before RNase A addition to unity. 
Chaperone concentrations in afore mentioned reactions were as above (2.4.2). 
Apyrase was added to 10 U/ml final. 
2.4.4 Actin refolding assay 
Radiolabeled denatured mouse β-actin was prepared as follows: actin 
was synthesized in the S30 translation system supplemented with [35S]-Met 
according to the manufacturer’s instructions. After completion of the reaction, 
actin was pelleted by centrifugation (22,000 g for 30 min at 4 °C) and 
resuspended in an equal volume of urea-containing buffer (20 mM Tris pH 7.5, 
10 mM DTT, 7.5 M urea). The denatured actin (~4 µM) was diluted 100-fold into 
dilution buffer (20 mM MOPS pH 7.4, 2.5 mM MgCl2, 1 mM DTT, 0.2 mM CaCl2, 
EDTA-free Complete protease inhibitors, 1 mM PMSF) containing 1 µM TRiC. 
The sample was then divided into four equal aliquots (I-IV). Aliquot (I) was 
diluted into SDS-sample buffer and later run on a 12% SDS-PAGE for accurate 
determination of the total amount of actin in the refolding reaction. Whereas 
aliquot (II) and (III) both received an ATP-regenerating system (1 mM ATP, 
8 mM creatine phosphate, 50 µg/ml creatine kinase); aliquot (III) additionally 
received DNase I (2 µM). Aliquot (II) and (III) as well as the remaining, untreated 
control aliquot (IV) were then incubated for 1 h at 30 °C. Refolding reactions 
were stopped by dilution into native Bis-Tris gel loading buffer (supplemented 
with 15 mM CDTA). The reaction products were run on native PAGE as 
described previously (2.3.1.3). Actin bands on SDS- and native PAGE were 
quantified using phosphoimaging and AIDA software. The percentage of 
refolded actin was determined by comparing the total amount of synthesized 
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actin on the SDS-PAGE with the material bound to DNase I on the native PAGE 
(indicated by a mobility shift). 
2.4.5 DNase I mobility shift assay 
Supernatants from S30 and RRL translation reactions were diluted 5-fold 
into DNase I-containing buffer (20 mM MOPS pH 7.4, 10 U/ml apyrase, 1 mM 
DTT, EDTA-free Complete protease inhibitors, 1 mM PMSF, 5 µM DNase I) and 
incubated for 30 min at 30 °C. To ensure complete translation termination, the 
dilution buffer for S30 and RRL translations additionally received 200 µg/ml 
chloramphenicol or 200 µM cycloheximide, respectively. DNase I-bound actin 
was analyzed by its mobility shift on native PAGE and quantified as described 
(2.3.1.3). 
2.4.6 DNase I binding assay 
DNase I was crosslinked to CNBr-activated Sepharose 4B according to 
the manufacturer’s protocol. RRL reactions were carried as described previously 
(2.3.4). After a 90 min, reactions were treated with 10 U/ml apyrase for 2 min at 
30 °C following incubation with 500 U/ml TEV-protease for 30 min at 30 °C, if 
required. The reactions were then diluted into 400 µl glass-bead lysis buffer 
(2.2.7.3) and the actin bound to 40 µl of DNase I-beads (1:1 suspension in PBS) 
during a 2 h incubation at 4 °C (Lazarides and Lindberg, 1974). Prior to protein 
elution with SDS sample buffer, the beads were essentially washed as described 
(Ewalt et al., 1997). Protein analysis was performed using SDS-PAGE and 
phosphoimaging. 
Yeast ∆reg cells expressing actin fusion proteins (3 h at 30 °C in SC-Leu, 
supplemented with 2% glucose and 2% galactose) were lysed with glass beads in 
presence of 0.36 mM cycloheximide and 10 U/ml apyrase, as described (2.2.7.3). 
After removal of non-lysed cells, TEV-cleavage (500 U/ml) of actin fusion 
proteins was carried out for 30 min at 30 °C. After centrifugation (20,000 g for 
10 min at 4 °C), actin in the supernatant was bound to 60 µl of DNase I-beads (1:1 
suspension in PBS) and analyzed as described above. 
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2.4.7 Determination of actin folding kinetics in S30 and RRL 
Two identical S30 and two identical RRL translations were set up as 
described (2.3.4) and the appearance of total actin as well as actin bound to 
DNase I was followed over time, as reported above (2.4.5). At the time of 
mid-logarithmic protein translation in the different translation systems (at 30 min 
and 60 min for S30 and RRL, respectively), one out of the two translation 
reactions was stopped by addition of RNase A (100 µg/ml), and monitoring 
continued for 1 h. The final values of total as well as folded actin protein of 
untreated reactions were set to 100%. Time points of RNase A addition were set 
to the equivalent percentage values at the same time point as in untreated 
reactions. 
2.4.8 Fluorescence microscopy analysis 
Samples from RTS reactions were incubated with 10 µM rhodamine-
phalloidin (rPh) for 30 min at 37 °C, transferred to a microscope slide and 
air-dried to bind proteins to the glass surface. Upon removal of excess rPh by 
washing with PBS, actin filaments (F-actin) were analyzed by fluorescence 
microscopy (Axiovert200 equipped with filter set 15, an AxioCAM HRm digital 
camera and Axiovision 3.1 software). 
For fluorescence microscopy analyses in yeast, ∆reg cells were grown to 
OD600~0.5 in SC-Leu (containing 2% glucose) and protein expression induced 
with 0.5% galactose for 3 h at 30 °C. Fixation of the cells was performed by 
adding 3.7% formaldehyde into the medium, following incubation for 30 min on 
a rotor (Adams and Pringle, 1991). After washing the cells twice with PBS, the 
pellet was resuspended in 40 µl PBS, 0.3 µM rPh, 0.1% TritonX-100 and incubated 
in the dark for 10 min. The stained cells were washed with PBS and visualized by 
UV-illumination in an Axio ImagerA.1 fluorescence microscope (equipped with 
filter sets 15 and 38) and a CoolSnap HQ digital camera. To compare the location 
of rPh stained actin patches with those resulting from GFP-labeled actin fusion 
proteins, images from the red and green emission channels were merged with 
Metamorph 6.3 software. 
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2.4.9 Fluorescence measurements 
Emission spectra of purified proteins or proteins translated in vitro and 
diluted into PBS were acquired at 25 ºC on a Fluorolog-3 fluorescence 
spectrometer. GFP fluorescence was measured at an excitation wavelength of 
397 nm and emission spectra were collected from 450 to 575 nm. mCherry was 
excited at 585 nm and the emission was recorded from 595 to 700 nm. Band 
passes were set to 5 nm for all measurements. 
2.4.10 Quantitation of rPh-stained F-actin 
Actin was translated in the presence of 5 µM TRiC as described 
previously (2.3.4). The reaction was stopped after 60 min by the addition of 
RNase A (100 µg/ml). After incubation for 60 min at 37 °C with rPh (10 µM), the 
reaction was passed through a Sephadex-G50 size exclusion column equilibrated 
in F-actin stabilizing buffer (2 mM Tris pH 7.4, 1 mM ATP, 0.5 mM DTT, 0.2 mM 
CaCl2, 150 mM KCl, 2 mM MgCl2) to separate rPh-labeled actin filaments from 
free dye. Fractions were collected and the fluorescence was measured at 
540/572 nm (Excitation/Emission). 
2.4.11 Electron microscopy 
For negative staining, the protein sample was adsorbed onto a carbon-
coated copper grid (400x100 mesh) made hydrophilic by glow discharge for 
1 min. After removal of excess liquid by wicking to filter paper, staining was 
performed by incubation on a drop of 2% uranyl acetate for 1 min. The 
preparations were inspected in a Philips CM20 electron microscope. 
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3 Results 
3.1 Role of trigger factor and DnaK in multi-domain protein 
folding 
In the cell, a large number of newly translated proteins are dependent 
on the assistance of molecular chaperones to acquire their native state on a 
biologically relevant time scale (Ellis, 1987; Bukau et al., 2000; Frydman, 2001; 
Hartl and Hayer-Hartl, 2002). Interestingly, although the major chaperone 
families have been conserved throughout evolution, complex modular proteins 
of eukaryotic origin often fold with low efficiency upon recombinant expression 
in bacteria (Baneyx, 1999). Differences between bacterial and eukaryotic 
chaperones regarding their functional coupling to the translation process might 
contribute to this phenomenon (Netzer and Hartl, 1997; Netzer and Hartl, 1998; 
Hartl and Hayer-Hartl, 2002). 
This part of the work was performed in close collaboration with Drs. 
Vishwas Agashe and Suranjana Guha. 
3.1.1 Misfolding of eukaryotic firefly luciferase in E. coli lysate 
To investigate the effects of bacterial chaperones on the folding of 
modular eukaryotic proteins upon translation in an E. coli-based cell-free 
translation system, firefly luciferase (FL) was chosen as a model eukaryotic multi-
domain protein. FL from the North American beetle Photinus pyralis is a two-
domain protein of 62 kDa in size. Its structure has been solved to 2 Å resolution, 
showing a large N-terminal domain and a smaller C-terminal domain (Conti et 
al., 1996). FL catalyzes the oxidation of the heterocyclic compound luciferin with 
molecular oxygen in the presence of ATP and Mg2+. This reaction is very rapid 
and results in the emission of yellow-green light, which makes FL an ideal 
candidate for protein folding studies. FL is naturally located in specialized 
peroxisomes of the firefly and its uptake into the organelle is thought to occur 
after folding in the cytosol (McNew and Goodman, 1996). Importantly, the 
apparent folding rate of FL is strongly affected by the folding environment. 
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Refolding of fully denatured FL in the absence of cellular factors is exceedingly 
slow, reaching equilibrium after days (Herbst et al., 1998). This is due to 
kinetically trapped species imposed by intramolecular misfolding (Herbst et al., 
1998; Frydman et al., 1999). Refolding in the presence of the E. coli Hsp70 system 
DnaK, DnaJ, and GrpE (KJE) takes only ~10-15 min (Szabo et al., 1994). GroEL 
does not support FL refolding but can mediate its transfer to DnaK (Buchberger 
et al., 1996). In striking contrast, newly synthesized FL in eukaryotic cell lysates is 
fully active within seconds upon completion of synthesis (Kolb et al., 1994), 
resulting from co-translational folding assisted by the Hsp70/40 chaperone 
system and the cytosolic chaperonin TRiC (Frydman et al., 1994; Frydman et al., 
1999). 
In order to gain more information about the role of chaperones in the 
early stages of protein synthesis, FL was expressed to similar levels in bacterial 
(E. coli) and eukaryotic (S. cerevisiae) cells (Figure 10, left side). Upon expression 
in yeast, essentially all of the synthesized FL protein was soluble and 
enzymatically active. In contrast, expression of FL in E. coli revealed only 40% 
soluble and 5-10% active protein, respectively. Size exclusion chromatography 
analysis of soluble FL from E. coli showed that ~30-40% of the protein was 
monomeric but not functional. The remaining ~60-70% were found in higher 
molecular weight fractions, forming oligomeric structures (H.-C. Chang: personal 
communication). Expression of FL in coupled transcription/translation lysates of 
rabbit reticulocytes (RRL) and E. coli (S30) confirmed these findings (Figure 10, 
right side). These lysates support efficient protein synthesis (up to ~200 µg/ml 
per hour), but represent dilute cytosol preparations with low levels of 
endogenous chaperones (3.1.2). The translation reactions were typically run for 
1 h at 30 °C in the presence of radiolabeled [35S]-Met following separation of 
soluble and insoluble material by centrifugation. Quantitation of the 
radioactively labeled FL bands upon SDS-PAGE analysis revealed FL translated 
in RRL to be ~100% soluble (Figure 10, top panel).  FL activity of total 
synthesized protein was estimated to be approximately 55%. In contrast, the 
specific activity of FL translated in the S30 lysate was only ~5%, with ~45% of the 
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protein being in the soluble state. Thus, intramolecular misfolding followed by 
aggregation accounts for the low specific activity of bacterially expressed FL. 
 
 
Figure 10: Folding of FL is inefficient in bacteria compared to eukaryotes. 
 
FL was expressed to similar levels in vivo in E. coli and S. cerevisiae (Agashe et al., 
2004) and in vitro in E. coli (S30) and rabbit reticulocytes lysate (RRL) translation 
reactions. Top panel: Distribution of FL protein upon fractionation of total cell extracts (T) 
into soluble (S) and pellet fractions (P) by centrifugation. Bottom panel: FL relative 
activities (white bars) and amount of soluble FL in % of total (gray bars). The specific 
activity in yeast was set to 1. 
 
3.1.2 Cooperative effect of TF and DnaK on folding 
In general, misfolding of FL in the bacterial cytosol can result either 
from the lack of specific eukaryotic factors or the presence of inhibitory 
prokaryotic factors, or a combination of both. As shown in the past, TF and DnaK 
have partially overlapping functions in de novo protein folding in E. coli cells 
(Teter et al., 1999; Deuerling et al., 2003). Therefore, the contribution of TF and 
DnaK to FL folding in the in vitro S30 translation lysate was analyzed. The in vivo 
concentration of TF and DnaK under standard growth conditions in E. coli cells 
are ~40 µM and ~50 µM, respectively (Lill et al., 1988; Hesterkamp and Bukau, 
1998). In contrast, the S30 lysate used throughout this study represents a highly 
diluted cytosol with final concentrations of both TF and DnaK of ~0.5 µM as 
determined by quantitative western blotting (Agashe et al., 2004). In order to 
determine whether these residual amounts of TF and DnaK were still able to 
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successfully promote protein folding in vitro, refolding experiments of FL were 
performed (Figure 11). 
 
 
 
Figure 11: Refolding of chemically denatured FL. 
 
Time course of refolding of chemically denatured FL (final concentration: 100 nM upon 
100-fold dilution from 6 M GdnHCl) in unsupplemented bacterial S30 lysate (no 
chaperones, ?) and in lysates supplemented with TF (5 µM, ?), KJE (10, 2, 6 µM, ?), 
and TF with KJE (?) at 30 °C. The refolding yield is expressed as percent of a native 
enzyme control. 
 
Interestingly, ATP-dependent refolding of purified chemically 
denatured FL, diluted into the S30 lysate, was only ~10% efficient. In contrast, 
refolding in the S30 lysate upon supplementation with the purified bacterial 
Hsp70 chaperone system KJE (10, 2, and 6 µM) occurred with a half-time of 
~10 min and resulted in 80-90% native FL (Figure 11 and 12A). This effect was 
irrespective of the presence of TF (5 µM) (Figure 11 and 12A). Importantly, TF 
alone was not able to refold FL above background level. Together, the refolding 
efficiency of FL out of denaturant solely depends on the presence of KJE and 
cannot be further increased by the addition of TF. 
Next, the S30 lysate was supplemented with different combinations of 
purified bacterial chaperones (Figure 12A) and their effect on the specific activity 
of FL during de novo synthesis analyzed. In contrast to the results obtained for FL 
refolding (Figure 11), the sole addition of TF to the S30 lysate increased the 
specific activity of newly translated FL 2- to 3-fold (Figure 12B), while the 
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solubility improved from ~40% to ~60%. When the same experiment was 
performed in an S30 lysate that had been immunodepleted of DnaK to further 
reduce the DnaK concentration, TF had no effect (Agashe et al., 2004: 
Supplemental Figure S3). Thus, TF action is strongly dependent on the residual 
amounts of DnaK present in the lysate. Surprisingly, addition of purified KJE 
alone was without effect on FL activity, even though FL is maintained in an 
almost completely soluble state under these conditions (Figure 12B). Adding TF 
and KJE together resulted in a ~4-fold increase in specific activity. These findings 
lead to the assumption that, during de novo folding of FL, TF and KJE must 
cooperate in order to increase its folding efficiency while refolding of FL out of 
denaturant is TF independent (Figure 11). Thus, TF is critical in maintaining FL 
nascent chains competent for folding by the KJE system. 
 
 
 
Figure 12: Effect of purified chaperones on folding yields of FL during translation. 
 
(A) SDS-PAGE analysis of purified E. coli chaperones: Trigger factor wild-type (TF) and 
FRK/AAA-mutant (TFFRK/AAA), DnaK (K), DnaJ (J), GrpE (E), and the chaperonin GroEL 
(EL) with its co-chaperone GroES (ES). (B) Expression of FL in S30 translation reactions 
with and without chaperone supplementation, as indicated (TF, 5 µM; KJE, 10, 2, and 
6 µM; ELES, 1 and 2 µM). Specific FL activities after 1 h translation at 30 °C (white bars) 
are shown relative to the unsupplemented lysate (set to 1). Protein solubility (gray bars) is 
given as a fraction of total protein in the presence or absence of added chaperones, as 
indicated. 
 
However, the 4-fold increase in activity upon de novo synthesis of FL in 
the presence of TF and KJE (~20%, compared to ~5% in the unsupplemented S30 
lysate; Figures 10 and 12B) is lower than the yield obtained from FL refolding 
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(80-90% in presence of KJE alone; Figure 11). This finding suggests that TF 
functions inefficiently in stabilizing ribosome bound FL in a conformation 
productive for the interaction with DnaK. Moreover, a folding yield of ~20% with 
essentially all translated protein appearing in the soluble fraction indicates, that, 
similar to FL expression in E. coli, a large fraction of the protein must be in a 
misfolded sate. As expected, supplementation of the S30 lysate with purified 
GroEL/GroES (ELES; Figure 12A) at physiological concentrations (1 and 2 µM) in 
addition to TF and KJE did not further improve the yield of FL folding 
(Figure 12B). 
3.1.3 Chaperone enforced shift in folding mechanism 
As mentioned previously, refolding of denatured FL in the presence of 
the bacterial Hsp70 system takes approximately 10-15 min (Figure 11 and Szabo 
et al., 1994), whereas FL translated in a eukaryotic system is fully active within 
seconds upon completion of synthesis (Kolb et al., 1994). 
In order to find out whether the differences in FL folding efficiencies 
observed in eukaryotic and prokaryotic systems are based on different folding 
mechanisms, kinetics of FL translation and folding in the unsupplemented 
(chaperone diminished) S30 lysate were compared to those in RRL. In the latter 
system, folding of FL is assisted by mammalian Hsp70/40 and TRiC (Frydman et 
al., 1994). Surprisingly, despite the marked difference in folding yield (~5% in 
unsupplemented S30 versus ~60% in RRL; Figure 10), in both systems FL activity 
appeared virtually concurrently with the production of full-length protein 
(Figure 13A), indicative of the occurrence of co-translational folding. Further 
kinetic experiments were performed to test whether TF and KJE affect the 
mechanism of FL folding when present during translation at concentrations 
closer to physiological levels (3.1.2). Indeed, when TF (5 µM) was added to the 
S30 lysate, the kinetics of FL folding showed a significant deceleration 
(Figure 13B), indicative of a shift towards a post-translational mode of folding. 
Increasing amounts of added TF (up to 15 µM) did not cause a further delay in 
folding (S. Guha: personal communication). Importantly, upon addition of TF to 
the reaction, the speed of translation was not affected (Figure 13B). 
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Figure 13: TF and KJE delay folding relative to translation in vitro. 
 
(A) Apparent co-translational folding of FL in E. coli (S30) and rabbit reticulocytes (RRL) 
translation reactions. Appearance of full-length protein (?) and activity (?) were followed 
with time. Final values were set to 100%. (B) Appearance of FL activity during S30 
translation in the absence of added chaperones (?) and presence of added KJE (10, 2, 
6 µM, ?), TF (5 µM, ?) or a combination of both (?). The appearance of full-length FL in 
all translations was identical and is represented in red. 
 
Deceleration in FL folding was not observed when KJE was added in the absence 
of TF. However, concurrent with the increase in folding yield (Figure 12B), the 
post-translational component of folding became even more pronounced when 
the reaction was supplemented with TF and KJE together (Figure 13B). Thus, TF 
and the DnaK-system seem to cooperate in order to assure a post-translational 
folding mechanism. In contrast, the rapid folding observed in the 
unsupplemented S30 lysate apparently represents a co-translational but highly 
inefficient default-pathway. 
3.1.4 Shift in folding mechanism requires co-translational action of 
TF and DnaK 
A hallmark of co-translational folding is the immediate stop of the 
appearance of native, active protein after translation termination (Figure 14). In 
contrast, proteins following a post-translational folding mechanism typically 
continue to form native protein after translation is inhibited. This effect is due to 
the specific interaction of chaperones with the nascent polypeptide chain upon its 
release from the ribosome in order to mediate proper folding. The time necessary 
for post-translational completion of folding is thereby strongly dependent on the 
protein and the folding environment. 
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Figure 14: Co- versus post-translational protein folding model data. 
 
After a short lag phase, due to ribosome loading with mRNA, the appearance of 
enzymatically active protein in a coupled transcription/translation reaction in vitro typically 
occurs linear over time. Upon termination of protein synthesis by a translation inhibitor, 
the appearance of folded protein either stops concomitantly with translation termination 
(indicative for a co-translational folding mechanism) or increases further over time 
(indicative for a post-translational folding mechanism). 
 
To see whether the delay in folding caused by TF and KJE is dependent 
on the co-translational action of these chaperones, FL was translated in the 
S30 lysate. The appearance of FL activity was followed over time after the 
reaction was stopped by the addition of RNase A (an efficient translation 
inhibitor for both prokaryotic and eukaryotic systems), 22 min after translation 
initiation. Inhibition of translation in the unmodified S30 lysate was not followed 
by any further increase in FL activity (Figure 15; also see Figure 11), consistent 
with the virtually concurrent appearance of full-length protein and enzyme 
activity, reported previously (Figure 13A). In contrast, supplementation of the 
lysate with TF together with KJE resulted in a more than 2-fold increase of FL 
activity upon inhibition of translation (Figure 15). The kinetics for the 
post-translational appearance of FL activity (t1/2~10 min) was in good agreement 
to those observed for the ATP-dependent, KJE-mediated refolding of denatured 
FL (Figure 11; Szabo et al., 1994). Depletion of ATP by apyrase concomitant with 
RNase A addition eliminated the post-translational phase, consistent with an 
ATP requirement for DnaK function (Figure 15). Although the sole addition of TF 
Results   66                                  
showed a similar post-translational folding phase, the increase of FL activity was 
less pronounced when compared to the lysates supplemented with both TF and 
KJE. Addition of a triple-mutant form of TF, TFFRK/AAA (Figure 12A), defective in 
ribosome binding (Kramer et al., 2002), did not result in post-translational FL 
folding (Figure 15) or an increase in FL folding efficiency (data not shown). 
 
 
 
Figure 15: Co-translational actin of TF and KJE changes the mechanism of FL 
folding. 
 
Post-translational changes in FL activity were followed after translation inhibition with 
RNase A (22 min after initiation). S30 lysate without added chaperones (?) and with 
chaperones added at the beginning of translation: TF (5 µM, ?) and TFFRK/AAA (5 µM, ?), 
KJE (10, 2, 6 µM, ?), TF and KJE (?), TF together with KJE and apyrase (?). In another 
reaction, TF and KJE were added together with RNase A at the time of stopping 
translation (?). 
 
Thus, binding of TF to the ribosome is a prerequisite for both the switch in FL 
folding from a co- to a post-translational mechanism (Figure 13) and the resulting 
gain in FL activity seen with wild-type TF (Figure 12B). Strikingly, addition of TF 
and KJE after the translation was stopped with RNase A failed to produce any 
post-translational folding phase. These findings were corroborated by the lack of 
a post-translational folding phase upon translation of FL in a DnaK-
immunodepleted lysate, which contained TF from the beginning and received 
KJE after the translation was inhibited (S. Guha: personal communication). 
Hence, the co-translational action of TF and KJE, preventing misfolding or 
aggregation, is essential for productive, post-translational folding of FL. 
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Taken together, folding of the multi-domain protein FL in a 
chaperone-diminished S30 lysate occurs by a fast and co-translational default 
mechanism which is limited by misfolding and aggregation of the nascent chains. 
Although lysate supplementation with TF and KJE counteracts this off-pathway 
folding, directing nascent polypeptides to a post-translational folding route, the 
mechanistic shift applied cannot substitute for the efficient co-translational 
folding of FL in the eukaryotic system (Frydman et al., 1994). 
3.2 TRiC-assisted folding of actin upon bacterial translation 
The inability of the bacterial cytosol to support efficient folding of 
eukaryotic proteins results, among other factors, from the presence of 
incompatible molecular chaperones, as described for FL (3.1 and Agashe et al., 
2004). On the other hand, certain eukaryotic proteins, such as actin, are known to 
have specific chaperone requirements for efficient folding. In vivo folding and 
in vitro refolding of actin is strictly dependent on the eukaryotic chaperonin TRiC 
(Tian et al., 1995; Siegers et al., 1999). Although architecture and mechanism of 
TRiC function are thought to be similar to those of bacterial GroEL, the bacterial 
chaperonin cannot mediate actin folding. Indeed, recombinant expression of 
actins from multiple species (including Dictyostelium discoideum, S. cerevisiae and 
rabbit) in E. coli results in the generation of non-native species that aggregate into 
inclusion bodies (Frankel et al., 1990). 
Therefore, this part of the study focuses on the minimum chaperone 
requirements for the production of substantial amounts of native actin upon 
synthesis in the bacterial S30 lysate. 
3.2.1 Purified TRiC is active and does not affect in vitro translation 
efficiency of S30 lysates 
In order to investigate the effect of TRiC on actin translation rates during 
de novo synthesis in the bacterial S30 lysate, the chaperonin was purified from 
bovine testes with the following modifications of the protocol published by 
Ferreyra and Frydman (2000): Only four chromatographic steps were necessary 
to obtain >95% pure TRiC (Figure 16A), in contrast to six steps and an 
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ammonium sulfate precipitation in the published protocol (2.3.3.1). The 
modifications applied did not lead to a decrease in the overall yield of purified 
material: routinely ~8 mg of purified TRiC per 100 g of starting material were 
obtained. Characterization of the purified chaperonin complex by analytical gel 
filtration analysis resulted in a single homogenous peak eluting at the 
appropriate size of ~900 kDa, indicative of TRiC being pure and fully assembled 
(Figure 16B). 
 
 
 
Figure 16: Characterization of purified TRiC from bovine testes. 
 
(A) SDS-PAGE analysis of TRiC purified from bovine testes according to the protocol of 
Ferreyra and Frydman (Ferreyra and Frydman, 2000) with modifications (2.3.3.1). (B) 
Absorption profile of the purified TRiC complex applied to an analytical Superose 6 gel 
filtration column (SMART system). Arrows indicate the position of marker proteins (in 
kDa). 
 
Examination of purified TRiC samples by negative stain electron 
microscopy revealed particles extremely regular in size and shape (Figure 17). 
The predominant view was of ring-shaped structures with a central stain-filled 
hole. Aggregates or individual subunits resulting from disassembled TRiC 
complexes were not observed. These findings are consistent with previously 
reported electron microscopy analyses of large barrel shaped double ring 
complexes, including TRiC and ELES (Frydman et al., 1992; Langer et al., 1992b). 
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Figure 17: Electron micrograph of negatively stained TRiC. 
 
Purified TRiC was negatively stained with uranyl acetate and examined by electron 
microscopy on a carbon coated copper grid. Size bar = 50 nm. Image was recorded by 
Karoline Bopp, Department of Molecular Structural Biology, MPI of Biochemistry). 
 
To test whether TRiC purified by this method was active, its ability to 
refold actin upon dilution from denaturant was examined. Denatured 
radiolabeled actin (~4 µM) was diluted 100-fold into buffer containing TRiC 
(1 µM) in the absence and presence of ATP and DNase I. The resulting complexes 
were analyzed by native PAGE and phosphoimaging (Figure 18A). Throughout 
this study, generation of native monomeric actin (G-actin) was monitored by its 
characteristic mobility on native PAGE and the shift in position of this band upon 
formation of a binary complex with DNase I (Hansen et al., 1999). In the absence 
of ATP, most of the material was stably bound to TRiC, whereas actin was 
released upon incubation with ATP (Figure 18A). The released actin was native, 
since it was able to form a stable complex with DNase I, as evidenced by the shift 
associated with the decreased mobility of this complex upon native PAGE 
analysis. Quantitation of the band corresponding to native actin demonstrated 
that TRiC purified by this method was able to refold ~50% of the diluted actin 
within a 1 h incubation at 30 °C (Figure 18B), a similar amount to that reported 
previously (Gao et al., 1992). 
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Figure 18: TRiC assisted actin refolding. 
 
(A) Native PAGE of TRiC assisted actin refolding upon dilution from denaturant. All 
reactions were performed in the presence of TRiC. Supplementation with ATP and 
DNase I is indicated above the panel. Filled arrowhead: actin:TRiC complex; empty 
arrowhead: actin:DNase I complex; empty arrow: native monomeric actin (G-actin). (B) 
Quantitation of phosphoimaging results: G-actin bound to DNase I (DNase I) as assessed 
in (A) relative to the total amount of denatured actin (Total) used for refolding. 
 
The bacterial S30 translation lysate used in this work is designed to produce large 
quantities of recombinantly expressed protein (~200 µg/ml per hour; 3.1). To 
make sure that supplementation of the bacterial lysate with purified TRiC did not 
lead to any detrimental effects on translation, the amount of total actin 
synthesized in translation reactions in absence and presence of 5 µM TRiC (the 
amount used throughout this study; Figure 21) were compared by quantitative 
immunoblotting (Figure 19). Importantly, the addition of purified TRiC to the 
S30 lysate had no effect on the actin translation efficiency, which typically 
resulted in the production of ~175 µg/ml (~4 µM) per hour when compared to 
purified actin standard protein (2.3.3.3). 
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Figure 19: Supplementation of bacterial lysates with purified TRiC did not affect 
translation efficiency. 
 
Quantitative immunoblotting of translated actin protein (42 kDa). Left: duplicate 
experiments of actin translations (1 µl of total reaction) in absence or presence of TRiC 
(5 µM), as indicated. Right: actin standard protein purified from inclusion bodies of E. coli 
(2.3.3.3). 
 
3.2.2 TRiC is capable to assist the folding of newly synthesized actin 
Next, the effect of TRiC on the behavior of actin synthesized in the 
S30 lysate was characterized. Actin translation reactions, supplemented with 
[35S]-Met, were performed in the absence and presence of TRiC (5 µM) and 
subsequently centrifuged to separate soluble and insoluble fractions (2.3.4). In 
absence of TRiC, quantitation of the corresponding actin bands upon SDS-PAGE 
analysis revealed ~90% of synthesized actin to be in the insoluble fraction. In 
contrast, lysate supplementation with TRiC turned approximately 80% of the 
translated actin into soluble protein (Figures 20A and 20B). The supernatants of 
these reactions were incubated with DNase I and the actin:DNase I complexes 
examined by native PAGE (Figures 20B and 20C; 2.4.5). Only the reaction 
supplemented with TRiC resulted in material that formed complexes with 
DNase I (Figure 20C). Quantitation revealed that ~40% of the total actin 
synthesized in the presence of TRiC bound to DNase I in form of monomeric 
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G-actin (a similar amount was present as F-actin, but incapable of binding to 
DNase; 3.2.5). 
 
 
 
Figure 20: TRiC supplementation of a bacterial translation lysate results in the 
production of native actin. 
 
(A) SDS-PAGE of total (T), supernatant (S) and pellet (P) fractions of actin (42 kDa) 
produced in unsupplemented and TRiC-supplemented bacterial S30 translation reactions, 
as indicated. (B) Phosphoimaging quantitation of actin translations as shown in (A) as 
well as DNase I-bound native actin (D) as assessed in (C). (C) Native PAGE of actin 
synthesized in absence and presence and of TRiC (5 µM), as indicated. After translations 
were stopped, DNase I was added to the supernatants of the reactions. Filled arrowhead: 
actin:TRiC complex; filled arrow: actin:GroEL complex (determined by comparing the 
mobility of a complex between purified GroEL and actin, data not shown); empty 
arrowhead: actin:DNase I complex; empty arrow: native actin. 
 
In order to determine the optimal TRiC concentration required for the 
folding of the substantial actin quantities synthesized in this lysate, translation 
reactions with increasing concentrations of TRiC were performed. The amount of 
actin capable of binding to DNase I was examined by native PAGE, as described 
above (Figure 21A). The yield of DNase I-bound actin (~40%) did not increase at 
concentrations >5 µM, which correlated well with the observed actin solubility 
(Figure 21B). Therefore, a concentration of 5 µM TRiC was used in subsequent 
experiments. 
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Figure 21: Titration of purified TRiC added to the bacterial translation lysate. 
 
(A) Native PAGE of actin S30 translations performed in presence of increasing amounts 
of supplemented TRiC (indicated above the panel). Reactions in lanes 2-6 received 
DNase I, as indicated. Symbols are as in Figure 20C. (B) Phosphoimaging quantitation of 
the actin:DNase I band as assessed in (A) (filled circles) and the material remaining in the 
pellet fraction as assessed by SDS-PAGE analysis (empty circles and data not shown). 
 
3.2.3 Bacterial chaperones are not able to fold actin nascent chains 
It is well known that recombinant expression of actin in E. coli cells 
results in the formation of insoluble aggregates (Frankel et al., 1990).  Moreover, 
the bacterial S30 translation lysate used in this study represents a dilute cytosol 
preparation functionally-depleted of endogenous chaperones and thus unable to 
support the efficient folding of the eukaryotic multi-domain protein FL, as 
mentioned previously (3.1). 
In order to examine the effects of bacterial chaperones on actin solubility 
and folding during de novo synthesis in the S30 lysate, translation reactions were 
supplemented with purified ELES (1 and 2 µM) and the major nascent chain 
binding chaperones TF (5 µM) and KJE (10, 2 and 6 µM) (Figures 22A and 12A). 
Addition of these chaperones did not affect translation rates when compared to 
unsupplemented lysate (Figure 22A). The reactions were centrifuged to separate 
soluble and insoluble material and examined as before (Figures 22A and 22B). 
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Figure 22: Supplementation of the S30 translation lysate with purified bacterial 
chaperones does not result in the production of native actin. 
 
(A) SDS-PAGE of total (T), supernatant (S) and pellet (P) fractions of actin (42 kDa) 
produced in unsupplemented (unsuppl.) and trigger factor- (TF, 5 µM), DnaK/DnaJ/GrpE- 
(KJE, 10, 2, and 6 µM) or GroEL/GroES- (ELES, 1 and 2 µM) supplemented S30 lysate 
reactions. (B) Phosphoimaging quantitation of actin translations as shown in (A) as well 
as DNase I-bound native actin (D) as assessed in (C). (C) Native PAGE of actin 
synthesized in absence and presence of bacterial chaperones or TRiC, as indicated. 
After translations were stopped, supernatants of all reactions received DNase I. Symbols 
are as in Figure 20C. 
 
Supplementation with ELES or KJE in the above mentioned concentrations 
resulted in ~90% of the synthesized actin remaining in the soluble fraction, 
whereas addition of TF did not improve actin solubility when compared to the 
unsupplemented reaction (~10%) (compare Figures 22A and 22B with Figure 20A 
and 20B). Higher chaperone concentrations did not lead to any further increase in 
actin solubility (data not shown). Next, actin present in the supernatants of these 
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chaperone-supplemented reactions was examined regarding the capability of 
forming a complex with DNase I as described above. In contrary to the 
production of native actin upon supplementation with TRiC, none of the 
bacterial chaperones tested were able to generate actin capable to bind to DNase I 
(Figure 22C). 
3.2.4 Folding of actin assisted solely by TRiC occurs more slowly than 
folding in the eukaryotic cytosol  
TRiC-mediated refolding of actin upon dilution from denaturant occurs 
with a half-time of ~15-30 min, which reflects the need for several cycles of actin 
binding and release from the chaperonin for the generation of native protein 
(Tian et al., 1995). In contrast, de novo folding of newly synthesized actin in the 
cytosol of wild-type eukaryotic cells is much faster, with half-times of ~1 min 
(Siegers et al., 1999). This finding suggests that actin translation and folding are 
normally efficiently coupled, and that actin leaves TRiC in a native or near-native 
state. This rapid folding process has been explained by the presence of a “folding 
compartment” in the eukaryotic cytosol, in which additional factors, such as 
PFD/GimC, sequester folding intermediates during TRiC-assisted folding and 
prevent their premature release into the crowded environment of the cytosol 
(Hartl and Hayer-Hartl, 2002). Indeed, when actin was synthesized in 
GimC-deficient yeast strains, the rate of actin folding was decrease 5-fold, with 
the overall yield of native actin being reduced by 40-50% (Siegers et al., 1999). 
Since the bacterial S30 translation system lacks all of the factors normally 
present in the eukaryotic cytosol and E. coli chaperones are unable to mediate 
actin folding, this provided the opportunity to investigate the folding kinetics of 
newly translated actin assisted solely by TRiC. Therefore, the appearance over 
time of total translated actin (monitored by SDS-PAGE, as above) versus 
DNase I-binding actin (monitored by native PAGE, as above) was followed in a 
translation reaction supplemented with TRiC and [35S]-Met (Figures 23A and 
23B). 
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Figure 23: Folding of bacterially-translated actin assisted solely by TRiC occurs 
more slowly than actin folding in RRL. 
 
Appearance of total (?) and DNase I-bound (?) actin in TRiC-supplemented bacterial 
S30 translation lysates (S30) (A, B) or unsupplemented reticulocyte lysates (RRL) (C, D) 
that received no treatment (A, C; final values set to 100%) or that received RNase A 
treatment to stop translation at the time point indicated by the arrow (B, D; point of 
RNase A addition set to the equivalent percentage value at the same time point in A and 
C, respectively). Lower panels: SDS-PAGE and native PAGE used for quantitation. 
 
As can be observed, there is a delay of ~15 min in the appearance of native actin 
relative to full-length actin synthesized (Figure 23A). This finding suggests that 
translation is poorly coupled to TRiC-mediated folding in this system and that 
actin folds through a slow post-translational mechanism. If actin folding in the 
S30 lysate is not tightly coupled to translation, then addition of a translation 
inhibitor to an ongoing translation reaction should result in the accumulation of 
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native actin over the next few minutes after translation has stopped (for general 
information see Figure 14). Thus, RNase A was added to an ongoing reaction, 
supplemented with TRiC and [35S]-Met as above. Subsequently, the appearance 
of native protein after translation termination was monitored over time 
(Figure 23B). Strikingly, whereas RNase A addition resulted in an immediate 
cession of translation, DNase I-binding actin continued to increase over the next 
minutes with a half-time of ~10-15 min. This result was in good agreement to the 
delay in actin folding observed in the untreated S30 reaction (Figure 23A). Thus, 
TRiC-assisted actin folding in the bacterial lysate occurs with similar kinetics 
resembling that of actin refolding upon dilution from denaturant (Tian et al., 
1995). 
The slow kinetics of actin folding relative to translation observed in the 
TRiC-supplemented bacterial lysate could be due to intrinsic properties of 
coupled transcription/translation lysates (such as general dilution of cytosolic 
factors, decreased crowding, etc.) or to a lack of specific factors that promote 
efficient actin folding. To investigate these possibilities, actin was translated in 
RRL and the kinetics of folding analyzed as described for TRiC-supplemented 
S30 reactions (Figure 23C). After a characteristic phase associated with 
transcription of the actin mRNA and ribosome loading, DNase I-binding actin 
was detectable shortly after the appearance of full-length actin, with a delay of 
only ~2-3 min. The fast folding kinetics observed were in good agreement to 
those reported for actin mRNA translation in RRL (Frydman and Hartl, 1996). If 
the majority of actin nascent chains are folding rapidly after their release from the 
ribosome, the addition of a translation inhibitor should lead to no further 
substantial increase of native actin after cessation of translation (for general 
information see Figure 14). Therefore, RNase A was added to an ongoing actin 
translation in RRL, similar to the one described above (Figure 23D). As expected, 
the accumulation of DNase I-binding actin stopped concurrently with 
translation, in sharp contrast to the result obtained with the bacterial lysate 
(Figure 23B). Taken together, these results suggest that, in the absence of 
additional factors, TRiC-mediated folding of newly translated actin is a slow 
process that necessitates several cycles of TRiC binding and release. 
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3.2.5 Bacterial S30-translated actin folded by TRiC readily 
polymerizes into filaments 
A hallmark of actin that has reached its native state is its ability to 
polymerize into filaments (F-actin). Phalloidin, a bicyclic heptapeptide from the 
poisonous mushroom Amanita phalloides, binds specifically to F-actin and its 
fluorescent derivatives have been used extensively to visualize actin filaments 
in vivo and in vitro (Cooper, 1987). In order to find out whether actin that has 
been translated in the bacterial S30 lysate and assisted in its folding by TRiC is 
able to polymerize into filaments, products of a TRiC-supplemented actin 
translation reaction were stained with rhodamine-derivatized phalloidin (rPh) 
and examined by fluorescence microscopy (Figure 24A). 
 
 
 
Figure 24: Bacterially-produced actin in the presence of TRiC readily polymerizes 
into filaments. 
 
(A) Fluorescence microscopy of rhodamine-phalloidin binding actin filaments produced in 
bacterial S30 lysates containing a plasmid encoding actin (pActin) and/or supplemented 
with TRiC (TRiC), as indicated. Size bar = 20 µm. (B) SDS-PAGE of total (T), supernatant 
(S) and pellet (P) fractions of actin (42 kDa) produced in bacterial S30 lysates containing 
a plasmid encoding actin (pActin) and/or supplemented with TRiC (TRiC), as indicated. 
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Abundant rPh-binding structures of filamentous shape with diverse lengths and 
no evident branching or amorphous aggregation were visible. Thus, the observed 
structures are likely to represent bona fide rPh-binding F-actin since they were not 
observed in actin translation products of unsupplemented reactions (Figure 24A) 
(even though the amounts of actin synthesized were equivalent; Figure 24B), nor 
in TRiC-supplemented lysates devoid of the actin-encoding DNA plasmid 
(Figure 24A). Supplementation of actin S30 translation reactions with the 
bacterial chaperones ELES, KJE or TF at concentrations used in previous 
experiments (3.2.3) did not lead to the appearance of rPh-binding structures (data 
not shown). 
The equilibrium between monomeric actin (G-actin) and polymerized 
actin (F-actin) is strongly favored towards F-actin at salt concentrations 
>50 mM K+ or Na+ and >2 mM Mg2+ (Pardee and Spudich, 1982). Therefore, it is 
plausible that in the translation lysates, which contain physiological salt 
concentrations, a considerable fraction of the actin polymerizes soon after it is 
released from TRiC as a native species. Since DNase I forms stable complexes 
with G-actin but not with F-actin (Hitchcock et al., 1976; Blikstad et al., 1978), the 
use of DNase I binding to quantitate the total amount of folded actin (G-actin + 
F-actin) under physiological salt concentrations may result in underestimation. If 
saturating quantities of rPh are used to bind F-actin, fluorescence can be used as 
a quantitative measure of the amount of filamentous actin present in the sample 
(Howard and Oresajo, 1985). To this end, the yield of F-actin present in the 
TRiC-supplemented reactions was estimated by measuring the amount of bound 
rPh. As phalloidin is known to bind with a stoichiometry of 1:1 to each F-actin 
protomer (Steinmetz et al., 1998), and ~4 µM actin is produced in a translation 
reaction, the product of an actin S30 translation reaction was incubated with 
10 µM rPh. rPh bound to F-actin was separated from unbound material by gel 
filtration chromatography and fluorescence intensities of the individual fractions 
were measured (Figure 25). As a control, a similar experiment was performed 
upon translation of FL in an unsupplemented S30 translation reaction. Strikingly, 
since FL does not bind rPh, an increase of rPh-fluorescence in fractions eluting 
early from the gel filtration column (reflecting fractions containing high 
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molecular weight complexes) was only observed in the case of actin synthesized 
in presence of TRiC. Thus, the amount of F-actin produced in 
TRiC-supplemented translations was estimated to be ~1.6 µM, corresponding to 
~40% of total actin synthesized. 
 
 
 
Figure 25: Quantiation of F-actin produced in a TRiC-supplemented S30 reaction. 
 
Actin, translated in a TRiC-supplemented (?) and FL, translated in an unsupplemented 
bacterial lysate (?) and incubated with 10 µM rhodamine-phalloidin (rPh). Reactions 
were then passed through a Sephadex-G50 gel filtration column to separate rPh-labeled 
F-actin from unbound, free dye. Fractions were collected and rPh-fluorescence was 
measured at 540/572 nm (Excitation/Emission). 
 
Notably, phalloidin is known to have a stabilizing function, and thus 
can prevent F-actin against depolymerization (Low and Wieland, 1974). In order 
to make certain that the amount of TRiC-folded actin, capable of binding to 
DNase I, remained unaffected upon rPh-treatment, actin labeling with rPh was 
additionally performed prior to DNase I incubation (Figure 26A). Importantly, 
the amount of DNase I-bound actin remained constant at a level of ~40-50%, 
irrespective of the time point of rPh treatment (compare Figures 26B and 20B). 
Thus, the overall percentage of newly synthesized, TRiC-folded actin in the 
bacterial system is ~80%, which corresponds to ~140 µg/ml (~3.2 µM) per hour. 
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Figure 26: Incubation of actin with rPh does not affect DNase I binding efficieny. 
 
(A) Native PAGE of actin synthesized in the presence of TRiC. Actin translation was 
stopped with RNAse A after 1 h and incubated with rPh (10 µM) before addition of 
DNase I to the supernatant, as indicated. Filled arrowhead: actin:TRiC complex; empty 
arrowhead: actin:DNase I complex; empty arrow: native actin. (B) Phosphoimaging 
quantitation of actin bound to DNase I (DNase I) as assessed in (A) relative to the 
amount of total actin synthesized (Total). 
 
3.3 Role of TRiC in the folding of actin-fusion proteins 
Despite a uniform size distribution of protein domains throughout all 
three kingdoms of life (Blake, 1985), the number of complex proteins combining 
multiple domains is proportionally larger in eukaryotes than in bacteria. In 1998, 
Netzer and Hartl proposed most eukaryotic multi-domain proteins to fold 
co-translationally in a domain-wise and conceivably Hsp70-assisted manner, but 
independent of the interaction with the TRiC chaperonin. In fact, it was 
suggested that TRiC is specialized for the post-translational completion of 
folding of modular proteins (including actin), which are constructed of 
discontiguous or structurally unstable sequence segments and therefore 
incapable of forming native tertiary structures during translation (Netzer and 
Hartl, 1998). Support for TRiC being involved in domain-wise protein folding 
mechanisms came from previous studies using pulse-chase experiments, where 
the chaperonin was shown to transiently associate with large substrate proteins, 
clearly exceeding the ~50 kDa size limit of the TRiC folding cavity (Ditzel et al., 
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1998; Thulasiraman et al., 1999). Furthermore, cross-linking studies demonstrated 
that TRiC can interact co-translationally with actin nascent chains, soon after they 
emerge from the ribosomal exit site (McCallum et al., 2000; Etchells et al., 2005). 
These results strongly support a close association between the chaperonin and 
the translation machinery and strengthen the idea of TRiC being able to shield 
hydrophobic patches of discontiguously organized domains of modular proteins 
during synthesis (Netzer and Hartl, 1998). However, experimental evidence for a 
domain-wise mode of TRiC-mediated folding has not yet been provided. 
In the following section, various actin-fusion proteins were generated 
and served as model multi-domain chaperonin substrates to elucidate the role of 
TRiC in domain-wise protein folding. Upon expression of the individual 
actin-fusions in S. cerevisiae, the folding state of actin within the fusion protein 
was examined by its capability to incorporate into yeast cytoskeletal structures, 
such as cortical patches and actin cables. Additionally, the actin-fusions were 
expressed in RRL and analyzed with regard to their specific binding to DNase I. 
3.3.1 Actin-GFP fusions integrate into yeast actin cortical patches 
Green fluorescent protein (GFP), a ~27 kDa single domain protein from 
the jellyfish Aequorea victoria (Prasher et al., 1992), is a frequently utilized fusion 
partner to analyze the intracellular localization of proteins in various cells types 
(Stearns, 1995; Simpson et al., 2000). Recently, several multi-domain GFP-fusion 
proteins were generated by domain recombination and demonstrated to fold 
with high efficiency upon expression in yeast (Chang et al., 2005). Based on this 
observation, modular proteins consisting of yeast actin, N- and/or C-terminally 
fused to different fluorescent proteins, were generated in order to investigate the 
capacity of TRiC to fold multi-domain proteins in vivo (Figure 27A). Depending 
on the number of attached fluorescent proteins, the actin fusion proteins varied 
in size between ~70-100 kDa and thus clearly exceeded the upper size limit of 
~50 kDa, determined for group II chaperonin folding cavities (Ditzel et al., 1998). 
Individual domains between the fused proteins were connected by flexible linker 
regions as described previously (2.1.5.1; Chang et al., 2005). Upon recombinant 
expression of actin-GFP (AG) and GFP-actin (GA) in exponentially growing yeast 
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∆reg cells (theses cells allow regulated protein expression from GAL1-controlled 
plasmids in presence of glucose) both fusion proteins displayed punctate, 
fluorescent cortical patches, asymmetrically localized to the bud and mother-bud 
neck (Figure 27B). Visualization of the actin cytoskeleton by rPh-staining 
demonstrated a co-localization of GFP- and rPh-labeled cortical patches, 
indicative for AG and GA being properly incorporated into the cellular actin 
cytoskeleton as well as actin having acquired its native state in both fusion 
variants. Co-localization of AG and GA with rPh-stained actin cables aligning 
along the mother-bud axis was not observed. Importantly, expression of AG and 
GA did not affect the actin distribution within the cells as the staining patterns 
with rPh were similar to those obtained for control cells harboring an empty 
plasmid or solely expressing actin or GFP, respectively. 
In order to investigate whether TRiC is also able to fold actin when 
fused to both an N- and C-terminal fluorescent protein, an actin double-fusion 
was made. To this end, blue fluorescent protein (BFP: a GFP-variant with 
blue-shifted spectroscopic properties), whose fluorescence signal does not 
interfere with the detection of co-localized GFP- and rPh-labeled proteins in vivo, 
was N-terminally fused to the previously described AG, yielding the 
three-domain protein BAG (Figure 27A). Upon expression of BAG in ∆reg cells, 
the fluorescence signal resulting from the C-terminal GFP-moiety showed a 
diffuse cytosolic distribution, similar to that observed for GFP expression alone 
(Figure 27B). Incorporation of BAG in rPh-stained endogenous actin structures 
was not detectable. 
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Figure 27: Expression of actin-fusion proteins in yeast. 
 
(A) Actin-fusion proteins with the size (in kDa) of each protein being indicated on the 
scale depicted above the fusion constructs. (B, C) Fluorescence microscopy analysis of 
actin-fusions in fixed yeast ∆reg cells. (B) Cytoskeletal actin structures (cortical patches 
and actin cables) where visualized by staining with rhodamine-phalloidin (rPh). (C) 
Fusion-proteins containing both GFP and mCherry fluorescent proteins. Empty vector 
(Control), actin-GFP (AG), GFP-actin (GA), BFP-actin-GFP (BAG), mCherry-GFP (CG), 
mCherry-actin-GFP (CAG). Size bar = 4 µm. 
 
To assess whether this effect is due to the multi-domain structure of 
BAG and accompanying steric hindrances during the process of F-actin assembly 
or whether it is an intrinsic problem caused by BFP, a second three-domain 
fusion was made. Therefore, BFP at the N-terminus of BAG was replaced by the 
equally sized and similarly folded red-fluorescent protein mCherry (monomeric 
Cherry: an improved DsRed-variant from Discosoma sp.) which was recently 
demonstrated to properly incorporate into cytoskeletal structures when fused to 
β-actin (Shaner et al., 2004). Expression of the newly made double-fusion CAG in 
∆reg cells resulted in a diffuse cytosolic distribution of red and green 
fluorescence, similar to the GFP signal observed for BAG (Figure 27C). 
Essentially the same result was obtained upon expression of mCherry-GFP (CG), 
lacking the entire actin domain (Figure 27C). This supports the notion that, 
although both fluorescent protein domains in the actin-fusions are folded 
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correctly, CAG and BAG are not able to incorporate in preexisting cellular actin 
structures. 
The in vivo expression of all actin-fusion proteins to their correct size 
was verified by western blot analyses. After cell lysis, equal amounts of yeast 
crude protein extracts were run on SDS-PAGE followed by immunoblotting with 
antibodies directed against GFP, actin (Act1p), and alcohol dehydrogenase 
(Adh1p), with the latter serving as an internal loading control (Figure 28). All 
fusion proteins were correctly expressed with GFP being part of their multi-
domain structure. Furthermore, translation of the respective fusion proteins in 
RRL revealed the majority of synthesized protein to be in the soluble fraction 
(3.3.3). 
 
 
 
Figure 28: Western blot analyses of actin-fusion proteins upon expression in yeast. 
 
Yeast ∆reg crude protein extracts of recombinantly expressed proteins, as indicated, 
were analyzed by SDS-PAGE and immunoblotting with antibodies directed against GFP 
(top), actin (Act1p, middle), and alcohol dehydrogenase (Adh1p, bottom), respectively. 
Numbers 1 to 5 indicate the position of equally sized proteins on the respective western 
blots: BAG and CAG (1), AG and GA (2), CG (3), GFP (4), actin (5). The band marked by 
an asterisk was not analyzed further. Abbreviations of the individual proteins are as in 
Figure 27. 
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3.3.2 Actin does not affect folding of GFP and mCherry in actin 
double-fusion proteins 
In order to determine whether actin located between two fluorescence 
partners in a multi-domain protein imposes any constraints on their folding, 
in vitro fluorescence studies were performed. CAG was overexpressed in yeast 
and enriched to a semi-pure state by affinity purification (His-tag) and gel 
filtration (Figure 29A; 2.3.3.4). Additionally, CAG and CG (lacking the actin 
domain), were translated in cell-free wheat germ lysate (WG; Figure 29A) in 
order to reveal possible differences in the folding of multi-domain actin-fusions 
in vitro and in vivo. Notably, protein synthesis performed in the WG system is 
significantly more efficient than in RRL. Furthermore, the thus produced proteins 
are directly applicable to fluorescence analyses as WG does not contain 
hemoglobin, the iron-containing protein of red blood cells interfering with 
fluorescence measurements. The fluorescence emission spectra acquired for CAG 
(enriched from yeast) revealed an approximately 9-fold higher GFP-fluorescence 
intensity when compared to the signal obtained for mCherry (Figure 29B, top 
panel). Essentially the same ratios of GFP/mCherry-fluorescence were measured 
in the soluble fractions of CAG and CG upon expression in WG (Figure 29B and 
29C). These findings suggest that mCherry and GFP, N- and C-terminally fused 
to actin, are able to fold with similar efficiencies upon expression in vivo and 
in vitro. Thus, folding of the individual fluorescent proteins in CAG seems to 
occur independently and unimpaired by the folding state of actin. Furthermore, 
these results are in accordance to the previously reported in vivo fluorescence 
data (Figure 27). 
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Figure 29: Actin does not affect fluorescence intensities of GFP and mCherry in the 
double-fusion CAG. 
 
(A) SDS-PAGE (left) and Western blot analysis directed against GFP (right) of enriched 
CAG upon expression in yeast (Yeast) as well as samples of the soluble lysate fraction of 
CAG and CG upon expression in wheat germ lysates (WG). Full-length fusion proteins 
are indicated by arrowheads. (B) Combined fluorescence emission spectra of GFP 
(excited at 397 nm, solid line) and mCherry (excited at 585 nm, dotted line) acquired from 
CAG and CG upon expression in yeast (Yeast) or wheat germ lysates (WG), as indicated. 
(C) Ratios of GFP/mCherry-fluorescence intensities as assessed in (B), obtained at their 
fluorescence maxima at 506 nm and 606 nm, respectively. 
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3.3.3 TRiC is capable of assisting domain-wise protein folding   
Next, the ability of TRiC to facilitate the folding of discrete domains of 
large multi-domain actin-fusion proteins was investigated in vitro. To this end, 
the already existing actin fusion constructs (Figure 27A) were subcloned in 
in vitro expression vectors suitable for T7-promoter driven protein expression 
(Figure 30A). In addition to that, BAG variants containing a TEV-(Tobacco Etch 
Virus)-protease cleavage site in the linker connecting BFP and actin (referred to 
as BTAG and BTAG-G150P, respectively) were made. This allowed the specific 
protein processing upon translation, and subsequent evaluation of the folding 
state of actin in the remaining AG-fusion by binding to DNase I (see below). To 
assess whether actin can reach its native state when embedded between two 
fusion partners is of particular interest, since only AG and GA have been shown 
to properly integrate into yeast cortical patches upon expression in vivo 
(Figure 27B). 
In vitro translation reactions of individual actin-fusions were performed 
in RRL supplemented with [35S]-Met, as described (2.3.4). Examination of the 
translation products by SDS-PAGE analysis revealed all fusions to appear almost 
exclusively in the soluble fraction (Figure 30B). Since the folding cavity of 
group II chaperonins was reported to have an upper size limit of ~50 kDa (Ditzel 
et al., 1998), the ability of TRiC to interact with actin-fusion proteins ranging 
between ~70-100 kDa (thus, too large for complete encapsulation) was analyzed. 
Therefore, samples of total RRL translation products were run on native PAGE 
and the resulting complexes analyzed by phosphoimaging (Figure 30C). TRiC 
was found to interact with all fusions containing actin as part of their protein 
composition, irrespective of the actin position within the molecule. As expected, 
complex formation between TRiC and BG (BFP-GFP), lacking the actin domain, 
was not observed. BTAG-G150P, a BTAG variant with the highly conserved 
glycine-150 in actin being mutated to proline (1.3.4) did not display any 
abnormalities with regard to solubility and TRiC binding when compared to 
other fusion proteins (Figures 30B and 30C). Since this particular point-mutation 
was recently reported to cause impaired actin folding due to protein arrest on the 
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TRiC chaperonin (McCormack et al., 2001), BTAG-G150P was utilized as a 
control fusion-protein for subsequent in vitro experiments. 
 
 
 
Figure 30: Actin-fusions expressed in RRL are soluble and interact with TRiC. 
 
A) Actin-fusion constructs for in vitro expression in RRL with the size (in kDa) of each 
protein being indicated on the scale depicted above the fusion constructs. (B) SDS-PAGE 
of total (T), supernatant (S) and pellet (P) fractions of actin-fusions translated in RRL, as 
indicated. (C) Native PAGE of total protein samples from translation reactions as 
performed in (B) showing TRiC:substrate complexes (TRiC:substrate). actin-GFP (AG), 
GFP-actin (GA), BFP-actin-GFP (BAG), BFP-GFP (BG), BAG containing a TEV-protease 
cleavage site in the linker region between BFP and actin (BTAG), BTAG with actin amino 
acid 150 being mutated from glycine to proline (BTAG-G150P). 
 
If the eukaryotic chaperonin TRiC is indeed able to fold large modular 
proteins in a domain-wise manner, one would expect that TEV-cleavage of BTAG 
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and BTAG-G150P, upon translation in RRL, results in stable AG-fragments able 
to bind to DNase I. To ensure that actin had acquired its native state in the 
context of the fusion protein, TRiC function had to be efficiently abolished prior 
to protease treatment. Actin folding in desalted RRL was previously 
demonstrated to be dependent on the addition of hydrolyzable ATP (Frydman 
and Hartl, 1996). In analogy, refolding of denatured radiolabeled actin in 
untreated, ATP-containing RRL resulted in the production of native actin 
(Figure 31, lane 6) as evidenced by the characteristic mobility shift on native 
PAGE after addition of DNase I (Figure 31, lane 7). Similar results were obtained 
when actin was refolded in presence of purified TRiC (Figure 31, lanes 1-3; also 
see Figure 18) or upon de novo synthesis of actin in untreated RRL (Figure 31, 
lanes 8-9). Treatment of RRL with apyrase for 2 min prior to actin refolding 
efficiently inhibited TRiC function and did not lead to the formation of native 
actin (Figure 31, lanes 4-5). 
 
                   
 
Figure 31: Depletion of ATP in RRL efficiently inhibits TRiC-mediated actin folding. 
 
Native PAGE of actin refolding experiments performed with purified TRiC (lanes 1-3) or in 
rabbit reticulocyte lysate (RRL, lanes 4-7). Reactions were conducted in presence or 
absence of ATP and upon completion additionally received DNase I, as indicated. 
Lanes 8-9: actin synthesized in RRL as described (2.3.4). Bands marked with an asterisk, 
probably representing actin bound to PFD, were not analyzed further. 
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Based on these results, translation reactions of yeast actin as well as AG 
and GA fusion proteins were carried out in RRL for 90 min. Upon depletion of 
ATP by treatment with apyrase for 2 min, folded actin was precipitated with 
DNase I-Sepharose beads for 2 h in the cold. In every case tested, substantial 
amounts of radiolabeled material specifically associated with DNase I as 
analyzed by SDS-PAGE and phosphoimaging (Figure 32A). Thus, TRiC is able to 
meditate folding of newly translated actin even when the actin molecule is N- or 
C-terminally fused to GFP and hence is lager than the determined capacity of the 
chaperonin cavity (~71 kDa compared to ~50 kDa of the chaperonin cavity). 
Importantly, this result is consistent with the proper incorporation of AG and GA 
into actin cortical patches upon expression in yeast (Figure 27B). Next, the ability 
of TRiC to accomplish folding of actin when bilaterally fused to two fluorescent 
proteins was investigated. To this end, similar experiments to the ones described 
above were performed with actin double-fusion proteins (Figure 32B). In 
addition to treatment with apyrase, the translation reactions were subjected to 
TEV-protease cleavage for 30 min at 30 °C. As expected, cleavage only occurred 
in BTAG and BTAG-G150P containing a TEV-site in the linker between BFP and 
actin, liberating BFP from the remaining AG-fragment (Figure 32B: compare 
lanes 1, 3, 5, and 7 with lanes 9-12, respectively). Upon incubation with 
DNase I-beads, similar amounts of BG and AG-G150P (resulting from 
BTAG-G150P) relative to the input material were precipitated (Figure 32B and 
32C). Since BG does not contain actin, this was considered the background level 
of non-specific DNase I binding. Strikingly, complex formation with DNase I was 
~7-fold more efficient for AG (originating from BTAG) than for AG-G150P 
containing an actin-mutant with impaired folding properties. Interestingly, even 
though the AG-fragment of cleaved BTAG efficiently bound to DNase I, 
uncleaved BAG (Figure 32B, lane 4: arrow) did not show DNase I binding above 
background level (Figure 32C). Together, TRiC is not only able to facilitate the 
folding of AG and GA, with actin being accessible at least from one side of the 
protein, but also mediates the domain-wise folding of actin double-fusions, with 
actin embedded between two fluorescent partners. 
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Figure 32: TRiC is able to facilitate domain-wise folding of actin-fusion proteins. 
 
(A, B) DNase I-precipitations of actin-containing fusion proteins upon de novo synthesis 
in RRL and subsequent apyrase treatment, analyzed by SDS-PAGE and 
phosphoimaging. (A) Input (10% of total; odd numbers) and eluate fractions from 
DNase I-beads (even numbers). (B) Prior to DNase I-precipitation, reactions were 
additionally subjected to TEV-protease treatment, as indicated. Lanes 1-8: input (10% of 
total; odd numbers) and eluate fractions from DNase I-beads (even numbers). 
Lanes 9-12: untreated total protein fractions. (C) Phosphoimaging quantitation of 
DNase I-precipitates as assessed in (B: lanes 2, 4, 6 and 8); band used for quantitation of 
BAG (lane 4) is indicated by an arrowhead. Abbreviations of the individual proteins are as 
in Figure 30. 
 
In view of these observations and the inability of BAG to properly 
integrate into actin cortical patches (Figure 27B), the folding state of actin within 
BTAG and BTAG-G150P was further investigated in vivo. Upon protein 
expression in yeast ∆reg cells to similar levels, cell lysis under native conditions 
was performed in presence of cycloheximide and apyrase in order to inhibit 
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protein synthesis and TRiC function, respectively (2.4.6). Treatment with TEV-
protease (30 min at 30 °C) and subsequent DNase I-precipitation of the cleavage 
products for 2 h in the cold revealed a ~5-fold higher binding efficiency of AG, 
originating from BTAG, than for AG-G150P containing the actin mutant protein 
(Figure 33). 
 
          
 
Figure 33: TRiC facilitates the folding of multi-domain proteins in vivo. 
 
BTAG and BTAG-G150P were expressed to similar levels in yeast ∆reg cells. Following 
cell lysis in presence of cycloheximide and apyrase, the crude extracts were treated with 
TEV-protease and the resulting AG-fragments precipitated by DNase I-Sepharose beads. 
Upper panel: DNase I-bound AG-fragments (top) and endogenous yeast actin (bottom) 
analyzed by immunoblotting against GFP and yeast actin (Act1p), respectively. Lower 
panel: Quantitation of AG-fragments upon TEV-cleavage and precipitation by 
DNase I-beads as assessed by immunoblotting. 
 
As the in vivo experiment perfectly matched the data obtained in vitro (see 
above), TRiC was assumed to indeed facilitate the domain-wise folding of 
multi-domain fusion proteins, too large for complete encapsulation in the 
chaperonin cavity. 
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4 Discussion 
In this work, the role of molecular chaperones in the folding of 
eukaryotic multi-domain proteins was investigated upon translation in cell-free 
translation systems. Protein expression in a chaperone-diminished E. coli lysate 
allowed a detailed analysis of how chaperone intervention during de novo 
synthesis affects the mechanism of protein folding and its coupling to translation. 
In the case of FL, supplementation of the bacterial lysate with purified TF and the 
Hsp70 chaperone system KJE not only affected the efficiency but also the 
mechanism of de novo folding. 
Furthermore, the absence of eukaryotic chaperones in the E. coli lysate 
provided the possibility to determine the minimum requirements for the efficient 
production of native actin upon de novo synthesis. Formation of correctly folded 
actin was assayed in the absence and presence of the above mentioned E. coli 
chaperones as well as ELES or the eukaryotic chaperonin TRiC. Importantly, 
TRiC was found to be necessary and sufficient for the folding of actin without 
further manipulations. 
Additionally, using multi-domain proteins, the previously suggested 
role of TRiC in domain-wise folding of complex modular proteins was 
investigated. In yeast, the expression of actin fused to various fluorescent 
proteins not only allowed the exact location of these proteins within the cell, but 
also the detection of any incorporation into pre-existing actin structures. The 
formation of native actin within the fusion-proteins upon expression in vivo and 
in eukaryotic cell-free translation systems was verified by its ability to bind to 
DNase I. 
4.1 TF and DnaK affect the efficiency and mechanism of de 
novo protein folding in the bacterial cytosol 
The Gram-negative bacterium E. coli is the most extensively used 
prokaryotic organism for the recombinant expression of proteins for research and 
biotechnology. Unfortunately, overproduction of heterologous (eukaryotic 
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multi-domain) proteins in the bacterial cytosol is often accompanied by 
misfolding and subsequent segregation of non-native intermediates into 
insoluble aggregates, known as inclusion bodies (Marston, 1986; Baneyx and 
Mujacic, 2004). Although inclusion bodies mainly consist of highly concentrated 
and almost pure protein, hence simplifying purification, in vitro refolding yields 
of complex modular proteins are usually very low (Marston, 1986; Jaenicke, 
1987). A frequently used approach to improve the solubility of heterologous 
aggregation-prone proteins in E. coli involves the overexpression of molecular 
chaperones implicated in de novo protein folding. Since in many cases the 
“yield-limiting” step for the generation of native protein is folding, rather than 
synthesis, the beneficial effects of increased chaperone concentrations like that of 
TF, KJE as well as ELES were demonstrated multiple times  (Caspers et al., 1994; 
Dale et al., 1994; Thomas and Baneyx, 1996; Nishihara et al., 2000; Baneyx and 
Palumbo, 2003). On the other hand, E. coli cells lacking both TF and KJE 
(∆tig∆dnaKdnaJ) display fundamental defects in cytosolic protein folding 
(Genevaux et al., 2004). Notably, deletion of GroEL and/or its cofactor GroES is 
lethal since both protein complexes are absolutely essential for bacterial growth 
(Fayet et al., 1989). 
4.1.1 The bacterial cytosol does not support efficient folding of 
eukaryotic multi-domain proteins 
In order to investigate the effect of bacterial chaperones on the folding of 
eukaryotic multi-domain proteins, FL was expressed in a bacterial S30 lysate. 
Whereas the in vivo concentrations of TF, DnaK, and GroEL under standard 
growth conditions are ~40 µM, ~50 µM, and ~3 µM, respectively (Lill et al., 1988; 
Hesterkamp and Bukau, 1998; Hartl and Hayer-Hartl, 2002), the chaperone 
concentrations in this lysate were determined to by ~0.5 µM for both TF and 
DnaK, and ~0.1 µM for GroEL (Agashe et al., 2004). Hence, this lysate represents 
a dilute cytosol, drastically depleted of bacterial chaperones. 
Refolding of fully denatured FL in the absence of chaperones is known 
to be an extremely slow process (equilibrium is reached only after days). This 
phenomenon is attributed to kinetically trapped folding intermediates imposed 
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by intramolecular misfolding (Herbst et al., 1998; Frydman et al., 1999). In 
contrast, FL refolding in the presence of the Hsp70 system occurs with a half-time 
of ~10-15 min and with approximately 80% efficiency (Szabo et al., 1994). To 
assess whether the residual amounts of bacterial chaperones in this system are 
able to support protein folding in vitro, refolding experiments of chemically 
denatured FL were performed in the S30 lysate (Figure 11). Efficient refolding 
(up to ~80-90%) was only seen when the lysate was supplemented with purified 
components of the bacterial Hsp70 chaperone system KJE, irrespective of the 
presence of TF. Since neither the unsupplemented nor the TF-supplemented 
lysate could restore FL activity above background level (~10%), refolding of FL 
was demonstrated to depend solely on the presence of KJE as described 
previously (Schroder et al., 1993; Szabo et al., 1994). Refolding experiments in the 
presence of ELES were not performed, as the bacterial chaperonin does not 
support FL folding in vitro (Frydman et al., 1992). Given these findings, the S30 
lysate was considered to be a dilute bacterial cytosol preparation, functionally 
depleted of endogenous chaperones. 
As shown initially, FL expression in E. coli and S. cervisiae resulted in 
dramatic differences regarding protein solubility and enzyme activity (Figure 10). 
Whereas in yeast, FL was almost exclusively soluble and active, its solubility in 
E. coli was only ~40% with most of the protein being inactive due to 
intramolecular misfolding and/or interchain aggregation. This observation is 
astonishing, since the bacterial cytosol contains high amounts of KJE (see above), 
demonstrated to be the only chaperones necessary and sufficient for FL refolding 
in vitro (Figure 11). Together, these findings strongly suggest that the chaperone 
interaction of FL nascent chains during de novo folding differs considerably from 
that required for efficient refolding of FL out of denaturant. 
To elucidate the phenomenon of why eukaryotic multi-domain proteins 
fold inefficiently in the bacterial cytosol, FL was translated in cell-free lysates of 
eukaryotic (RRL) and bacterial (S30) origin. In accordance to the data obtained in 
yeast, folding of FL in RRL occurred with ~60% efficiency and essentially all the 
protein was recovered in the soluble fraction (Figure 10). Further, comparing the 
kinetics of translation and folding revealed that FL enzyme activity appeared 
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virtually concurrently with the production of full-length chains (Figure 13A), 
indicative of a co-translational folding mechanism. This observation was in good 
agreement to the co-translational folding of the N-terminal domain of FL during 
synthesis, and the rapid formation of native protein upon chain release from the 
ribosome (Frydman et al., 1994; Kolb et al., 1994; Frydman et al., 1999). Thus, 
efficient folding of multi-domain proteins in the eukaryotic cytosol may be 
facilitated by a mechanism of sequential, co-translational domain folding, similar 
to that observed for the artificial two-domain protein Ras-DHFR (Netzer and 
Hartl, 1997). Moreover, the eukaryotic Hsp70 system was suggested to play a 
critical role in stabilizing nascent chains of multi-domain proteins at early times 
of translation in order to prevent intramolecular misfolding and protein 
aggregation (Frydman et al., 1994). Unexpectedly, co-translational folding of FL 
was also observed in the unsupplemented S30 lysate (Figure 13A). However, 
under these conditions, the folding yield was very low (~5% compared to ~60% 
in RRL) and only ~45% of the protein was recovered in the soluble fraction 
(Figure 10). This supports the notion that successful folding of complex 
eukaryotic proteins in the bacterial cytosol not only depends on the applied 
mechanism but also on the availability of suitable chaperones promoting their 
effective folding. 
Although supplementing the lysate with bacterial chaperones improved 
the solubility of newly translated FL considerably, an increase in specific activity 
was only observed when TF was added alone or in combination with KJE. 
Moreover, the beneficial effect of TF on FL activity was demonstrated to strongly 
depend on the residual amounts of DnaK in the lysate, as the specific activity did 
not increase when DnaK levels were reduced further by immunodepletion 
(Agashe et al., 2004). These findings suggest that, in order to increase the folding 
efficiency of newly translated FL, TF and KJE have to cooperate, whereas 
refolding of denatured FL in the same lysate only depends on KJE. Further, given 
a refolding efficiency of ~80-90% in presence of KJE (Figure 11), and a recovery of 
only ~20% of active enzyme upon translation in the TF/KJE-supplemented lysate 
(3.1.2), TF seems to function inefficiently in stabilizing FL nascent chains in a 
conformation competent for folding by KJE. Together, the folding yield of newly 
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translated FL appears to be critically dependent on the ability of bacterial 
chaperones in order to prevent misfolding events in elongating chains as soon as 
they emerge from ribosomal tunnel. The validity of this assumption becomes 
obvious when looking at the expression of  bacterial β-galactosidase (β-gal; a 
tetrameric complex with five domains per subunit (Jacobson et al., 1994)) in the 
same chaperone supplemented lysate. In that case, translation in the presence of 
TF and KJE resulted in ~90% soluble and active protein (Agashe et al., 2004). This 
strongly indicates that β-gal utilizes the E. coli chaperone system with high 
efficiency, whereas TF and KJE seem to be incompatible with the co-translational 
mechanism observed for FL folding in the eukaryotic cytosol. 
4.1.2 Post-translational folding improves protein solubility and 
folding yield 
FL folding in both in vitro systems, RRL and the unsupplemented S30 
lysate, occurs rapidly and via a co-translational folding mechanism (Figure 13A). 
However, the tight coupling of translation and folding is only highly efficient in 
the eukaryotic lysate (~60%, compared to ~5% in the bacterial lysate; Figure 10), 
where FL folding is assisted by the mammalian Hsp70 system (Frydman et al., 
1994). Strikingly, supplementing the S30 lysate with purified TF increased the 
amount of active FL 2 to 3-fold and concurrently imposed a significant 
deceleration in the kinetics of FL folding without affecting the actual speed of 
translation (Figures 12B and 13B). The delay in FL folding relative to protein 
synthesis was even more pronounced when the system was supplemented with 
TF and KJE together. Under these conditions, the folding yield was 
approximately 4-fold higher compared to FL translation in the unsupplemented 
lysate, indicative for a functional cooperation between TF and KJE in the S30 
lysate. More generally, these findings suggest that in the presence of TF and KJE, 
de novo folding of FL is shifted from a rapid but inefficient folding pathway to a 
post-translational folding regime increasing both solubility and enzyme activity 
(Figures 12B and 13). However, with only ~20% of the protein being native, 
compared to ~60% or ~100% upon FL synthesis in RRL or yeast cells, 
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respectively, folding in the chaperone supplemented S30 lysate is much less 
efficient than in the eukaryotic cytosol (Figure 10). 
Although previous data demonstrated that TF and KJE need to 
cooperate in order to improve the folding efficiency of FL in the bacterial lysate 
(3.1.2), their time of action during de novo folding remains unknown. Therefore, 
protein translations of ongoing FL reactions were terminated with RNase A and 
the appearance of FL enzyme activity was followed over time. In accordance to 
the TF/KJE-imposed delay in FL folding (Figure 13B), FL translation in the 
presence of these chaperones caused a more than 2-fold increase in enzyme 
activity upon inhibition of translation (Figure 15) Notably, the kinetics of activity 
increase were identical to that of KJE-mediated FL refolding out of denaturant 
(Figures 11 and 15). Since this post-translational folding phase was only observed 
when both chaperones were present from the beginning of the translation 
reaction, a functional cooperation between TF and KJE had to occur 
co-translationally (Figure 15). Thereby, TF binding to the large subunit of 
translating ribosome constitutes a prerequisite for its productive interaction with 
elongating nascent chains as post-translational FL activity was not observed with 
a triple-mutant form of TF, TFFRK/AAA, which does not bind to the ribosome 
(Kramer et al., 2002). Post-translational folding was also abolished upon 
depletion of ATP in the system, arguing for the important role of the 
ATP-regulated bacterial Hsp70 system in FL folding. Additionally, control 
experiments releasing ribosomal stalled FL nascent chains into unsupplemented 
or TF/KJE-supplemented lysate demonstrated that TF and KJE do not delay the 
completion of FL folding upon protein release from the ribosome, but instead 
cause a genuine switch in the folding mechanism (Agashe et al., 2004). Together, 
these findings suggest that the co-translational action of both TF and KJE during 
de novo synthesis of FL is essential for enforcing post-translational folding, 
accompanied by an increase in protein solubility and the amount of active 
enzyme synthesized. Interestingly, the default-pathway of both β-gal folding and 
assembly in active tetramers in the unsupplemented S30 lysate was shown to be 
co-translational with an efficiency of about 25% (Agashe et al., 2004). Further, 
addition of TF and KJE, separately or together, markedly delayed folding relative 
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to translation, thereby improving β-gal activity up to ~75% and ~100%, 
respectively. Thus, in contrast to the combined action required in order to delay 
FL folding, TF and KJE seem to have overlapping functions in the folding and 
assembly process of β-gal. Moreover, as refolding of denatured β-gal in the 
chaperone supplemented lysate occurred with only ~10% efficiency, de novo 
folding of the bacterial multi-domain protein was suggested to be critically 
dependent on the co-translational activity of TF and KJE (Agashe et al., 2004). 
4.1.3 How do TF and KJE delay protein folding? 
A possible mechanism of how the combined action of TF and DnaK, 
which both recognize similar hydrophobic regions in newly synthesized proteins 
(Rudiger et al., 1997; Patzelt et al., 2001), could cause delayed folding in the 
bacterial cytosol was suggested in the work of Agashe et al. (2004). By 
conducting recruitment experiments of radiolabeled TF to translating ribosomes, 
the number of recruited TF molecules was shown to correlate well with the size 
of the translated protein and/or differences in the occurrence of hydrophobic 
peptide regions, recognized by the chaperone (Patzelt et al., 2001). Furthermore, 
TF was suggested to delay folding and misfolding of nascent chains by a 
dynamic interaction cycle in which the initially ribosome bound TF leaves its 
docking site at the 50S subunit and maintains contact with the elongating 
polypeptide chain, thereby providing room for a new TF molecule to dock onto 
the then vacant ribosome. Importantly, the mechanism proposed above was 
recently confirmed and described in more detail (Kaiser et al., 2006). By using 
fluorescence spectroscopy, TF function was monitored on translating ribosomes 
in real-time. As TF does not form long-lived complexes with newly synthesized 
substrate proteins (Hesterkamp et al., 1996; Maier et al., 2003; Kaiser et al., 2006), 
retention of the folding competence in protein regions, distantly located from the 
ribosome, may thus require the engagement of DnaK, whose chaperone function 
is independent of the ribosome. Since several high affinity DnaK-binding sites 
were determined in each structural domain of both FL and β-gal (Agashe et al., 
2004) and DnaK binding/rebinding to non-native proteins occurs within seconds 
(Pierpaoli et al., 1997), rapid co-translational domain folding in each protein 
Discussion   101                                
would require the coordinated release of multiple DnaK molecules for which 
there is so far no experimental evidence.  Considering the translation speed to be 
~5-10 times faster in bacteria (~20 amino acids per second) when compared to the 
eukaryotic system (Bremer and Dennis, 1996), the functional cooperation 
between TF and KJE might be optimized for stabilizing nascent chains of 
complex modular architecture  in a state competent for efficient post-translational 
folding. Interference by TF with the post-translational completion of folding is 
supposedly not a problem, since TF-nascent chain complexes are only formed 
subsequent to TF binding at the ribosome (Kaiser et al., 2006). 
4.1.4 Default folding versus chaperone-assisted folding 
Based on the in vitro data obtained for FL folding in the bacterial and 
eukaryotic cell lysates in this study, and the body of work generated with a 
second model protein (β-gal) in the same lysates as well as in living cells (E. coli 
and S. cerevisiae) (Agashe et al., 2004), a model explaining the role of TF and 
DnaK in determining both the mechanism and yield of protein folding in the 
bacterial cytosol was suggested (Figure 34). In the absence of TF and KJE, a 
default co-translational pathway produces a small proportion of native or 
native-like domain structures which complete folding rapidly after chains are 
released from the ribosome (Figure 34, (1)); the majority of nascent polypeptides 
misfold due to intermolecular misfolding or interchain aggregation (Figure 34, 
(2)). TF and KJE delay any folding (or misfolding) events, until the chain is 
released from the ribosome (Figure 34, (3)). The capacity of the chaperones to 
prevent folding is sufficient for bacterial proteins of average size, but is limited 
for long nascent chains. For proteins such as FL, the chaperone-imposed delay in 
folding would result in a high proportion of misfolded molecules (Figure 34, (6)). 
Large bacterial proteins such as β-gal, on the other hand, are adapted to this 
chaperone mechanism and could initiate productive folding co-translationally 
(Figure 34, (4)). Following nascent chain release from the ribosome, 
post-translational folding would be completed by KJE through ATP-dependent 
binding and release cycles (Figure 34, (7)), or upon protein transfer to 
downstream chaperones such as GroEL. In this scheme, the inherent propensity 
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of a protein to undergo intramolecular misfolding (kinetic trapping), either co- or 
post-translationally, would determine the yield of the folding process. Inefficient 
folding (and aggregation) would occur for those eukaryotic proteins (Figure 34, 
(6, 8)) that are highly dependent on a mechanism of timely co-translational 
domain folding in order to avoid kinetic traps. Such a pathway is actively 
supported by the chaperones in the eukaryotic cytosol (Figure 34, (5)) (Frydman 
et al., 1994). 
 
 
 
Figure 34: Effects of nascent chain-binding chaperones on the folding of 
multi-domain proteins, a working model. 
 
The translating polypeptide chain is shown in pink with folded domains represented by 
hexagons and squares. Bacterial chaperones are given in blue and eukaryotic 
chaperones in green. Left: Default-pathway of co-translational domain folding (1) or 
misfolding (2) during rapid elongation in bacteria in the absence of nascent chain-binding 
chaperones. Right: Chaperone-assisted post-translational (3) or delayed co-translational 
folding (4) in bacteria, and efficient chaperone-assisted co-translational folding in the 
eukaryotic cytosol (5). Co-translational misfolding of proteins such as FL in the presence 
of bacterial chaperones (6). Folding (7) and misfolding (8) through post-translational 
chaperone cycling in the bacterial cytosol. 
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More generally, since TF only exists in bacteria which, on average, have 
smaller and fewer multi-domain proteins than eukaryotes (Netzer and Hartl, 
1997), this ribosome associated chaperone may reflect an evolutionarily ancient 
principle of assisted folding. On the other hand, the efficient co-translational 
domain folding, as it occurs in the eukaryotic cytosol, may have contributed to 
the evolution of the variety of complex modular proteins characteristic of 
eukaryotic cells (Netzer and Hartl, 1997). 
4.2 TRiC function is compatible with the bacterial translation 
machinery 
In the E. coli cytosol, the majority of proteins (>60%) consist of only a 
single folding unit (up to ~300 amino acids). It has been suggested that these 
proteins can fold rapidly and without further assistance upon release from the 
ribosome (Hartl and Hayer-Hartl, 2002). In contrast, larger bacterial proteins 
consisting of several domains (such as β-gal) are strongly dependent on the 
productive interaction of molecular chaperones in order to avoid intramolecular 
misfolding and/or aggregation (4.1.1). Although the bacterial chaperone 
machinery is highly effective in folding endogenous proteins, overexpression of 
modular eukaryotic proteins in the same systems often leads to misfolding and 
aggregation (Baneyx and Mujacic, 2004). The low folding yield of FL, for 
example, was shown to result from a reduced compatibility with bacterial 
chaperones (4.1). However, misfolding of actin in the bacterial cytosol is due to 
the lack of the eukaryotic chaperonin TRiC, the only chaperone able to direct 
actin to its native state (Tian et al., 1995). 
4.2.1 TRiC promotes efficient de novo folding of actin 
From its discovery, TRiC has been reported to be a molecular chaperone 
for actin and tubulin folding in the eukaryotic cytosol (Gao et al., 1992; Lewis et 
al., 1992; Yaffe et al., 1992). Many protocols for its purification have been 
described and the sources have varied from RRL (Gao et al., 1992; Yaffe et al., 
1992; Norcum, 1996; Cowan, 1998) to bovine and mouse testis (Frydman et al., 
1992; Liou and Willison, 1997; Ferreyra and Frydman, 2000), to guinea-pig and 
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rat brain (Roobol and Carden, 1993), to yeast (Miklos et al., 1994) as well as to 
different cell lines (Lewis et al., 1992; Roobol et al., 1995; Liou and Willison, 1997). 
Due to the complexity associated with expression, correct folding and proper 
assembly of the eight different TRiC subunits, attempts to obtain functionally 
active chaperonin complexes upon recombinant co-expression of all subunits 
have been unsuccessful so far. For this part of the work, TRiC was purified from 
bovine testis, where its expression is known to be highly upregulated during 
spermatogenesis (Willison et al., 1990). The purification was performed 
according to the protocol of Ferreyra and Frydman (Ferreyra and Frydman, 2000) 
with additional modifications as described in detail in the material and methods 
section (2.3.3.1). In brief, to avoid any adverse effects upon TRiC activity, the 
ammonium sulfate precipitation which applies high physical stress to the protein 
complex was omitted. Furthermore, the number of chromatographic steps was 
reduced to four, instead of five in the published protocol. Importantly, these 
modifications neither affected the overall yield of purified TRiC (~8 mg per 100 g 
testis) nor its activity and the ability to refold chemically denatured actin had a 
similar efficiency (~50%) to that reported previously (Gao et al., 1992; Ferreyra 
and Frydman, 2000) (Figures 16 and 18). 
Given the combination of purified and functional TRiC and a highly 
productive bacterial in vitro translation system, which did not contain eukaryotic 
chaperones, the effect of TRiC on the behavior of actin folding during de novo 
synthesis in a bacterial lysate was analyzed in detail. In accordance to actin being 
sequestered into inclusion bodies upon expression in E. coli (Frankel et al., 1991) 
and TRiC being the only chaperone known to support efficient actin folding 
in vivo and in vitro (Tian et al., 1995), actin synthesis in the unsupplemented 
lysate resulted in ~90% of the protein found in the insoluble fraction (Figure 20A 
and 20B). Approximately ~10% of translated actin remained soluble, probably as 
a result of transient binding to residual bacterial chaperones present in the lysate 
(Figure 20C). On the other hand, when actin translations were performed in 
presence of purified TRiC (5 µM), ~80% of total synthesized protein appeared in 
the soluble faction (Figure 20). By taking advantage of the fact that only native 
monomeric actin (G-actin) forms a stable binary complex with DNase I 
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(Lazarides and Lindberg, 1974), approximately half of the soluble actin was 
demonstrated to exist as actin monomers with a correctly folded 
three-dimensional structure. Strikingly, as will be discussed later (4.2.2), the 
remainder of soluble protein was also native, but had already polymerized into 
actin filaments (F-actin) which are incapable of DNase I-binding (Hitchcock et al., 
1976). Together, these findings clearly indicate that a bacterial translation system, 
functionally depleted of endogenous chaperones (3.1.2), is compatible with 
TRiC-assisted folding of a eukaryotic protein. Further, TRiC was demonstrated to 
be the only chaperone necessary and sufficient for the folding of substantial 
amounts of native actin (~140 µg/ml) without any further manipulation. More 
generally, since the bacterial cytosol did not contain any eukaryotic chaperones, 
the S30 lysate might thus constitute an ideal system to analyze the detailed 
mechanism of TRiC-mediated protein folding. 
In view of the chaperone-impoverished S30 lysate and the effect on 
protein solubility/activity of FL observed upon chaperone supplementation 
(Figure 12B), actin was translated in the presence of individual bacterial 
chaperones. Although actin overexpression in E. coli cells results in the formation 
of inclusion bodies (Frankel et al., 1991), its de novo synthesis in the KJE or ELES 
supplemented S30 lysate yielded almost completely soluble protein (Figures 22A 
and 22B). However, the thus produced actin was not native as it did not form a 
stable complex with DNase I (Figure 22C). On the other hand, lysate 
supplementation with TF neither affected actin solubility nor its folding when 
compared to the unsupplemented lysate. In the past, recombinant protein 
expression in bacterial hosts was demonstrated to be able to exceed >50% of total 
cellular protein (Baneyx and Mujacic, 2004). Thus, massive overexpression of 
actin in E. coli cells is likely to overwhelm the chaperone capacity of the KJE and 
ELES system. As a logical consequence, actin chains without access to the 
beneficial effects of chaperone binding might be susceptible to aggregation and 
directed into inclusion bodies. Hence, it would be interesting to know whether 
low level expression of actin in E. coli could increase its solubility. Assuming an 
in vivo concentration of DnaK and GroEL (under standard growth conditions) of 
~50 µM and ~3 µM, respectively (Hartl and Hayer-Hartl, 2002), a similar amount 
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of actin chains (~50 µM, corresponding to ~0.8 mg/ml) could principally be 
maintained in a soluble state. 
4.2.2 Coexistence of G-actin and bona fide F-actin in the bacterial 
lysate 
Actin constitutes the major component of the thin filaments of muscle 
cells and of the cytoskeleton of nonmuscle cells, taking part in a multitude of 
biological processes (Pollard et al., 2000). To accomplish these diverse set of 
functions inside the cell, actin molecules underlie a permanent turnover of 
polymerization into paired-helical F-actin microfilaments and dissociation into 
monomeric G-actin (Moseley and Goode, 2006). Under physiological salt 
concentrations, as observed in vivo and in cell-free translation systems, the 
equilibrium of this process is shifted towards F-actin formation (Pardee and 
Spudich, 1982). The critical G-actin concentration at which association and 
dissociation reactions are balanced at the fast growing end of the actin filaments 
(also called the “barbed end” or “(+)-end”) was determined to be ~0.1 µM 
(>12-fold lower than that of the slow growing end; also called the “pointed end” 
or “(-)-end”) (Wegner and Isenberg, 1983). 
The amount of soluble actin translated in the TRiC-supplemented S30 
lysate is approximately 3.2 µM, hence clearly exceeding the critical G-actin 
concentration (Figures 19 and 20). Since only half of the soluble actin (~1.6 µM) 
formed a stable complex with DNase I (Figure 20), the remainder was assumed to 
be readily polymerized into filamentous F-actin which does not bind to DNase I 
(Hitchcock et al., 1976). Indeed, staining of actin translation products with rPh, 
which tightly and specifically binds to F-actin (but not to G-actin) (Estes et al., 
1981; Vandekerckhove et al., 1985), revealed substantial amounts of filamentous 
shaped structures of diverse lengths and without evident branching (Figure 24A). 
Strikingly, these structures were only observed in TRiC-supplemented actin 
translations but not upon reaction supplementation with any of the bacterial 
chaperones. Thus, for the first time, supplementation of a cell-free bacterial 
translation lysate with the eukaryotic chaperonin TRiC could be demonstrated to 
be capable of producing sufficient amounts of de novo folded actin in order to 
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promote polymerization into bona fide F-actin filaments. Furthermore, as rPh 
binds at a stoichiometry of 1:1 to each F-actin protomer (Steinmetz et al., 1998), 
fluorescence was used as a measure to quantitate the amount of filamentous actin 
present in the sample (Howard and Oresajo, 1985; Cooper, 1987). It turned out 
that in the TRiC-supplemented reaction approximately 1.6 µM of the soluble 
actin had polymerized into filamentous F-actin. These finding correlated well 
with the previously determined 3.2 µM of soluble actin present in the system 
whereof ~1.6 µM could be shown to exist as monomeric G-actin (evidenced by 
binding to DNase I; Figure 20). Notably, phalloidin is well known to stabilize 
F-actin against depolymerization by preventing monomer dissociation at both 
the barbed and pointed ends of the filament (Estes et al., 1981). Thus, incubation 
of the actin translation product with rPh could potentially shift the equilibrium 
from G-actin towards actin filaments and therefore lead to a decrease in 
DNase I-binding material. Importantly, when TRiC-folded actin was incubated 
with rPh prior to DNase I treatment, the amount DNase I-bound actin was not 
affected and remained constant at a level similar to that observed for an 
untreated reaction (compare Figures 20 and 26). Hence, rPh addition to the 
translation product does not shift the equilibrium between F- and G-actin 
towards a decrease of monomeric actin. In summary, supplementation of the 
bacterial lysate with purified TRiC is sufficient to generate ~140 µg/ml (~3.2 µM) 
per hour of correctly folded actin, detectable either as monomers or actin 
filaments. 
4.2.3 Actin translation in the S30 lysate is poorly coupled to 
TRiC-mediated folding 
The lack of eukaryotic chaperones in the bacterial lysate provided the 
possibility to investigate the kinetics of actin in de novo folding solely assisted by 
the TRiC chaperonin in more detail (Figure 23). By comparing the kinetics of 
translation and folding in presence of TRiC, native actin appeared with a delay of 
~15 min relative to full-length actin synthesized (Figure 23A). This finding 
correlates well with the slow kinetics of TRiC-assisted actin refolding upon 
dilution from denaturant (t½ ~15-30 min) and thus may reflect a similar folding 
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pathway, which necessitates multiple cycles of binding and release from the 
chaperonin until actin acquires its native conformation (Gao et al., 1992; Tian et 
al., 1995). In contrast, de novo folding of actin in the eukaryotic cytosol is a rapid 
process tightly coupled to translation (Siegers et al., 1999). There, newly 
synthesized actin chains transit efficiently from the ribosome into the TRiC 
chaperonin and fold into their native structure with a half time of ~1 min upon 
synthesis. In accordance to these observations, native actin was detectable within 
2-3 min after the appearance of full-length actin upon translation in RRL 
(Figure 23C; Frydman and Hartl, 1996). It should be mentioned that due to its 
discontiguous sub-domain architecture (Figure 9A; Kabsch et al., 1990), actin can 
attain its native state only once its complete sequence has emerged from the 
ribosome. However, the rapid folding process in the eukaryotic cytosol has been 
explained by the existence of an integrated “folding compartment”, constituted 
by TRiC and the jellyfish-shaped chaperone PFD, in which actin nascent chains 
are allowed to fold unimpaired and sequestered from the crowded cellular 
environment (Siegers et al., 1999; Hartl and Hayer-Hartl, 2002). Although 
biochemical and genetic analyses revealed PFD to be dispensable for efficient 
TRiC-substrate interactions (Figure 20; Rommelaere et al., 1999; Siegers et al., 
1999), deletion of individual PFD genes caused a significant decrease in actin 
folding rates as well as the release of non-native actin chains into the bulk cytosol 
(Siegers et al., 1999). Furthermore, the co-translational action of PFD may allow 
actin nascent chains to be delivered to TRiC in a restricted set of particular 
conformations that the chaperonin is able to productively assist in folding. Since 
the bacterial lysate does not contain any of the eukaryotic nascent chain binding 
proteins, the delayed actin folding in the chaperone-supplemented lysate may be 
due to the inappropriate delivery of actin to TRiC. Consequently, if actin binding 
occurs in an unfavorable conformation relative to the subunit topology of the 
chaperonin ring, TRiC may have to release and re-bind actin repeatedly until the 
correct regions of the protein contact the appropriate chaperonin subunits. In 
agreement with this concept are the observations that in cryo-EM reconstructions 
or upon cross-linking of TRiC to actin nascent chains, specific chaperonin 
subunits appear to bind defined regions of the actin protein (Llorca et al., 2000; 
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Etchells et al., 2005). The significant amount of actin folding observed upon 
translation termination in the bacterial lysate may thus reflect a need for actin 
chains to occupy TRiC for a prolonged period during folding and/or the 
requirement of actin for multiple rounds of chaperone binding and release, as 
mentioned above. Together, de novo actin folding in the bacterial lysate solely 
assisted by TRiC is efficient but occurs via a slow post-translational mechanism 
poorly coupled to translation (Figures 23A and 23B). In sharp contrast, 
termination of protein synthesis in the eukaryotic lysate did not lead to any 
further increase in the amount of DNase I-bound actin (Figure 23D), validating 
the tight interconnection between folding and translation (Frydman and Hartl, 
1996; Siegers et al., 1999). Additionally, folding compartmentation and the 
proposed “proofreading” function of PFD in the eukaryotic cytosol (Siegers et al., 
1999) may reduce the need of actin cycles on and off the chaperonin to a 
minimum (possibly to only one cycle!) and prevent premature release of 
incompletely folded actin molecules that would otherwise be susceptible to 
aggregation, degradation and/or improper interactions with other components 
of the cytosol. However, the exact mechanism of how protein folding occurs in 
the eukaryotic cytosol remains to be elucidated. 
4.2.4 Implications for the cell-free protein synthesis of eukaryotic 
proteins  
 To date, the production of sufficient amounts of mutant forms of actin 
for biochemical and structural analysis is very limited. Purification of 
biochemical amounts of mutant actins from eukaryotic systems amenable to 
recombinant protein expression, such as S. cerevisiae, has been described for 
mutants that are compatible with cell viability (Kron et al., 1992). Expression of 
actin-mutants carrying more drastic mutations, such as sub-domain substitutions 
with parts of the prokaryotic actin homologue MreB (Carballido-Lopez, 2006), 
results in cellular toxicity and/or aggregation of the expressed protein in yeast 
(C. M. Kaiser and J. M. Barral, unpublished observations). The system described 
here, however, may circumvent these limitations and allow robust production of 
actin mutants for their subsequent characterization. Similar to actin, the 
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cytoskeletal protein tubulin is a major substrate of TRiC (Yaffe et al., 1992; Melki 
et al., 1993). Unlike actin, however, tubulin folding and polymerization into 
microtubules requires several cytosolic cofactors in addition to TRiC (Cowan and 
Lewis, 2001). Experiments, similar to those reported here for actin, may allow the 
assessment of the minimal requirements for de novo folding and assembly of 
tubulin. 
 The compatibility between a bacterial translation system and a 
eukaryotic chaperone, as described for actin and TRiC, may represent a more 
general solution for the efficient production of correctly folded eukaryotic 
proteins that otherwise misfold or lead to cellular toxicity upon recombinant 
expression. 
4.3 TRiC-mediated folding of actin fusion proteins too large 
for entire encapsulation in the chaperonin cavity 
The evolution of eukaryotes is characterized by an enormous increase in 
the diversity and structural complexity of proteins. Recent comparative studies of 
the proteomes from different organisms revealed that approximately two-thirds 
of eukaryotic proteins consist of two or more domains (Apic et al., 2001; Ekman 
et al., 2005). This observation was explained by the evolution of complex 
genomes where random gene fusion events led to the generation of modular 
polypeptides with novel functions (Kummerfeld and Teichmann, 2005). Previous 
work has demonstrated that during translation on eukaryotic ribosomes, 
modular proteins fold extremely efficient by sequential and co-translational 
folding of their individual domains (Netzer and Hartl, 1997). However, modular 
proteins whose domains are constructed of discontiguous sequence segments, 
including actin, are unable to form native tertiary structures co-translationally. 
Folding of these proteins was suggested to depend strongly on the shielding 
function provided by the TRiC cavity (Netzer and Hartl, 1998). Whether TRiC-
assisted folding requires the entire encapsulation of the substrate protein inside 
the folding cage (Meyer et al., 2003) or whether the chaperonin also facilitates 
sequential and domain-wise folding of modular proteins which cannot be 
accommodated as a whole and would therefore partially extend through a gap in 
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the apical domains  (Frydman et al., 1994; Ditzel et al., 1998; Thulasiraman et al., 
1999), remained to be elucidated. 
4.3.1 Localization of actin fusion proteins in yeast 
The yeast actin cytoskeleton consists of two types of F-actin containing 
structures: cortical patches, which are localized to sites of cell surface growth; 
and cables, running through the cytoplasm along the mother-bud axis. 
Visualization of these filamentous actin structures was accomplished in fixed 
cells using fluorescently labeled phalloidin or actin antibodies, respectively 
(Adams and Pringle, 1984; Kilmartin and Adams, 1984; Novick and Botstein, 
1985). In recent years, the generation of recombinant fusion proteins consisting of 
actin or actin-binding proteins and GFP provided the opportunity to perform live 
cell image analyses, revealing both actin structures to be motile and highly 
dynamic (Doyle and Botstein, 1996; Carlsson et al., 2002; Yang and Pon, 2002). 
Concurrently, these findings deomonstrated that actin fused to GFP is able to 
acquire its native three-dimensional conformation since it readily integrates into 
F-actin structures (Doyle and Botstein, 1996). Furthermore, by fusing GFP to 
either side of a robustly folding protein Chang et al. recently showed that 
expression of these proteins in S. cerevisiae resulted in correctly folded domains, 
corroborating the enhanced capacity of the eukaryotic system for co-translational 
folding (Chang et al., 2005). 
Based on these observations, actin fusion proteins, varying in size and 
position of the attached fluorescent proteins, were generated and their folding 
ability and proper integration into the yeast actin cytoskeleton investigated 
(Figure 27). Expression of the actin variants AG and GA in exponentially 
growing yeast cells produced a robust GFP-fluorescence signal that localized 
exclusively to actin cortical patches and had no obvious effect on cell growth or 
the overall organization of the actin cytoskeleton (Figure 27B). The appropriate 
integration of AG and GA into cortical patches was additionally confirmed by 
the subsequent visualization of F-actin containing cellular structures using rPh. 
Strikingly, the GFP signal of both fusion proteins co-localized with rPh-stained 
patches, asymmetrically situated in the bud and at the mother-bud neck, but was 
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not detectable in cables aligning along the mother-bud axis. These findings are in 
good agreement to the data obtained upon live cell image analyses of yeast cells 
expressing C-terminally GFP-tagged actin (Doyle and Botstein, 1996). There, AG 
was demonstrated to properly assemble into cortical patches, indicative of actin 
having acquired its native state, unimpaired by supposable constraints associated 
with the consecutive folding of the GFP moiety. Furthermore, similar to the work 
presented here, AG incorporation in actin cables was not detectable. 
Interestingly, expression of the ~100 kDa sized actin double fusion 
proteins did not result in the localization of these proteins to any actin 
cytoskeletal structures. Instead, the fluorescence signal of both mCherry and GFP 
in CAG showed a diffuse cytosolic distribution, comparable to that obtained for 
the expression of GFP alone (Figures 27B and 27C). In contrast to AG and GA, the 
bilateral occupation of actin with fluorescent proteins might lead to sterical 
hindrances which possibly interfere with the assembly process of G-actin into 
actin filaments. This hypothesis is further supported by the actin crystal 
structure, in which both the N- and C-terminus are located in close proximity in 
subdomain 1 of the small domain (Kabsch et al., 1990). Hence, fusion of a second 
fluorescent protein to actin may not only hinder interactions among actin 
monomers in order to from F-actin,  but may also affect the association with actin 
binding proteins, such as the Arp2/3 complex and profilin (Mockrin and Korn, 
1980; Mullins et al., 1998), which are involved in the formation of cortical patches 
or the acceleration of nucleotide exchange on G-actin, respectively. Importantly, 
full-length expression of all actin fusion proteins investigated was confirmed by 
western blot analysis (Figure 28). Therefore, fluorescence solely resulting from 
mCherry or GFP upon proteolytical cleavage from the double fusion and/or 
premature translation termination after synthesis of the N-terminal fluorescent 
partner is considered to be unlikely. 
Together, these results suggest that actin fused to GFP is capable of 
folding into its native state, as demonstrated by the localization to cortical 
patches, regardless of its actual position within the fusion protein. Expression of 
the large multi-domain actin double fusion proteins, however, did not result in 
the integration of these proteins into yeast cytoskeletal structures. Nevertheless, 
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since mCherry and GFP were shown to be correctly folded in CAG, assessed by 
their fluorescence signal (Figures 27C and 29), actin in between these proteins is 
likely to be also native. The exact folding state of actin in various fusion proteins 
will be discussed in detail in the following section. 
4.3.2 Domain-wise folding in the eukaryotic cytosol 
GFP fluorescence was recently utilized as a reliable indicator to monitor 
folding of proteins to which it was recombinantly fused (Waldo et al., 1999; 
Chang et al., 2005). In vitro refolding as well as de novo folding experiments of 
GFP fusion proteins in E. coli and S. cerevisiae suggested that, if the GFP domain 
is not able to acquire its β-barrel structure within a time-frame compatible with 
the synthesis of the partner domain, it may interfere with the folding of the latter 
(Chang et al., 2005). Notably, in contrast to the bacterial cytosol, folding of 
modular GFP-fusions in yeast was highly efficient. This phenomenon was 
explained by the existence of a sequential and co-translational folding 
mechanism in the eukaryotic cytosol (Netzer and Hartl, 1997), thus, reducing the 
interference between domains during folding. 
Since actin folding is strictly dependent on the chaperonin TRiC, and 
correctly folded fluorescent proteins are assessable by monitoring their 
characteristic fluorescence, fusion of these proteins to actin provided an ideal 
means to investigate a suggested role of TRiC in domain-wise protein folding 
(Frydman et al., 1994; Thulasiraman et al., 1999). First evidence for TRiC 
supporting such a mechanism came from the observation that AG and GA 
properly integrated into yeast cortical patches (Figure 27B). Furthermore, upon 
in vitro translation in RRL, both proteins formed a stable complex with DNase I 
(Figure 32A), indicative of correctly folded actin. As AG and GA exceed the 
upper size limit of the chaperonin cavity by ~20 kDa (Ditzel et al., 1998), it might 
well be that only the actin domain is enclosed inside the folding cage, while the 
GFP-moiety remains outside during folding. Such an action is mechanistically 
conceivable, as group II chaperonins lack a GroES-like cofactor and lid closure 
proceeds through the conversion of flexible, solvent exposed apical protrusions 
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into an ordered arrangement of β-strands following an iris-like mechanism 
(Llorca et al., 2001). 
In the case of AG and GA, TRiC could in principle interact with actin 
from at least one side of the fusion protein. To investigate whether the 
chaperonin was also able to facilitate actin folding when both termini of the 
protein were occupied by fluorescent fusion partners, the double-fusions BAG, 
BTAG, and BTAG-G150P were translated in RRL. Upon protein synthesis and 
subsequent inhibition of TRiC function by depletion of ATP (Figure 31), the 
translation products were subjected to TEV protease treatment. Thereby, BTAG 
and BTAG-G150P, containing a TEV-cleavage site in the linker region between 
BFP and actin, efficiently released their N-terminal BFP-moiety (Figures 32B and 
32C). Subsequently, the folding state of actin in the resulting truncations AG and 
AG-G150P as well as full-length BAG was monitored by its ability to form a 
stable complex with DNase I. In accordance to the inability of actin 
double-fusions to properly integrate into cortical patches in vivo (Figure 27; 4.3.1), 
DNase I-binding of unprocessed BAG occurred only at background levels, 
similar to those observed for the control protein BG (Figure 32C). These findings 
suggest that either TRiC is simply not able to fold actin when embedded between 
two proteins or that both fusion partners restrain actin in DNase I-binding due to 
steric hindrance in a defined actin region, known as the DNase I binding-loop 
(residues 39-51 in actin subdomain 2). An answer to these speculations was 
provided by the result obtained for AG, originating from the double-fusion 
BTAG. Upon secession of BFP from BTAG, AG was freed from steric hindrances 
and bound to DNase I with 5-fold higher efficiency when compared to BAG 
(Figures 32B and 32C). In contrast, AG-G150P, containing an actin mutant with 
impaired folding properties, did not bind to DNase I above background level 
(Figure 32C). Thus, actin in BTAG must have acquired its native state prior to 
protease treatment, as TRiC function and therefore folding was abolished by 
depletion of ATP before TEV cleavage. Essentially the same result was obtained 
when BTAG and BTAG-G150P were expressed in yeast ∆reg cells (Figure 33). In 
turn, the amount of AG (originating from BTAG) precipitated by DNase I-bead 
was ~5-fold higher compared to AG-G150P originating from BTAG-G150P. 
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Together, these data strongly support the notion that TRiC is indeed able to assist 
in the domain-wise folding of large multi-domain proteins which cannot be 
accommodated in the chaperonin cavity as a whole. 
4.3.3 Model for TRiC-assisted folding of large modular proteins 
Lately, ATP-induced lid closure and subsequent confinement of actin 
inside TRiC was proposed to be essential for the production of native actin 
(Meyer et al., 2003). However, TRiC-mediated folding of large modular proteins 
was suggested to occur in a domain-wise manner outside of the cavity, by a 
mechanism which does not require encapsulation of the whole substrate protein 
(Thulasiraman et al., 1999; Spiess et al., 2004; Young et al., 2004). The exact 
modus operandi of how and when TRiC interacts with its putative substrate 
proteins and which additional chaperones might be involved in this process is 
still controversial (Farr et al., 1997; Siegers et al., 1999; Etchells et al., 2005). 
In this work, various actin fusion proteins were utilized to investigate 
the possibility of TRiC being able to efficiently bind to and fold actin when fused 
to either an N-/C-terminal fusion partner or both. The data obtained are 
summarized in a working model, illustrating how TRiC might facilitate the 
de novo folding of multi-domain proteins during protein synthesis in the 
eukaryotic cytosol (Figure 35). Considering an artificial three-domain protein, 
such as BAG, only the intermediate actin domain would require TRiC for folding. 
Thus, folding of the N- and C-terminal fluorescent proteins is likely to occur 
spontaneously during translation and without further assistance of chaperones 
(Figure 35, (1), (2), and (6)). On the other hand, proteins consisting of 
discontiguous or structurally unstable protein domains, such as actin, are 
strongly dependent on the productive interaction with TRiC and can only fold, 
once their sequence has completely emerged from the ribosome (Netzer and 
Hartl, 1998). In principle, TRiC binding to the growing actin chain in BAG is 
virtually feasible at two stages. Firstly, co-translationally (Figure 35, (5)), as 
suggested by recent cross-linking studies (McCallum et al., 2000; Etchells et al., 
2005), while the remainder of the fusion protein is still synthesized. Secondly, 
post-translationally (Figure 35, (3)), upon completion of synthesis and 
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subsequent transfer of BAG to the chaperonin. The latter might be accomplished 
by a so-called “folding compartment”, closely coupled to the translation 
machinery (Siegers et al., 1999). However, the final conversion of actin into its 
native state is considered to occur by the sole encapsulation of the actin domain, 
while the rest of the BAG fusion remains outside and extends through a gap in 
the apical domains (Figure 35, (3) and (5)). This assumption is consistent with the 
determined size of the folding cavity of group II chaperonins which can only 
accommodate proteins with less than 50 kDa (Ditzel et al., 1998). 
 
 
 
Figure 35: TRiC-mediated domain-wise protein folding in the eukaryotic cytosol, a 
working model. 
 
The individual domains of the translating polypeptide chain are shown in blue (BFP), red 
(actin), and green (GFP), with the folded domains represented by circles and squares. 
The ribosome and TRiC are represented in gray and black, respectively. For reasons of 
simplicity, ribosome-associated and cytosolic chaperones were omitted. (1, 2) Upon 
translation, the N- and C-terminal domains fold spontaneously and without assistance of 
chaperones. (3, 4) Specific encapsulation and post-translational folding of the TRiC-
dependent actin domain, while BFP and GFP remain outside of the chaperonin. (5) 
During translation, TRiC interacts co-translationally with the intermediate actin domain 
and facilitates its folding. (6) Upon chain release from the chaperonin and completion of 
protein synthesis, folding of the C-terminal GFP-moiety occurs spontaneously. 
 
Interestingly, the above mentioned model bears a striking resemblance 
to the degradation of proteins facilitated by the 20S proteasome (Pickart and 
Cohen, 2004). In analogy to the enclosure of protein domains for TRiC-assisted 
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folding, the multi-chambered proteasome complex uses a similar mechanism to 
catalyze the endoproteolytical cleavage of disordered polypeptide loops 
embedded between stable proteins segments (Liu et al., 2003). 
4.4 Perspective 
At present, the genomes of many organisms have been sequenced. 
Following this success, the detailed characterization of previously unknown 
proteins requires a highly efficient and reliable protein expression system able to 
generate versatile native proteins. Since chemical protein synthesis is not 
practicable for the production of long polypeptides, and in vivo expression is only 
applicable to proteins that do not affect host cell physiology, cell-free translation 
systems overcoming both limitations are becoming increasingly popular (Spirin, 
2004; Endo and Sawasaki, 2006). Up to now, in vitro protein synthesis systems are 
available from several organisms (Jackson et al., 2004). 
In this study, cell-free translation systems have proven to be an ideal 
tool for addressing a multitude of highly interesting aspects in the field of 
biochemistry and biotechnology. Besides the insights gained into existing 
differences in the coupling of translation and folding of multi-domain proteins in 
the bacterial and eukaryotic cytosol, TRiC was found to be able to facilitate 
domain-wise folding of large modular proteins which do not entirely fit into the 
folding cavity. Additionally, the compatibility between bacterial translation 
systems and eukaryotic chaperones, as described for actin and TRiC, may 
provide a more general solution for the efficient production of correctly folded 
eukaryotic proteins (Baneyx and Mujacic, 2004). 
Notably, in parallel to this work, first promising attempts were made to 
utilize cell-free translation systems to determine the structure of large oligomeric 
complexes. Following subunit synthesis and in vitro assembly, the multi-subunit 
complexes were subjected to cryo-EM microscopy analysis without preceding 
purification. In the future, such a strategy may prove especially useful in gaining 
fast access to medium resolution structures of short lived or semi-stable 
macromolecular assemblies. 
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6 Abbreviations 
Units are expressed according to the international system of units (SI), including 
outside units accepted for use with the SI. Amino acids are abbreviated with their 
one or three letter symbols. 
 
ADP    adenosine 5'-diphosphate 
AG    actin-GFP fusion protein (→ GFP) 
ATP    adenosine 5'-triphosphate 
AU    arbitrary unit 
bp     base pair 
BAG    BFP-actin-GFP fusion protein (→ BFP; → GFP) 
BFP    blue fluorescent protein 
BG     BFP-GFP fusion protein (→ BFP; → GFP) 
β-gal    β-galactosidase 
BTAG    BAG containing a TEV-cleavage site (→ BAG; → TEV) 
CAG    mCherry-actin-GFP fusion protein (→ GFP) 
Cα     alpha carbon atom 
CCT    chaperonin containing TCP1 (→ TRiC) 
CDTA    trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid 
CECF    continuous exchange cell-free 
CG    mCherry-GFP fusion protein (→ GFP) 
CIP    calf intestinal alkaline phosphatase 
cryo-EM   cryoelectron microscopy 
C-terminus  carboxy-terminus 
Da     Dalton 
DMSO   dimethylsulfoxid 
DNA    deoxyribonucleic acid 
DNase I   deoxyribonuclease I 
dNTP    didesoxy-nucleoside triphosphate 
DTT    dithiothreitol 
E     GrpE (bacterial nucleotide exchange factor of DnaK; → K) 
ECL    enhance chemiluminescence 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
EGTA    glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid 
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EL     GroEL (bacterial Hsp60 chaperonin) 
ES     GroES (bacterial Hsp10 co-chaperonin) 
F-actin   filamentous actin  
FL     firefly luciferase 
FPLC    fast performance liquid chromatography 
g     acceleration of gravity, 9.81 m/s2 
GA    GFP-actin fusion protein (→ GFP) 
G-actin   monomeric actin 
GdnHCl   guanidinium hydrochloride 
GFP    green fluorescent protein 
GimC    genes involved in microtubule biogenesis complex (→ PFD) 
HEPES   N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid 
HMW    high molecular weight 
HRP    horseradish peroxidase  
Hsp    heat shock proteins 
HU    high urea 
HY    high yield 
IB     inclusion body 
IPTG    isopropyl-β-D-1-thiogalactopyranoside 
J     DnaJ (bacterial Hsp40 chaperone) 
K     DnaK (bacterial Hsp70 chaperone) 
KJE    DnaK, DnaJ, and GrpE (→ E; → J; → K)  
LB     Luria Bertani 
LMW    low molecular weight 
mCherry   monomeric Cherry 
MOPS    3-(N-morpholino)propanesulfonic acid 
MW    molecular weight 
MWCO   MW cut-off (→ MW) 
mRNA   messenger RNA 
NAC     nascent chain-associated complex 
Ni-NTA   nickel-nitrilotriacetic acid 
N-terminus  amino-terminus 
OD    optical density 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate-buffered saline 
PCR    polymerase chain reaction 
PDI    protein disulfide isomerase 
PEG    polyethylene glycol 
PFD    prefoldin (→ GimC) 
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pH  reverse logarithm of relative hydrogen proton (H+) 
concentration 
Pi     inorganic phosphate 
PMSF    phenylmethylsulfonyl fluoride 
PPIase    peptidyl-prolyl cis/trans isomerase 
PK     Proteinase K 
RAC     ribosome-associate complex  
RNA    ribonucleic acid 
RNase A   ribonuclease A 
rPh    rhodamine-phalloidin 
RRL    rabbit reticulocyte lysate 
RT     room temperature 
RTS    rapid translation system 
[35S]    sulfur isotope 
S30    soluble cell lysate fraction when centrifuged at 30,000 g 
SC     synthetic complete 
S. cerevisiae  Saccharomyces cerevisiae 
SDS    sodiumdodecylsulfate 
sHsp    small heat shock protein 
TAE    Tris-acetate-EDTA (→ EDTA; → Tris) 
TBS    Tris-buffered saline (→ Tris) 
TBS-T    TBS containing Tween20 (→ TBS; → Tween20) 
TCA    trichloroacetic acid 
TE     Tris-EDTA (→ EDTA; → Tris) 
TEMED   N,N,N',N'-tetramethylethylenediamine 
TEV    Tobacco Etch Virus 
TF     trigger factor 
TFFRK/AAA   TF with residues 44FRK46 replaced by alanines (→ TF) 
TNT    coupled transcription and translation 
TRiC    TCP1 ring complex (→ CCT) 
Tris    tris(hydroxymethyl)aminomethane 
TritonX-100  octyl phenol ethoxylate 
Tween20   polyoxyethylen-sorbitan-monolaurate 
UV/VIS   ultraviolet/visible 
VHL    Von Hippel-Lindau tumor suppressor protein 
v/v    volume/volume 
WG    wheat germ 
w/v    weight/volume 
YPD    medium containing yeast extract, peptone, and dextrose 
